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Abstract
It has become increasingly apparent that, besides targeting proteins for proteasomal 
degradation, ubiquitination has a role in regulating the trafficking of proteins between 
intracellular compartments. One well-documented example of this is the nitrogen- 
regulated trafficking of the general amino acid permease. Gap Ip, through the endosomal 
system of the yeast Saccharomyces cerevisiae. It has previously been noted that the 
nitrogen-regulated trafficking of Gap Ip bears similarity to the insulin-regulated trafficking 
of the glucose transporter, GLUT4, in fat and muscle cells. Both proteins move from an 
intracellular location to the cell surface in response to an extrinsic trigger. In this thesis, I 
show that human GLUT4 is subject to nitrogen-regulated trafficking when expressed in 
yeast. Furthermore, I demonstrate that, like Gap Ip trafficking in yeast, the regulated 
trafficking of GLUT4, both in yeast and in the insulin-sensitive cell line 3T3-L1 
adipocytes, requires the ubiquitination of the transporter. A model in which ubiquitination 
is required for the sorting of GLUT4 into the insulin-responsive pool, from where it is 
mobilised to the cell surface in response to insulin, is presented and discussed.
Table o f Contents
Abbreviations................................................................................................................................. 1
Chapter 1 : Introduction ..........................................................................................................6
1.1. Type-2 Diabetes........................................................................................................... 6
1.2. Insulin Action................................................................................................................ 8
1.3. GLUT4......................................................................................................................... 11
1.4. Intracellulai' trafficking of GLUT4........................................................................... 13
1.5. GLUT4 T argeting Motifs...........................................................................................15
1.6. A model for GLUT4 transport..................................................................................17
1.7. Yeast as a system to study GLUT4 trafficking...................................................... 19
1.8. The general amino acid permease, Gap Ip ...............................................................22
1.9. Ubiquitination.............................................................................................................25
1.9a. The role of ubiquitin in protein transport................................................................ 27
1.9b. Ubiquitin Binding Domains..................................................................................... 27
1.9c. Ubiquitination as a signal in regulated traffic........................................................ 28
1.10. A role for ubiquitination in the insulin-regulated trafficking of GLUT4? 29
1.11. Aims of project...........................................................................................................31
Chapter!: Materials and Methods........................................................................................... 33
2.1. M aterials......................................................................................................................33
2.1.1. General reagents and enzymes.......................................................................... 33
2.1.2. Bacterial and yeast strains..................................................................................33
2.1.3. M edia....................................................................................................................33
2.1.4. Antibodies............................................................................................................34
2.2. M ethods.......................................................................................................................34
2.2.1. DNA manipulations............................................................................................ 34
2.2.2. Plasmid construction...........................................................................................36
2.2.3. DNA sequencing..................................................................................................38
2.2.4. Transformation of E. coll and S. cerevisiae....................................................39
2.2.5. APNE assay..........................................................................................................39
2.2.6. Isolation of yeast chromosomal D N A ...........................................   39
2.2.7. Plasmid rescue from yeast..................................................................................40
2.2.8. Tissue culture techniques................................................................................... 40
2,2,8a. Cell culture of 3T3-L1 murine fibroblasts and adipocytes..............................40
2.2.8b. Cell culture of Plat-E cells .................................................................................40
2.2.8c. Preparation of virus using Plat-E cells..............................................................41
2.2.8 d. Infection of fibroblasts with retrovirus.............................................................41
2.2.9. Electrophoretic separation of proteins..............................................................41
2.2.10. Transfer of proteins onto nitrocellulose............................................................42
2.2.11. Immunoblot analysis........................................................................................... 42
2.2.12. Preparation of yeast cell extracts for immunoblot analysis........................... 42
2.2.13. Microscopic Analysis..........................................................................................43
2.2.13a. Direct fluorescence with yeast.......................................................................... 43
2.2.13b. Indirect immunofluorescence with yeast......................................................... 43
2.2.13c. Indirect immunofluorescence with 3T3-L1 adipocytes.................................. 44
2.2.14. Immunoprécipitation from yeast cell lysate..................................................... 45
2.2.15. Preparation of 3T3-L1 adipocytes lysate..........................................................46
2.2.16. Immunoprécipitation from 3T3-L1 adipocytes lysate....................................46
2.2.17. GST fusion protein expression and purification..............................................47
2.2.18. GST fusion protein pull down assays from adipocyte cell lysate................. 47
2.2.19. GST fusion protein pull down assays from yeast cell lysate.........................48
2.2.20. Subcellular membrane fractionation of 3T3-L1 adipocytes........................... 49
Chapter 3: Investigation ofG LU T4 trafficking in yeast Saccharomyces cerevisiae. .58
3.1. Introduction...................................................................................................................58
3.2. Expression of hGLUT4 in yeast Saccharomyces cerevisiae................................... 58
3.3. hGLUT4 is stabilised in yeast cells lacking active vacuolar proteases.................. 64
3.4. hGLUT4 localises to the Golgi in yeast.....................................................................6 6
3.5. hGLUT4 accumulates in the “class E” compartment in vps27 cells...................... 67
3.6. hGLUT4 is stabilised by growth on proline-containing media............................... 69
3.7. Chapter summary.........................................................................................................71
Chapter 4: Examination o f  the ubiquitination o f GLUT4............................................... 74
4.1. Introduction...................................................................................................................74
4.2. hGLUT4 is ubiquitinated in yeast...............................................................................74
4.3. GLUT4 is ubiquitinated in adipocytes....................................................................... 82
4.4. Mapping the ubiquitination sites of hGLUT4........................................................... 8 6
4.5. Chapter summary......................................................................................................... 90
Chapter 5: Analysis o f  the role o f  ubiquitination in GLÜT4 trafficking.......................91
5.1. Introduction...............................................   92
5.2. Ubiquitination of hGLUT4 in yeast targets it for degradation by
vacuolar proteases...................................................................................................... 92
5.3. Expression of recombinant GLUT4 proteins in 3T3-L1 adipocytes...................... 96
5.4. Ubiquitination of GLUT4 is required for its exit from the Syntaxinl6
positive compaitment into insulin responsive GSVs.............................................. 98
5.5. GGAs are required for ubiquitin-dependent hGLUT4 trafficking........................110
5.6. Chapter summary........................................................................................................116
Chapter 6: Final Discussion ............................................................................................... 117
Future W ork............................................................................................................ 125
Bibliography............................................................................................................................... 126
I
' .
■N:.
1
List o f Tables
Table 2.1. E.coli and S,cerevisiae strains used in this study............................................... 50
Table 2.2. Oligonucleotides used in this study....................................   53
Table 2.3. Plasmids used in this study...................................................................................56
List o f Figures
Figure 1.1. Schematic diagram showing factors that maintain blood sugar
homeostasis ...................................................................................................... 7
Figure 1.2. GLUT4 translocation in 3T3-L1 adipocytes.....................................................10
Figure 1.3. Targeting motifs of GLUT4 and Gap I p ...........................................................11
Figure 1.4. A model depicting the insulin-regulated trafficking of GLUT4....................18
Figure 1.5. Comparison of insulin-regulated GLUT4 trafficking in adipocytes (a)
with nitrogen-regulated Gap Ip trafficking in S.cerevisiae (b)......................20
Figure 1.6 . The C-terminal tail of Gap Ip directs GLUT4 to the plasma membrane
in an insulin-dependent manner........................................................................ 2 1
Figure 1.7. The ubiquitination pathway................................................................................26
Figure 1.8. Domains and interactions of a typical GGA protein.......................................30
Figure 3.1. Schematic of pWTG4 (pRM2) construction.................................................... 60
Figure 3.2. hGLUT4 primer sequences................................................................................61
Figure 3.3. Expression of hGLUT4 in SF838-9Da cells....................................................63
Figure 3.4. hGLUT4 expression increases in relation to CuSO^in media........................64
Figure 3.5. hGLUT4 is stabilised in yeast lacking active vacuolar proteases................. 65
Figure 3.6. hGLUT4 colocalises with Kex2p (TGN) in yeast........................................... 67
Figure 3.7. hGLUT4 accumulates in the class E compartment in vps27A cells..............69
Figure 3.8. hGLUT4 is stabilised by growth on proline-containing media......................71
Figure 4.1. hGLUT4 is conjugated to HA-tagged ubiquitin in yeast................................75
Figure 4.2. Schematic diagram of the predicted membrane topology of GLUT4
indicating the positions of cytoplasmic lysine residues................................. 76
Figure 4.3 hGLUT4 is conjugated to endogenous ubiquitin in yeast...............................78
Figure 4.4. SDS-PAGE protein assay for immobilised GST fusion proteins.................. 80
Figure 4.5. hGLUT4 interacts with GST-UBA in a GST pull down assay......................81
Figure 4.6. GLUT4 is ubiquitinated in 3T3-L1 adipocytes................................................83
Figure 4.7. GST pull down with adipocytes expressing HA-GLUT4 or
HA-GLUT4-7K/R.............................................................................................. 85
Figure 4.8. Investigation into the ubiquitination of GLUT4 lysine ‘knock-out’
mutants.................................................................................................................87
Figure 4.9. Investigation into the ubiquitination of GLUT4 lysine ‘knock-in’
mutants.................................................................................................................89
Figure 5.1. hGLUT4-7K/R is stabilised in PEP4 cells.......................................................93
Figure 5.2. hGLUT4~7K/R-HAUb is degraded by vacuolar proteases regardless
of the nitr ogen source.........................................................................................95
Figure 5.3. HA-GLUT4-7K/R fails to translocate to the plasma membrane in
response to insulin............................................................................................ 1 0 0
Figure 5.4. HA-GLUT4-7K7R fails to translocate to the plasma membrane in
response to insulin............................................................................................ 1 0 2
Figure 5.5. GLUT4 is ubiquitinated in 3T3-L1 adipocytes with and without
insulin stimulation............................................................................................103
Figure 5.6. HA-GLUT4-7K/R and GLUT4-7K/R-HAUb co-locahse with the
Syntaxinl6  positive compartment...................................................................105
Figure 5.7. HA-GLUT4-7K/R and GLUT4-7K/R-HAUb do not colocalise
with E E A l.....................   107
Figure 5.8. GGAs are required for ubiquitin-dependent hGLUT4 trafficking.............. I l l
Figure 5.9. Immunoprécipitation to determine an interaction between hGLUT4
and HA-tagged GGA2, in yeast................................................................... . 113
ÏI.
5"
Figure 5.10. Immunoprécipitation to determine an interaction between endogenous
GLUT4 and GGA2, in adipocytes.................................................................. 114
Figure 5.11. GST pull down assays to determine an interaction between endogenous
GLUT4 and GGA proteins, in adipocytes..................................................... 115
Acknowledgements
And to my labmate-in-crime, Lindsay Cog, thank-you for all of the ‘time-out’ Tinderbox 
trips, for introducing me to circwits, (for the singing, for the confidence boosts -  BTW 
these two can stop now), and for being a best bud.
Finally, a huge loving thanks to my parental unit (and Iona) for the unending support, 
encouragement and for all of the reassurance that ‘I ’ll get there’.
TA
Firstly, I would like to thank my supervisor Dr. Nia Bryant for all of the support, advice 
and encouragement given throughout my PhD, but particularly for putting up with my 
occasional ‘freak out’ moments during the ‘writing up’ stage. :-) ;-) :-)
sI would also like to thank Prof. David James and the rest of the James lab for making my time in Sydney so enjoyable, but would particulaiiy like to thank Jacky Stoeckli for all of 
her help and for taking me tlnough some of the techniques I used while there.
fI thank all of the members of Lab 241 for any helpful comments, for making work in the 
lab so enjoyable, and of course for the essential stress-relief (pub) sessions. I’d particularly 
like to mention my colleagues, and now good friends, Jenny and Fiona, who have taught 
me the value of enjoying things in moderation, especially with respect to red wine.
I ’d also like to thank the Bryant lab, Maz, Scott, Curly Chris and Tall Chris for all of the |
giggling and craziness and dress-up Fridays.
I
Abbreviations
m
approximately 
ABC ATP"binding cassette
ADP adenosine 5 ’ diphosphate
ALP alkaline phosphatase
AP adaptor protein complex
APNE ALacetyl-DL-phenylalanine P-naphthyl ester
AQP2 aquaporin-2
ARE ADP ribosylation factor
AS 160 Akt substrate of 160kDa
ATP adenosine 5’ triphosphate
A VP arginine vasopressin
P-Me p-mercaptoethanol
BSA bovine serum albumin
°C degrees Celsius
CD-MPR cation-dependent mannose-6 -phosphate receptor
CEN centromeric
CI-MPR cation-independent mannose-6 -phosphate receptor
cm centimetre
CPY carboxypeptidase Y
C-terminal carboxyl terminal
CUSO4  copper sulphate
Cu-MT copper metallothionein
ddHzO double distilled water
DMEM Dulbecco’s modified Eagle’s medium
DMF dimethyl formamide
DMSO dimethyl sulfoxide
DNA deoxyribonucleic acid
DTT dithiothreitol
DUB deubiquitinating enzyme
E l ubiquitin activating enzyme
E2 ubiquitin conjugating enzyme
E3 ubiquitin ligase
E.coli Escherichia coli
ECL enhanced chemiluminescence
EDTA ethylenediaminetetiaacetic acid
EEAl early endosome antigen 1
ER endoplasmic reticulum
FCS foetal calf serum
FM4-64 N-(3-triethylammoniumpropyl)-4-(p-diethylaminophenyl-hexatrienyl)
pyridium dibromide 
5-FOA 5 fluoroorotic acid
g gram
g gravitational force
Gap Ip general amino acid permease
GAE y-adaptin ear
GAT GGA and TOM
GFP aequorea victoria green fluorescent protein
GGA golgi localised y-ear containing ARE binding protein
J
GLUT glucose tr ansporter protein isoform
GSC GLUT4 storage compartment
GST glutathione S-transferase 1
GSV GLUT4 storage vesicle
H2 O 2 hydrogen peroxide ÿ
HA influenza hemagglutinin epitope tag
HCl hydrochloric acid Î3HDM high-density microsome
HECT homologous to the E6 -AP carboxyl terminus IHEPES 2- [4-(2-Hydroxyethyl)-1 -piperazinejethanesulfonic acid
HES HEPES, sucrose, EDTA
hr hour
HRP horseradish peroxidase 1
IgG immunoglobulin G
IP immunoprécipitation
IPTG isopropyl-p-D-thiogalactopyranoside
1RS insulin-receptor substrate 4kb kilobase of DNA -f:kDa kiloDalton (atomic mass)
KCl potassium chloride
K2 HPO4 dipotassium hydrogen orthophosphate
KH2 PO4 potassium dihydrogen orthophosphate
K Michaelis constants 1KOAc potassium acetate 1;
KOH potassium hydroxide 'A
KPi potassium phosphates buffer^ 3L litre
LDM low density microsome
LiOAc lithium acetate 3%
LSB laemmli sample buffer Î;n micro 'I
M molar
mA milliamp ■img milligram
MgCL magnesium chloride
MgS04 magnesium sulphate
M HCII major histocompatibility complex class 1 1  molecule
min minute 1MIU motif interacting with ubiquitin
ml millilitre
mM millimolar y. . .
M/N mitochondria/nuclei
MVB multivesicular body ?
n nano '1
NaCl sodium chloride '1Na2HP0 4 disodium hydrogen orthophosphate
NaOH sodium hydroxide
NCS newborn calf serum
NEM N-ethylmaleimide
NH4+ ammonium ■S
;
NIDD non-insulin dependent diabetes
NSF N-ethylmaleimide-sensitive factor
GDgoo optical density at 600nm
OMP orotine-5 ’ -monophosphate ;lORF open reading frame 3PBS phosphate-buffered saline 3PBST 0.1% (v/v) Tween-20 in PBS
PCR polymerase chain reaction SPFA paraformaldehydePI phosphatidylinositol
PIPES 1,4-Piperazinediethanesulfonic acid
PKB protein kinase B
PKC protein kinase C
PM plasma membrane ,
PMSF phenylmethylsulphonyl fluoride A
PTB phosphotyrosine binding ;=/PrA protein A
PVC prevacuolar compartment IRab-GAP Rab-GTPase activating protein
RING really interesting new gene 1RS-ALP retention sequence ALP
rpm revolutions per minute
S.cerevisiae Saccharomyces cerevisiae ■SD yeast synthetic media, dextrose
SDM site-directed mutagenesis ■
SDS sodium dodecyl sulphate ;?
SDS-PAGE sodium dodecyl sulphate polyaciylamide gel electrophoresis
SH2 Src-homology-2
SM yeast synthetic media, maltose
SNARE soluble NSF attachment protein receptor :
SOEingPCR splicing by overlap extension polymerase chain reaction 33
3
SUMO small ubiquitin-like modifier
TAE tris-acetic acid-EDTA
TE tris-EDTA 3TEMED N,N,N’,N’, - tetramethyl ethylene diamine -3:
TfR transferrin receptor 3TGN trans~Go\gi network
t-SNARE target-SNARE
TOM target of MyB
Tris 2-amino-2-(hydroxymethyl)-1,3-propanediol
Ub ubiquitin iUBA ubiquitin associated domain
Ubc ubiquitin conjugating enzyme IUBD ubiquitin-binding domains rUbl ubiquitin-like
UBM ubiquitin-binding motif sUEV ubc E2 varient JUIM ubiquitin-interacting motif
UTR untranslated region fVAMP2 vesicle associated membrane protein 3
■/LT
VHS Vps27, Hrs, Stam 3'VPS vacuolar protein sorting 1
v-SNARE vesicle-SNARE '1
v/v units volume per unit volume ‘V
iw/v units weight per unit volume
YPD yeast extract, peptone, dextrose
1YPM yeast extract, peptone, maltose
YT yeast extract, tiyptone, NaCl 3ZnF zinc-finger domain
■i
I
' J
Chapter 1: Introduction
Rebecca K McCann, 2007 Chapter One, 6
Chapter 1 : Introduction
In the disease state of diabetes, insulin fails to bring about the aforementioned decrease in 
plasma glucose levels (Saltiel and Kahn, 2001). Type-1 diabetes is characterised by the
I . l .  Type-2 Diabetes
Diabetes mellitus is characterised by persistent hyperglycemia (Saltiel and Kahn, 2001). In 
normal individuals, plasma glucose levels are maintained within a narrow range between 4 
and 7mM (Saltiel and Kahn, 2001). This level rises following a carbohydrate meal due to 
the absorption of glucose from the intestine. The pancreatic (3-cells sense this increase and 
respond by secreting insulin, which acts to lower the elevated plasma glucose levels in a 
number of ways, including, inhibiting hepatic glucose production, and increasing the 
uptake of glucose into fat and muscle tissues (Saltiel and Kahn, 2001). Conversely, under 
conditions of hypoglycemia, glucagons (secreted by the a-cells of the pancreas) raise 
plasma glucose levels by, for example, stimulating the breakdown of glycogen stored in 
the liver, and by activating gluconeogenesis (Figure 1.1 - taken from 
http://health.howstuffworks.com/diabetesl.htm).
I,
autoimmune-mediated destruction of pancreatic P-cell islets, leading to a failure of insulin 
production and/or insulin secretion (Zimmet et al., 2001). Type-1 diabetic sufferers must
therefore take exogenous insulin for survival (Zimmet et al., 2001). Type-2 diabetes (also 
known as non-insulin-dependent diabetes, NIDD) is characterised by an underlying insulin 
resistance; a failure of normally insulin sensitive tissues, such as muscle and adipose, to 
respond to insulin and increase their glucose uptake (Zimmet et al., 2001). 
Hyperinsulinaemia often precedes the development of Type 2 diabetes as a compensatory 
response to insulin resistance, indicating that insulin resistance, rather than impaired 
insulin secretion, is involved in the development of Type 2 diabetes (DeFronzo, 1992). 
This, combined with an oversupply of glucose from the liver, results in high circulating 
plasma glucose levels, causing many of the complications associated with Type-2 diabetes, 
including eye, nerve, kidney and heait disease (Brownlee, 2001).
S
7
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Figure 1.1. Schematic diagram showing factors that maintain blood sugar homeostasis
(taken from http://health.howstuffworks.com/diabetesl.htm)
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The recent explosive increase in the number of people, worldwide, diagnosed with diabetes 
has led to the conviction that diabetes mellitus is now one of the major threats to human 
health in the 2F ‘ century (Zimmet et ah, 2001). Globally, the incidence of diabetes has 
been estimated to increase from the present value of around 150 million, to 2 2 0  million by 
2010; and this figure has been projected to increase further to 300 million by 2025 (Amos 
et ah, 1997; King et ah, 1998).
Although Type-1 diabetes is more commonly detected among children, its frequency 
among the general population is relatively low when compared to Type-2 diabetes, which 
accounts for over 90% of diabetic cases globally (Zimmet et ah, 2001). Its increased 
prevalence among children and adolescents in various countries, including the UK, has 
underlined a serious new aspect of this epidemic, which is strongly associated with obesity 
and an inactive lifestyle (Zimmet et ah, 2001). As a multifactorial disease, understanding 
Type-2 diabetes is an overwhelming task. It is not clear, for example, why the disease is 
particularly pronounced in certain ethnic groups, such as. Pacific and Indian Ocean 
Islanders, groups in India and Australian Aboriginal communities (Zimmet et ah, 2001).
What is clear is that insulin-resistance and Type-2 diabetes are disease states that constitute
■ ■;an enormous healthcare problem in both the developed and developing world.
Understanding the actions of insulin will go a long way towards arming us to tackle this 
epidemic and this represents the overall goal of the work presented in this thesis.
1.2. Insulin Action
Following its secretion from the pancreas, insulin binds to its receptor on the surface of 
insulin-sensitive cells in its primary targets, skeletal muscle, adipose tissue and liver (Lee 
and Pilch, 1994; Sesti, 2006). The insulin receptor is a cell-surface heterotetrameric 
tyrosine kinase consisting of two extracellular a-subunits, which bind insulin, and two 
transmembrane {3-subunits with tyrosine kinase activity (Lee and Pilch, 1994). The 
binding of insulin to the a-subunits of the receptor induces the transphosphorylation of one 
of the {3-subunits by the other which, in turn, results in the increased catalytic activity of 
the kinase (Saltiel and Pessin, 2003; Watson et ah, 2004a). The activated insulin receptor 
catalyses the tyrosine phosphorylation of a number of intracellular substrates, including 
members of the insulin-receptor substrate (1RS) family, 1RS 1/2, She, Cbl and APS (Saltiel 
and Kahn, 2001). The phosphorylated tyrosines of these substrates act as docking sites for
3
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signalling proteins containing Src-homology-2 (SH2) or phosphotyrosine binding (PTB) 
domains (Czech and Corvera, 1999; Saltiel and Kahn, 2001), triggering a series of 
signalling cascades that regulate a plethora of cellular processes; including vesicle 
trafficking, protein synthesis, enzyme activation and inactivation, and gene expression 
(Czech and Coivera, 1999; Saltiel and Kahn, 2001). The 1RS family of proteins are the 
best-characterised intracellular substrates to be phosphorylated by the insulin receptor. 
They interact with a variety of SH2 domain containing effector molecules, but perhaps 
most importantly with the p85 regulatory subunit of phosphatidylinositol (PI) 3-kinase, 
which has an essential role in insulin-stimulated glucose uptake and GLUT4 translocation, 
likely through its downstream targets, the serine/threonine kinase Akt/protein kinase B 
(PKB) and the atypical protein kinase C (PKC) isoform PKC^ (Czech and Corvera, 1999). 
The exact mechanism(s) by which PKB and PKC^ regulate glucose transport remains 
undefined but one particulai' downstieam target of Akt/PKB, the protein Akt substrate of
160kDa (AS 160), has the potential in providing a functional link between the insulin
signalling cascade and glucose uptake (Watson and Pessin, 2006). AS 160 contains 
multiple Akt/PKB phosphorylation sites in addition to a Rab-GTPase activating protein 
(Rab-GAP) domain (Sano et al., 2003). As Rab proteins regulate several steps of 
membrane transport, such as vesicle budding, motility, tethering and fusion (Zerial and 
McBride, 2001), AS 160 could translate the information carried by the insulin-signalling 
cascade into molecular events that result in glucose uptake (Watson and Pessin, 2006).
One of the major consequences of insulin binding to its receptor on fat and muscle cells is 
the translocation of the facilitative glucose transporter 4 (GLUT4) from an intracellular 
store to the plasma membrane (reviewed in (Bryant et al., 2002) Figure 1.2). Following 
this translocation, GLUT4 proteins transport glucose across the plasma membrane 
according to a model of alternate conformation (Mueckler, 1994). This model predicts that 
the transporter exposes a single substrate binding site toward the outside of the cell. The 
binding of glucose to this site provokes a conformational change associated with transport, 
and releases glucose to the other side of the membrane (Mueckler, 1994). This allows the 
rapid movement of glucose, down its concentration gradient, from the interstitial fluid into 
the fat or muscle cell, thereby increasing the uptake of glucose into muscle and adipose 
tissue and reducing the levels of plasma glucose (Biyant et al., 2002).
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Insulin resistance is associated with insufficient recruitment of GLUT4 to the plasma 
membrane, despite there being normal GLUT4 expression (Bjomholm and Zierath, 2005). 
Therefore, understanding the precise molecular mechanisms that control the insulin- 
regulated translocation of GLUT4 is a major focus of current research. Understanding this 
process could provide specific therapeutic targets to help treat and/or prevent Type-2 
diabetes.
- Insulin + Insulin
Figure 1.2. GLUT4 translocation in 3T3-L1 adipocytes.
A confocal image o f 3T3-LI adipocytes either treated with lOOnM insulin fo r 15 mins 
(right panel), or not (left panel). GLUT4 localisation was visualised using an antibody 
that specifically recognizes the transporter and a secondary antibody conjugated to alexa- 
488 (green). Taken from (Bryant et al., 2002)).
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1.3. GLUT4
GLUT4 is a member of a large family of facilitative sugar transporters, known as GLUTs, 
which distribute glucose throughout various tissues of the body (Gould and Bell, 1990; 
Mueckler, 1994; Olson and Pessin, 1996). GLUTs are highly related proteins, each 
predicted to span the membrane twelve times with both their amino- and carboxyl- termini 
located in the cytosol (Figure 1.3) (Joost and Thorens, 2001).
A Sugar moiety
Plasma
membrane
Cytoplasm ^*^2
COOH
FQQI
□  GAPIp C-terminal 
residues 570-601 EVDLDLLKQEIAEEKAIMATKPRWYRIWNFWC
Figure 1.3. Targeting motifs ofGLUT4 and Gaplp
A) Schematic diagram o f the predicted membrane topology o f GLUT4 indicating o f the 
position o f the targeting motifs (highlighted in red) (discussed in Section 1.5 (adapted from  
(Bryant et al., 2002)). B) Sequence o f the C-terminal tail o f Gaplp (residues 570-601), 
indicating important targeting motifs (highlighted in red) (discussed in Section 1.8 
(adapted from (Hein and Andre, 1997)).
As facilitative carriers, GLUT proteins act as shuttles to transport glucose down its 
concentration gradient in an energy-independent manner (Watson et al., 2004a). There are
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thirteen known members of the GLUT family, each of which differ in their tissue 
distribution and kinetic properties as well as in their intracellular localization; together, 
these allow for the acute regulation of glucose transport into various body tissues under 
various physiological conditions (Gould and Bell, 1990; Mueckler, 1994; Olson and 
Pessin, 1996). For example, mammalian tissues such as the brain, which require a constant 
supply of glucose, contain glucose transporters with a high affinity for glucose that are 
constitutively targeted to the cell surface, a property specific to GLUTl and GLUT3 
(Thorens, 1996). High affinity transporters such as GLUTl, GLUT3 and GLUT4 have 
Michaelis constants (K, )^ well below the normal blood glucose concentration, and so their 
levels of cell surface expression determines the flux of glucose into the cell (Thorens,
1996). Certain tissues, such as muscle and adipose, require a more regulated glucose 
transport system and have adapted methods to rapidly up-regulate their glucose transport 
rates in response to an extracellular stimulus (Bryant et al., 2002). Such systems enable the 
body to conti'ol the large fluctuations in blood glucose levels after a meal and supply 
skeletal muscle with the extra glucose it requires during exercise (Biyant et al., 2002). 
GLUT4, primarily expressed in skeletal muscle and adipose tissue is responsible for the 
insulin-stimulated transport of glucose into fat and muscle cells and for the increased 
transport of glucose into skeletal muscle during exercise (Bryant et al., 2002; Olson and 
Pessin, 1996; Watson et al., 2004a). Under basal conditions, in the absence of insulin, 
GLUT4 is retained intracellularly, but is mobilised (translocated) to the plasma membrane 
in response to insulin (Bryant et al., 2002; Watson et al., 2004a). This translocation of 
GLUT4 to the plasma membrane accounts for the increased transport of glucose into fat 
and muscle cells in response to insulin (Bryant et al., 2002; Watson et al., 2004a).
Despite the fact that the intracellular trafficking of GLUT4 has been intensely studied for 
nearly 20 years, two fundamental questions remain lai'gely unanswered (Bryant et al., 
2002).
• How does insulin cause the release of GLUT4 from the intracellular compartment(s) 
that it occupies under basal conditions?
• How is GLUT4 sorted into the location from which it is released in response to 
insulin?
,3
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1.4. Intracellular trafficking o f GLUT4
As noted above (Section 1.3 and Figure 1.2) GLUT4 is almost entirely sequestered within 
intracellular compartments and excluded from the plasma membrane of adipocytes in the 
absence of insulin (reviewed in (Bryant et al., 2002)). GLUT4 has been localised to a 
variety of intracellular organelles, including, sorting and recycling endosomes, the trans- 
Golgi network (TGN), the plasma membrane and vesicles that mediate transport between 
these compartments. This range of intiacellular localisations for GLUT4 indicates a 
complex intracellular tiafficking itinerary that adds to the complexity surrounding the 
debate regarding GLUT4 intiacellular trafficking (reviewed in (Bryant et ah, 2002)).
Although GLUT4 clearly overlaps to some extent with endocytic markers such as the 
transferrin receptor (TfR), a significant proportion of GLUT4 does not co-localise with the 
TfR, suggesting that endosomes do not represent the major storage compaitment of 
GLUT4 in adipocytes (Livingstone et ah, 1996). Furthermore, detailed analysis of GLUT4 
traffic to and from the cell surface in non-insulin-stimulated adipocytes highlights that the 
rate of GLUT4 exocytosis is approximately 10-fold slower than that of the TfR (which is 
regarded as one of the most well studied constitutive recycling proteins in mammalian 
cells) (Holman et ah, 1994; Tanner and Lienhard, 1987). This indicates that GLUT4 must 
be selectively retained either within a more static secretory pool, or involved in a dynamic 
cycle that is distinct from recycling endosomes. In support of this, chemical ablation of 
endosomes upon the uptake of horseradish peroxidase (HRP) conjugated transferrin not 
only demonstrated that only 30-40% of intracellular GLUT4 is subject to ablation 
(Livingstone et ah, 1996; Martin et ah, 1996), but also that chemical ablation of endosomes 
does not affect the insulin-stimulated translocation of GLUT4 in adipocytes (Martin et al., 
1998).
Immunogold labelling of GLUT4 identified a proportion of GLUT4 (-13% of total 
GLUT4 disti'ibution in basal cells), that is present in the TGN of both muscle and fat cells 
(Slot et ah, 1991a; Slot et al,, 1991b). Furthermore, GLUT4 co-localises significantly with 
proteins known to traffic between the TGN and endosomes, including the cation-dependent 
mannose 6 -phosphate receptor (CD-MPR) (Martin et al., 2000b), the cation-independent 
mannose 6 -phosphate receptor (CI-MPR) (Kandior and Pilch, 1996b) and adaptor protein 
complex-1 (AP-1) (Martin et ah, 2000b). This suggests the possibility of a recycling
.7
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pathway for GLUT4 between the TGN and endosomes. Following internalised GLUT4 
from the adipocyte cell surface (Palacios et al., 2001) demonstrated that GLUT4 transits 
through endosomes (localising with the early endosomal marker EEAl at early time 
points) to the TGN (localising with the SNARE proteins syntaxin 6  and syntaxin 16 at later 
time points after internalisation) (Shewan et al., 2003).
As well as there being evidence to support the intracellular retention of GLUT4 within a 
recycling loop between endosomes and the TGN (discussed above), the use of both 
morphological and biochemical techniques identified a discrete portion of small (50nm 
diameter) GLUT4-containing vesicles (Hashiramoto and James, 2000; Kandror and Pilch, 
1996a; Ramm et al., 2000), supporting the presence of a pool of GLUT4-containing 
membranes, devoid of GLUTl and other non-insulin regulated cargo, that move directly to 
the plasma membrane in response to insulin. This population of, somewhat ill-defined, 
vesicles are highly responsive to insulin and are often referred to as GLUT4 storage 
vesicles (GSVs) (Rea and James, 1997). GSVs have been found to exclude other recycling 
proteins, such as the TfR and the CD-MPR, but importantly, do contain the v-SNARE, 
vesicle associated membrane protein (VAMP2) (Ramm et al., 2000), which has previously 
been shown to facilitate the exocytosis of synaptic vesicles to the plasma membrane. 
VAMP2 forms a functional SNARE complex with the t-SNAREs Syntaxin 4 and SNAP23 
(Kawanishi et al., 2000), which are highly enriched at the plasma membrane of fat and 
muscle cells (Thmmond and Pessin, 2001). Formation of a SNARE complex between 
VAMP2 present in GSVs and Syntaxin 4/SNAP23 at the cell surface likely results in the 
delivery of GLUT4 from GSVs to the plasma membrane.
It is worth noting that the two models of intracellular sequestration of GLUT4 discussed 
here are not mutually exclusive. In the absence of insulin, GSVs are likely to represent a 
dynamic storage pool of GLUT4, in constant movement between the TGN and endosomes 
(Bryant et al., 2002). Otherwise, the endosomal and TGN pools would become depleted of 
GLUT4; to account for this models in which, in the absence of insulin, GSVs constantly 
re-enter the endosomal system have been proposed (Bryant et al., 2002).
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1,5. GLUT4 Targeting Motifs
A  variety of studies have been focussed on the goal of identifying specific targeting motifs 
in the primary sequence of GLUT4. By examining the subcellular distribution of either 
GLUT4 point mutants, or chimeras comprised of different portions of GLUT4 and GLUTl 
(the glucose transporter isoform constitutively targeted to the cell surface), two distinct 
tr afficking motifs in the cytosolic amino and carboxyl termini were identified in GLUT4 
(Marshall et al., 1993; Piper et al., 1992; Verhey et al., 1993); a phenylalanine-based motif, 
FQQI^ \  located in the N-terminus and a dileucine motif, ^^ 489.490^  the C-terminus 
(Figure 1.3). These motifs faU into two categories of stmcturally unrelated transport 
motifs (so called phenylalanine/tyrosine and dileucine based motifs) that are shared by a 
variety of other membrane proteins (Lalioti et al., 2001). These motifs have the ability to 
recruit clathrin adaptors (such as API and AP2) to membranes and thereby facilitate in the
al., 2001). These data indicate a role for Phe of GLUT4 in regulating its intracellular*
I
I
packaging of membrane proteins into clathrin-coated vesicles for further transport (Lalioti 
et al., 2001). Originally, the FQQL ® and l L'*®^ motifs in GLUT4 were shown to function
as internalisation motifs in the process of endocytosis (Garippa et al., 1996; Garippa et al., 
1994; Kao et al., 1998; Piper et al., 1993; Verhey et al., 1995); at the cell surface, GLUT4 
is localised to AP-2/clathrin coated pits and is endocytosed via a clathrin-mediated process 
(Kao et al., 1998; Robinson et al., 1992), this process was shown to be regulated by the N- 
terminal FQQL ® and C-terminal motifs (Garippa et al., 1996; Garippa et al., 1994;
Marsh et al., 1995; Piper et al., 1993; Verhey et al., 1995). However, further analysis 
revealed additional roles for these motifs in the intracellular sorting and sequestration of 
GLÜT4 and they have been proposed to function at distinct intracellulai* sorting steps 
(Melvin et al., 1999).
Mutation of the phenylalanine^ (Phe^) residue of GLUT4 causes the transporter to 
accumulate at the cell surface of unstimulated adipocytes (Marsh et al., 1995). This mutant 
also displays an enhanced susceptibility to endosomal ablation with Tfn-HRP as compared 
to the wild type GLUT4 (Melvin et al., 1999). By following the internalisation of GLUT4 
from the adipocyte cell surface, it was also found that Phe^ mutagenesis inhibits the 
recycling of endocytosed GLUT4 to the GLUT4 storage compartment and results in its 
mis-targeting to late endosomes/lysosomes (co-localising with the late 
endosomal/lysosomal marker, LIMPUl) where it undergoes rapid degradation (Palacios et
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sorting at the levels of both endocytosis and entiy into the GLUT4 storage compaitment. 
Examination of the trafficking of newly synthesised GLUT4 (studied at short time intervals 
within 2-12hr post-transfection), indicates that the transporter moves from the TGN 
directly to the GLUT4 storage compartment, without first transiting the plasma membrane 
(Watson et al., 2004b). Analyses of a variety of GLUT4/GLUT1 chimera proteins indicate 
that this transport step relies upon sequences in both the amino terminus and the large 
cytoplasmic loop, between transmembrane domains 6 and 7 (Khan et al., 2004).
A role for the dileucine'^^  ^'^ '^’ (diLeu'^ ®^ '^ '^^ ) motif in the intracellular sorting of GLUT4 was 
recognised when diLeu'^^ '^^^°/AA mutants were found to show increased resistance to 
endosomal ablation (Melvin et al., 1999), and exhibit increased cell surface distribution in 
basal adipocytes at high levels of expression (Marsh et al., 1995). This indicates a role for 
the diLeu'^ ®^ '^ ”^ motif, most likely at the TGN, as endosomal ablation does not significantly 
affect this compaitment (Livingstone et al., 1996). Moreover, it was found that diLeu'^ ®^ '^ '^^  
mutants were retained in the TGN, leading to their exclusion from the GLUT4 storage 
compartment (Martinez-Area et al., 2000). A major phosphoiylation site in GLUT4, 
serine'^ ®®, which resides adjacent to the diLeu^ ®^  '^ °^ motif, may play a role in the intracellular 
sorting of GLUT4 at the TGN, as the co-localisation of GLUT4 and the clathrin adaptor 
protein API in intracellular vesicles is enhanced when this residue is mutated (Marsh et al., 
1998).
Additional analyses of chimeric transporter proteins in insulin-responsive cells led to the 
suggestion of there being additional targeting information, besides the diLeu'’®^"^®° motif, in 
the C-terminus of GLUT4 (Haney et al., 1995; Verhey et al., 1995). A C-terminal 
truncation mutant of GLUT4, lacking the last five residues, is mis-targeted to late 
endosomes following trafficking through the TGN of fibroblasts (Martinez-Area et al., 
2000), and mutation of the diLeu'^ ®®"^ ®° motif in the context of this GLUT4 truncation 
mutant reveals a role in sorting to the GLUT4 storage compartment from the TGN 
(Martinez-Area et al., 2000). In addition, mutagenesis of a potential protein tyrosine 
kinase and phosphatase substrate, tyrosine^°^, within the truncation mutant, was shown to 
control the exit of GLUT4 from the GLUT4 storage compaitment (Maitinez-Arca et al., 
2000). Further evidence to indicate the importance of the extreme C-terminus of GLUT4 
in intracellular targeting was highlighted by the disruption of the acidic motif.
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TELEYLGP"^^®'^”^ , distal to the diLeu'^ ®^ '^ "^ motif, resulting in mutants being more 
susceptible to endosomal ablation, implying a role for this motif in the endocytic sorting of 
GLUT4 (Shewan et al., 2000). Given that GLUT4 was shown to traffic rapidly from the 
cell surface, via the early endosomal system, to a perinuclear compartment enriched in the 
TGN t-SNAREs, Syntaxin 6  and 16 (Shewan et ah, 2003), SNAREs previously implicated 
in the trafficking of material between endosomes and the TGN (Mallard et al., 2002), these 
data suggest that this C-terminal acidic targeting domain regulates the trafficking of 
GLUT4 to this perinuclear Syntaxin 6/16-positive compartment (Shewan et al., 2003).
1.6. A  model fo r  GLUT4 transport
The apparent complexity that surrounds the intracellular tr afficking itinerary of GLUT4 is 
highlighted by the finding that under basal conditions GLUT4 can be found distributed, to 
varying degrees, throughout the majority of intracellular membrane systems. The 
numerous studies outlined in Section 1.4 led to the proposal of a working model that could 
accommodate many of the apparently contradictory observations (Figure 1.4) (Bryant et 
al., 2002). This model suggests that GLUT4 is selectively targeted into an intracellular 
transport loop between the TGN and endosomes (cycle 2, Figure 1.4) in a seemingly futile 
cycle, which serves to exclude GLUT4 from the cell-smface recycling pathway (cycle 1, 
Figure 1.4). Contained within this intracellular transport loop is the intracellular- store of 
GLUT4, which, in the absence of insulin, moves slowly from the TGN to fuse with 
endosomes. In the presence of insulin, however, this intracellular store is released from the 
cycle and able to fuse directly with the plasma membrane. There are several lines of
evidence that support the existence of a unique pool of GLUT4 vesicles that can fuse 
directly with the plasma membrane in response to insulin. However, in the absence of 
insulin, this population of vesicles is highly unlikely to remain a static body (as discussed 
before, at the end of Section 1.4). If this were the case, the endosomal and TGN stores of 
GLUT4 would soon become depleted and all the GLUT4 would be present in GSVs.
Therefore, it seems likely that GSVs slowly fuse with endosomes, thus allowing GLUT4 to 
re-enter the endosomal system.
;>r
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Figure 1.4. A model depicting the insulin-regulated trafficking of GLUT4
Details are described in Section 1.6. Taken from (Bryant et al., 2002).
One of the major problems with the study of insulin-regulated GLUT4 trafficking is that, 
as terminally differentiated cells, fat and muscle are hard to work with experimentally 
(Quon et al., 1993). For example, they are notoriously difficult to transfect, giving 
inefficient and irreproducible results (Quon et al., 1993). As a consequence of this, the 
expression of exogenous constructs requires the use of viral expression vectors (Hertzel et 
al., 2000). This is an expensive and time-consuming process, and therefore not one to be 
taken lightly. A common approach used to circumvent such a problem is to use an 
experimentally tractable eukaryote system, such as the budding yeast Saccharomyces 
cerevisiae (Baker’s yeast) (Broach et al., 1991; Guthrie and Fink, 1991). However, since 
yeast neither responds to insulin, nor express GLUT4, it is not the immediately obvious 
model system in which to study the insulin-regulated trafficking of GLUT4.
:,fi3
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I J .  Yeast as a system to study GLJJT4 trafficking
S. cerevisiae is a well-established and powerful tool that has greatly furthered the 
knowledge of many aspects of cell biology, including membrane trafficking (Broach et al.,
1991 ; Guthrie and Fink, 1991). Until recently, it was thought that yeast are not subject to 
regulated membrane trafficking events akin to the insuhn-regulated trafficking of GLUT4.
1:It is now clear that yeast do indeed possess a regulated membrane trafficking step that
■Sbears remarkable similarity to the insulin-regulated trafficking of GLUT4; that is the 
nitrogen regulated trafficking of the general amino acid pennease Gap Ip. The general 
amino acid permease Gap Ip is stored intracellularly under nutrient rich conditions (Roberg 
et al., 1997). However, when nutrients are limited. Gap Ip is trafficked to the plasma 
membrane where it facilitates the uptake of amino acids from the extracellular media 
(illustrated in Figure 1.5b) (Roberg et al., 1997). This regulated trafficking bears many |
striking similarities to that of GLUT4 in insulin-sensitive cells and accounts for the 
increase in levels of Gap Ip on the cell surface of yeast in response to nitrogen availability 
(Roberg et al., 1997). On preferred sources of nitrogen, such as glutamate. Gap Ip is
a;?transported to the yeast endosomal system (Figure 1.5b) (Roberg et al., 1997). In contrast, 
when cells are grown on non-preferred sources of nitrogen, such as proline. Gap Ip is 
sorted from an intracellular storage pool to the cell surface, where it allows amino acids 
into the cell for use as a nitrogen source (Figure 1.5b) (Roberg et al., 1997).
A
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Figure 1.5. Comparison of insulin-regulated GLUT4 trafficking in adipocytes (a) with 
nitrogen-regulated Gaplp trafficking in S.cerevisiae (b)
{adapted from (Bryant et al., 2002))
Like GLUT4, Gaplp is predicted to span the membrane twelve times (Jauniaux and 
Grenson, 1990) and, intriguingly, contains motifs in the cytosolic carboxyl-terminal 
domain that are analogous to those involved in GLUT4 trafficking (Hein and Andre,
1997). The carboxyl-terminal tail of GLUT4 contains several motifs required for its 
insulin-regulated trafficking (Lalioti et al., 2001) (outlined in Section 1.5) that, when 
mutated, result in a loss of insulin-stimulated translocation (Lalioti et al., 2001). When the 
carboxyl-terminal tail of GLUT4 is replaced with the equivalent region from the yeast 
protein Gaplp, resulting in a GLUT4/Gap Ip chimeric protein, the chimera exhibits a 
similar trafficking response to insulin as endogenous GLUT4 (Figure 1.6, Nia Bryant and 
David James; unpublished results). In the absence of insulin, the chimera, like endogenous 
GLUT4, co-localises with the TGN marker, TGN38 (Figure 1.6a). Upon insulin 
stimulation, again like GLUT4 itself, the chimera translocates to the plasma membrane 
(Figure 1.6a). Fractionation of 3T3-L1 adipocytes (shown in Figure 1.6b, Nia Bryant and 
David James; unpublished results) also shows an insulin-dependent movement of the 
chimera out of the intracellular membrane (LDM) fraction to the plasma membrane (PM) 
fraction. The transferrin receptor (TfR), however, remained unaffected in these same cells. 
These data indicate that the targeting motifs and the molecular machinery that control the 
regulated trafficking of Gaplp and GLUT4 is conserved throughout evolution.
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Figure 1.6. The C-terminal tail of Gaplp directs GLUT4 to the plasma membrane in an 
insulin-dependent manner
(unpublished data; Nia Bryant and David James).
A chimeric protein in which the C-terminal tail ofGLUT4 was replaced with the 
analogous region from the yeast protein, Gaplp (GLUT4/Gaplp) carrying an HA-tag, was 
expressed in 3T3-LI adipocytes using a retroviral expression vector. Cells were either 
treated with lOnM insulin (+insulin) or vehicle alone (-insulin), before the following 
procedures were performed: (a) indirect immunofluorescence microscopy using an anti- 
HA antibody was used to visualise the chimera, (b) differential centrifugation was used to 
generate fractions enriched in either plasma membrane (PM) or intracellular GLUT4 
membranes (LDM; low density microsomes). These fractions were subjected to SDS- 
PAGE and immunoblot analysis.
Rebecca K McCann, 2007 Chapter One, 22
1.8. The general amino acid permease, Gaplp
The S. cerevisiae genome encodes a family of around twenty related amino acid 
permeases, which are delivered by the secretory pathway to the plasma membrane and 
function to allow amino acids into the cell for use in protein synthesis and as a source of 
nitrogen (Andre, 1995). These peimeases can be divided into two distinct classes 
according to theii* regulation and function (Sophianopoulou and Diallinas, 1995). 
Constitutive permeases are usually high affinity permeases that transport either specific 
amino acids, or a set of chemically related compounds, and are expressed in yeast 
regardless of the nitrogen conditions (Horak, 1986). Included within this class of 
permeases are the histidine peimease, Hip Ip (Tanaka and Fink, 1985) and the lysine 
permease, Lyplp (Sychrova and Chevallier, 1993). This class of permeases ar e thought to 
transport amino acids primarily for use in protein synthesis (Andre, 1995). It is the second 
class of permeases, regulated permeases, that includes the general amino acid permease, 
Gaplp, (which can transport all naturally occurring amino acids) (Grenson et al., 1970; 
Jauniaux and Grenson, 1990) and Put4p (which transports proline) (Lasko and Brandriss, 
1981 ; Vandenbol et al., 1989). Regulated permeases are induced by growth on poor 
nitrogen sources and Gaplp is thought to play a pivotal role in the control of nitrogen 
metabolism, since it transports amino acids that are both substrates for, and inducers of, 
amino acid utilisation pathways (Magasanik and Kaiser, 2002).
S.cerevisiae has the ability to utilise a variety of nitrogen-containing compounds as its sole 
source of nitrogen (Magasanik and Kaiser, 2002). Inside the cell, a range of enzymes 
catalyse the metabolism of these assorted compounds to generate ammonia, which then 
feeds into a common set of reactions that ultimately produce glutamate and glutamine 
(Magasanik and Kaiser, 2002). The amino nitrogen of glutamate and the amide group of 
glutamine serve as the basis of total cellular nitrogen in yeast and are donors for all of the 
amino acid and nucleotide biosynthesis pathways in the cell (Magasanik and Kaiser, 2002). 
When provided with a mixture of nitrogen sources in the growth medium, S.cerevisiae will 
show preference for the utilisation of particular nitrogen sources (Chen and Kaiser, 2002). 
Preferred nitrogen sources such as glutamine are used by the cell first and only once these 
are depleted will the cell then use the non-preferred nitrogen sources such as proline (Chen 
and Kaiser, 2002). In the laboratory, glutamine, glutamate and asparagine are commonly 
provided as preferable sources of nitrogen, while proline is mostly used as the non-
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preferable source; other non-preferred sources include ornithine, allantoin and urea 
(Magasanik and Kaiser, 2002).
Cell fractionation experiments localised Gaplp to the Golgi/endosomal system in cells 
grown on rich sources of nitrogen (Roberg et al., 1997) such as in the presence of
I
Gaplp activity is strictly regulated by nitrogen availability, to some extent at a 
transcriptional level, but largely by posttranslational means (Magasanik and Kaiser, 2002). 
The GATA-type transcription factors Gln3p and Gatl p/Nil Ip and the cytoplasmic factor 
Ure2p co-ordinately control the transcription of a variety of nitrogen-responsive genes,
which includes the expression of GAPl (Stanbrough et al., 1995). Gln3p and Gat Ip/Nil Ip 
positively regulate GAPl expression in cells grown on urea or glutamate as the nitrogen 
source, but when cells are grown on glutamine, Ure2p represses GAPl expression 
(Stanbrough and Magasanik, 1995). However, it became apparent that posttranslational 
modifications of Gaplp were also involved in its regulation (Stanbrough and Magasanik, 
1995): a comparison between Gaplp protein levels and permease activity on different 
nitrogen sources indicated that Gaplp protein levels were similar in cells grown either on 
glutamate or urea, but that Gaplp activity in cells grown on urea was 100-fold higher than 
that of cells grown on glutamate (Stanbrough and Magasanik, 1995). Therefore, although 
expression of GAPl was comparable in cells grown on either urea or glutamate, indicated 
by the similar protein levels, the Gaplp protein must be regulated at another point to 
account for the differences in permease activity (Stanbrough and Magasanik, 1995).
glutamate. Despite displaying steady state localisation to the endosomal system, Gaplp is
,eventually transported directly to the vacuole where it is degraded, without transiting 
through the plasma membrane (Roberg et al., 1997). When cells are then transfened to 
urea medium (an unfavourable source of nitrogen) the activity of Gaplp increases, as it 
redistributes to the plasma membrane (Roberg et al., 1997). It has been suggested that 
Gaplp is engaged within an intracellular recycling loop between the Golgi and prevacuolar 
compartment (PVC) that acts as an internal store of Gaplp, which is ready to be mobilised 
to the plasma membrane in response to the quality of the nitrogen source (Magasanik and 
Kaiser, 2002). This strengthens the parallels noted between the nitrogen-regulated 
pathway of Gaplp and the insulin-regulated trafficking pathway of GLUT4.
-a
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The exposure of cells to ammonia results in an increase in ubiquitinated forms of Gaplp 
(Springael and Andre, 1998). The products of the NPIl and NPI2 genes are required for 
the nitrogen-regulated inactivation and degradation of Gaplp (Grenson, 1983a; Grenson, 
1983b). NPIl is an essential gene that encodes the E3 ubiquitin ligase, Rsp5p, which 
catalyses the addition of a ubiquitin moiety to lysine residues in target proteins (Huibregtse 
et al., 1995; Springael and Andre, 1998) and NPI2 encodes the ubiquitin hydrolase 
Doa4p/Ubp4p/Ssv7p (Springael et al., 1999), further suggesting that the ubiquitin pathway 
is involved in the turnover regulation of Gaplp (Hein et al., 1995). In npil mutant cells, 
where the levels of the Npil/Rsp5 ubiquitin ligase are significantly reduced, and in npi2 
mutant cells, where the amount of free monomeric ubiquitin is around four times lower 
than in wild type cells, Gaplp ubiquitination is impaired, and the permease remains stable 
at the plasma membrane (Springael and Andre, 1998; Springael et al., 1999). This is 
because the monoubiquitination of Gaplp, like many cell surface proteins, is required for 
the internalisation step of endocytosis (Hicke and Dunn, 2003). However, the role of 
ubiquitination in Gaplp traffic is more complicated than this. For instance, overexpression 
of Bui Ip or Bul2p proteins, which form a complex with Rsp5p (Yashiroda et al., 1998; 
Yashiroda et al., 1996), cause Gaplp to be sorted to the vacuole for degradation regardless 
of the nitrogen source (Helliwell et al., 2001). Bullp and Bul2p, together with Rsp5p, 
specify the polyubiquitination of Gaplp, which is required for its intracellular targeting 
from the TGN to the vacuole (Helliwell et al., 2001). Therefore, ubiquitination of Gaplp 
is required, not only for the endocytosis and eventual down-regulation of Gaplp that has 
pre-accumulated at the cell surface, but also for the direct sorting of neosynthesised Gaplp 
from the late secretory pathway to the vacuole (Helliwell et al., 2001).
3
The carboxy- terminal tail of Gaplp plays an essential role in its nitrogen regulated down- 
regulation, as mutations within the last eleven amino acids of Gaplp or within a di-leucine 
peptide or glutamate residue located in a putative ex-helix of the carboxy- terminal tail, 
protects the permease against NH^^ induced inactivation (Figure 1.3) (Hein and Andre,
1997; Springael and Andre, 1998). However, these mutant permeases are still modified by 
the addition of ubiquitin moeities (Springael and Andre, 1998). Gaplp is poly- 
ubiquitinated at two lysine acceptor sites, with the ubiquitin moieties being attached to 
Lys®^  of the preceding ubiquitin, creating Lys^^-linked polyubiquitin chains (Springael et
.ï;
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al., 1999). Specifically Lys® and Lys^  ^of the amino-terminal cytosolic domain of Gaplp 
are poly-ubiquitinated with chains of at least two ubiquitin moieties (Soetens et al., 2001). ■
1.9. Ubiquitination
Ubiquitination is the post-translational conjugation of the small protein, ubiquitin, to 
specific lysine residues on a target protein (Hicke and Dunn, 2003). Ubiquitin is a 76 
amino acid polypeptide whose C-terminal glycine carboxyl group forms an isopeptide 
bond with either the e-amino group of specific lysine residues or, less commonly, with the 
amino group at the amino-terminus of a substrate protein (Hicke and Dunn, 2003). The 
conjugation of ubiquitin to a target protein can regulate a wide assortment of cellular 
processes including protein degradation and quality control, endocytosis and vesicular 
trafficking, cell-cycle control, stress response, DNA repair, signalling, transcription and 
gene silencing (Hicke and Dunn, 2003).
The covalent attachment of ubiquitin to target lysine residues in a substrate protein occurs
following the sequential action of three different enzymes (outlined in Figure 1.7)
(Weissman, 2001). A ubiquitin-activating enzyme (El) adenylates the carboxyl terminus
.of ubiquitin before forming a high-energy thiolester bond between ubiquitin and a 
cysteinyl side-chain, in an ATP-dependent reaction (Hershko and Ciechanover, 1998; 
Schwartz and Hochstrasser, 2003; Weissman, 2001). The activated ubiquitin is then 
transferred onto a cysteinyl group on one of the twenty known ubiquitin-conjugating 
enzymes (E2) by transthiolation, which, usually in cooperation with a ubiquitin ligase (E3), 
then transfers the ubiquitin moiety onto the lysine side chain of a target protein (Hershko 
and Ciechanover, 1998; Hicke and Dunn, 2003; Schwartz and Hochstrasser, 2003; 
Weissman, 2001). The substrate specificity and timing of the ubiquitination reaction is 
determined largely by the E3 ubiquitin ligase, which is therefore often regarded as the key 
regulatory determinant of the process (Hicke and Dunn, 2003). E3 ligases can either 
themselves form a thioester bond with ubiquitin before transferring it onto a substrate 
protein or can function as a bridge between an activated E2 enzyme and the substrate 
protein; with the ubiquitin molecule transferring directly from the E2 enzyme to the 
substrate (Schwartz and Hochstrasser, 2003). This depends on whether the E3 enzyme 
contains a HECT (homologous to the E 6 -AP carboxyl terminus) domain or RING (really 
interesting new gene) related domain, respectively (Hicke et al., 2005; Schwartz and
Rebecca K McCann, 2007 Chapter One, 26
Hochstrasser, 2003). De-ubiquitinating enzymes (DUBs) can trim or remove ubiquitin 
signals and are necessary to process ubiquitin precursors in order to generate a Gly-Gly 
sequence at their carboxy- terminal, which is the site of attachment to target molecules 
(Schwartz and Hochstrasser, 2003).
i
Figure 1.7. The ubiquitination pathway
(Weissman, 2001).
Different types of ubiquitin modification are associated with distinct cellular functions 
(Hicke and Dunn, 2003). Protein modification by a single ubiquitin molecule on one or 
more of its lysine residues is referred to as monoubiquitination or multi- 
monoubiquitination, respectively (Hicke and Dunn, 2003). However, at least three lysines 
within ubiquitin itself, Lys ’^, Lys'^ *, and Lys®^ , can themselves be ubiquitinated, thus 
forming chains of ubiquitination (Amason and Ellison, 1994). This is referred to as 
polyubiquitination (Amason and Ellison, 1994). A polyubiquitin chain of at least four 
ubiquitin moieties linked through Lys'^ ® of ubiquitin has been shown to regulate a large 
number of nuclear, cytosolic and ER membrane proteins by targeting them for degradation 
by the 26S proteasome (Chau et al., 1989; Thrower et al., 2000), a large barrel-shaped 
multicatalytic protease complex (Hershko and Ciechanover, 1998). Polyubiquitin chains 
linked through Lys'^ * facilitate the binding of substrate proteins to this complex (Thrower et 
al., 2000). This role for ubiquitin dominated early discussion as to ubiquitin function; 
however, it has become increasingly apparent that ubiquitin also has a distinct role in 
regulating the transport of proteins between intracellular membrane compartments (Horak, 
2003). Short di- or tri- chains of Lys^  ^linked polyubiquitin have been associated with 
regulating the endocytosis of some plasma membrane proteins and their subsequent
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delivery to the mammalian lysosome or yeast vacuole where they undergo eventual 
proteolysis (Fisk and Yaffe, 1999; Galan and Haguenauer-Tsapis, 1997; Hoege et al.,
2002). Monoubiquitination has been identified as a sorting signal throughout the endocytic 
pathway (Hicke, 2001; Hoege et al., 2002; Salghetti et al., 2001) and, in fact, ftision of a 
single ubiquitin moiety in-frame to many plasma membrane proteins is a sufficient signal 
for their internalisation (Dupre et al., 2004; Hicke and Dunn, 2003).
1.9a. The role o f  ubiquitin in protein transport
There are at least two distinct mechanisms by which ubiquitin can regulate protein 
transport; ubiquitin can either modify the activity of the protein transport machinery, or can 
serve as a sorting signal to direct the movement of transmembrane proteins between 
different intracellular compartments (Hicke and Dunn, 2003). For example, monoubiquitin 
acts as a signal to sort tiansmembrane proteins, from both endocytic and biosynthetic 
pathways, into vesicles that bud into the lumen of a late endosomal compartment known as 
the multivesicular body (MVB) (Katzmann et al., 2002). The MVB fuses with the 
mammalian lysosome or the yeast vacuole, which results in the eventual proteolysis of the 
MVB contents (Katzmann et al., 2002).
%
1.9b. Ubiquitin Binding Domains
The method by which a ubiquitin signal can regulate various cellular events has been 
attributed to the recently discovered collection of modular protein domains that non- 
covalently bind to ubiquitin, known as ubiquitin-binding domains (UBDs) (Hicke et al., 
2005; Hurley et al., 2006). These motifs allow ubiquitin to function as a signalling 
connection in the regulation of various cellular proteins and processes in a manner similar 
to that controlled by phsophorylation/dephosphoiylation of proteins (Hicke et al., 2005; 
Hurley et a l , 2006). For example, multiple ubiquitin-binding proteins containing a wide 
variety of UBDs function to deliver ubiquitinated proteins into the budding luminal 
vesicles of MVBs (Katzmann et al., 2002) by recognising two hydrophobic patches on the 
surface of the ubiquitin molecule (Di Fiore et al., 2003). UBDs are generally small (20- 
150 amino acid residues), independently folded motifs that recognise various surfaces on 
ubiquitin, which allows them to interact directly with monoubiquitin and/or polyubiquitin 
chains (Hicke et al., 2005). At least sixteen structurally diverse UBDs have been identified 
thus far, which are found in a wide vaiiety of proteins with differing structural features and
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biological functions (reviewed in (Hicke et al., 2005; Hurley et al., 2006)). The largest 
class of ubiquitin-binding domains are cx-helical domains and include, the ubiquitin- 
associated domain (UBA), the ubiquitin-interacting motif (HIM), the double-sided UBVt W
(DUIM), the motif interacting with ubiquitin (MIU), the GAT domain (GGA (Golgi- 
localised, gamma-ear-containing, ADP-ribosylation-factor-binding protein) and TOM 
(target of Myb)) and the CUE (similar to Cuel) domain (Hurley et al., 2006). All of the 
above are known to interact with a hydrophobic patch on ubiquitin that includes the residue 
Ile'*^  (Hurley et al., 2006). Zinc-finger domains (ZnFs) make up the second largest class of 
UBDs and offer more diversity with respect to recognition and binding affinity when 
compared to helical domains, lai’gely due to the fact they recognise three different regions 
on the surface of ubiquitin (Hurley et al., 2006). Other UBDs include, amongst others (as 
reviewed in (Hurley et al., 2006)), the Ubc (ubiquitin-conjugating enzyme) E2 variant 
(UEV) domain which contains an a/p  fold that contacts both the Ile^ '^  hydrophobic patch 
and a hydrophilic site centred around Gln^^of ubiquitin and the ubiquitin-binding motif 
(UBM), which is centred around Leu^ of ubiquitin (Hurley et al., 2006).
1.9c. Ubiquitination as a signal in regulated traffic
During the conversion of immature mouse dendritic cells to mature mouse dendritic cells, 
the major histocompatibility complex class H molecules (MHC II) are redistributed from 
late endosomal and lysosomal compartments to the plasma membrane (Shin et al., 2006).
The MHC II p-chain cytoplasmic tail is ubiquitinated in immature dendritic cells, resulting 
in its endocytosis (Shin et al., 2006). This ubiquitination ceases upon cell maturation, 
allowing for the accumulation of MHC II at the plasma membrane (Shin et al., 2006). A 
ubiquitination-deficient mutant of MHC II, where the single lysine residue in the p-chain is 
replaced by an arginine residue, is retained at the plasma membrane in immature dendritic 
cells (Shin et al., 2006). This effect is reversed upon the addition of a single ubiquitin 
moiety to the cytoplasmic tail of this mutant, creating a constitutively ubiquitinated MHC 
II molecule that is retained intracellularly (Shin et al., 2006).
■:s:
The short-chain ubiquitination of renal aquaporin-2 (AQP2) water channels provides a 
recently described example of ubiquitination regulating the endocytosis and subsequent 
targeting of a membrane protein into MVBs (Kamsteeg et al., 2006). Transmembrane 
water transport, and consequently water homeostasis, is contiolled by the insertion and
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retrieval of water channels, such as AQP2, to and from the cell surface (Kamsteeg et al., 
2006). Arginine-vasopressin (AVP) induces the phosphorylation of AQP2 at Ser^ ^®, 
causing its redistribution from intracellular vesicles to the apical membrane of kidney cells 
(Kamsteeg et al., 2006), thus allowing an increase in the water permeability of the kidney- 
collecting duct. Upon A VP removal or PKC activation, AQP2 is ubiquitinated at the 
apical membrane, with one Lys^^-hnked chain at Lys™ (Kamsteeg et al., 2006). 
Internalisation kinetic studies between wild type and a ubiquitination-deficient (K270R) 
AQP2 mutant revealed that ubiquitination enhanced AQP2 endocytosis (Kamsteeg et al., 
2006). Electron microscopy localised the ubiquitin-deficient mutant to the apical 
membrane, early endosomes, and the limiting membrane of MVBs, in contrast to a 
constitutively ubiquitinated form of AQP2 (AQP2-Ub) that localised primarily to the 
internal vesicles of MVBs (Kamsteeg et al., 2006). Furthermore, lysosomal degradation 
was found to be extensive for AQP2-Ub, low for AQP2-K270R, and intermediate for 
AQP2-wt, indicating that the short-chain ubiquitination of AQP2 has a role in its 
endocytosis, MVB sorting, and consequently, its lysosomal degradation (Kamsteeg et al., 
2006).
1.10. A  role fo r  ubiquitination in the insulin-regulated trafficking ofGLUT4?
Although GLUT4 has not previously been shown to be ubiquitinated, the small ubiquitin- 
like modifier protein, SUMO (also called sentrin), has been shown to modify GLUT4 
(Lalioti et al., 2002). Additionally, the SUMO-conjugating enzyme, mUbc9 was identified 
in a yeast two-hybrid screen to identify proteins that interact with the C-terminal tail of 
GLUT4 in insulin-sensitive cells (Giorgino et al., 2000). SUMO is related to ubiquitin and 
may also regulate protein transport, either by acting as a signal, or by competing with 
ubiquitin for lysine modification sites (Hay, 2005). Little is known about the interaction of 
mUbc9 with GLUT4, although several observations indicate that it has an important role in 
regulating the transporter: for example, expression of a dominant-negative version of 
mUbc9 causes the degiadation of GLUT4 and a decrease in the insulin-stimulated glucose 
transport in L 6 -myoblasts (Giorgino et al., 2000). A role for ubiquitin in GLUT4 
trafficking has also been implicated by the identification of a protein harbouring two 
ubiquitin-like (Ubl) domains as being involved in the intracellular retention of GLUT4 in 
adipocytes in the absence of insulin (Bogan et al., 2003). This protein, TUG, is found in a 
complex with GLUT4 in basal adipocytes, but this association is lost following insulin-
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Stimulation (Bogan et al., 2003). Furthermore, TUG disruption results in enhanced 
translocation of GLUT4, along with increased glucose uptake (Yu et al., 2007). These data 
support a model in which GLUT4-containing vesicles are tethered and thus retained 
intracellularly through interaction with TUG (Bogan et al., 2003). Insulin would then 
stimulate the release of tethered GLUT4, allowing its delivery to the plasma membrane 
(Bogan et al., 2003).
As discussed above in Section 1.8, the nitrogen-regulated trafficking of Gaplp in yeast is 
controlled by ubiquitination of the transporter, which occurs when cells are grown under 
nutrient-rich conditions (Helliwell et al., 2(X)1). This ubiquitination facilitates the binding 
of Gaplp to the GAT domain of the GGA (Golgi-localised, y ear-containing, ARF- 
binding) adaptor proteins (Scott et al., 2(X)4). The GGA proteins are a family of 
ubiquitously expressed, monomeric clathrin adaptors that facilitate protein sorting in the 
TGN/endosomal system (Bonifacino, 2004; Pelham, 2004). They have a conserved 
modular arrangement consisting of four distinct domains: the Vps27, Hrs, Stam (VHS) 
domain interacts with acidic di-leucine sorting signals found in the mannose-6-phosphate 
receptors; the GGA and TOM (GAT) domain binds Arf:GTP and ubiquitin; the hinge 
region recruits clathrin; and finally, the y-adaptin ear (GAE) domain (which has sequence 
similarity to the ear region of y-adaptin) binds a number of accessory factors (Figure 1.8) 
(Bonifacino, 2004; Pelham, 2004). GGA proteins are recruited to the TGN by the Arfl 
GTPase and therefore have the ability to select cargo destined for endosomes by recruiting 
ubiquitinated proteins and incorporating into clathrin-coated vesicles (Pelham, 2004).
Acidic di-leucine 
sorting signals Clathrin
VHS GAT GAEHinge
ARF:GFP Ubiquitin Accessoryfactors
Figure 1.8. Domains and interactions of a typical GGA protein
(Pelham, 2004).
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Gga proteins are essential for the nitrogen-regulated trafficking of Gaplp in yeast (Scott et 
al., 2004). The interaction between ubiquitin moieties on Gaplp and the GAT domain of 
the Gga proteins is an absolute requirement, as yeast cells carrying the gga2AGAT allele as 
the sole GGA gene are unable to sort G aplp in this regulated manner (Scott et al., 2004).
Î
I
GGA proteins have also been implicated in regulating the entry of GLUT4 into its insulin- 
responsive location in 3T3-L1 adipocytes (Li and Kandror, 2005; Watson et al., 2004b).
Initial studies expressing a ‘dominant-negative’ GGA mutant (containing only the VHS 
and GAT domains) blocked the entry of newly synthesized GLUT4 into its insulin- 
sensitive pool in 3T3-L1 adipocytes (Watson et al., 2004b) and selectively inhibited the in 
vitro budding of GLUT4-containing vesicles (while having no effect on the generation of 
vesicles containing GLUTl and/or the transferrin receptor) (Watson et al., 2004b).
'Furthermore, in adipocytes, the GGA2 isoform shows significant colocalisation with 
GLUT4 in the perinuclear region of the cell (Li and Kandror, 2005).
:
I
The involvement of GGA proteins in the regulated sorting of both Gaplp (in yeast) and 
GLUT4 (in adipocytes) underscores the parallels between these two systems and makes it 
tempting to speculate that ubiquitination may be involved in the biogenesis of the insulin- 
sensitive pool of GLUT4, perhaps utilising the GGA proteins to do so.
1.11. Aims o f project
As with many studies looking at the insulin-regulated trafficking of GLUT4, investigations 
into the role of ubiquitin in the process of GLUT4 trafficking have been hampered by the 
difficulties involved with using terminally differentiated fat and muscle cells. This study 
set out to overcome such issues by taking advantage of the easily manipulated, genetically 
tractable model eukaryote Saccharomyces cerevisiae in order to investigate the role of 
ubiquitination in the insulin-regulated trafficking of GLUT4.
Chapter 2: Materials and Methods
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Chapter 2 : Materials and Methods
2.1. Materials
2.1.1. General reagents and enzymes
All chemicals reagents were obtained from Sigma-Aldrich (Poole, UK), VWR (Poole, UK) 
or Fisher Scientific (Leicester, UK). Acrylamide was obtained from Severn Biotech Ltd 
(Kidderminster, UK). Media components were from Melford Laboratories Ltd (Suffolk, 
UK), FORMEDIUM (Norwich, UK) or Difco Laboratories Inc (Appleton Woods 
Laboratory Equipment and Consumables, Birmingham, UK). Solutions for enhanced 
chemiluminescence (ECL) and secondary antibodies for immunoblotting were from 
Amersham Biosciences (Buckinghamshire, UK). DNA restriction enzymes, T4 DNA 
ligase, Taq ® polymerase and Pfu ® polymerase were obtained from Promega 
(Southampton, UK). Platinum polymerase was obtained from Invitrogen (Paisley, 
UK). Broad range protein markers from Biorad (Hertfordshire, UK) were used for protein 
electrophoresis. Yeast lytic enzyme was from MP Biomedicals (Aurora, USA)
2.1.2. Bacterial and yeast strains 
The strains of E.coli and S.cerevisiae used in this study are listed in Table 2.1. Plasmids 
were routinely propagated in the E.coli host strain XL-1 Blue (Stratagene); recombinant 
proteins were produced in the E.coli host sti'ain BL-21 (DE3) (Invitrogen).
::2.1.3. MediaYeast cultures were grown in either rich medium (YPD; containing 1% (w/v) yeast extract, 
2% (w/v) peptone and 2% (w/v) glucose) or standard minimal (selective) medium (SD; 
containing 0.67% (w/v) yeast nitrogen base without amino acids, 2% (w/v) glucose and 
supplemented with synthetic complete amino acid dropout supplements as required)
(ForMedium; Norwich, UK) (Sheiman, 1986). Where stated, maltose was added as the
■sole carbon source in place of glucose to make YPM and SM. When solid medium was 
required micro agai' was added to 2 % (w/v).
Bacterial cultures were grown in standard 2YT medium (containing 1.6% (w/v) tryptone,
1% (w/v) yeast extract and 0.5% (w/v) NaCl) supplemented with lOO/fg/ml ampicillin. For 
solid plates, micro agar was added to 2% (w/v). For the production of recombinant
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proteins, bacterial strains were grown in nutrient enriched Terrific Broth medium (Melford 
Laboratories Ltd; 1.2% (w/v) tryptone, 2.4% (w/v) yeast extract, 0.4% (v/v) glycerol,
0.017M KH2 PO4 ,0.072M KjHPOJ, supplemented with lOO/tg/ml ampicillin.
2.1.4. Antibodies
Rabbit polyclonal antiserum that specifically recognises the carboxyl-terminal fourteen 
amino acids of hGLUT4 (Brant et al., 1992) were made in-house and used at a 1:1000 
dilution for immunoblotting or a 1:100 dilution for immunofluorescence. Rat monoclonal 
antibodies (clone 3F10; lOOfxg/ml) that specifically recognise the epitope YPYDVPDYA 
(derived from the human influenza hemagglutinin (HA) protein) were purchased from 
Roche (Mannheim) and used at a 1:2000 dilution for immunoblotting or a 1:100 dilution 
for immunofluorescence. Rabbit polyclonal anti-Vtilp antibodies have been previously 
described (Coe et al., 1999); antiserum was used at a 1:30000 dilution for immunoblotting. 
Mouse monoclonal antibodies (3-5pg/pl) that specifically recognise ubiquitin were 
purchased from Covance (Cambridge Bioscience Ltd, UK) and used at a 1:1000 dilution 
for immunoblotting. Living Colors® A.v. mouse monoclonal antibody (JL-8 ) that 
recognises Aequorea victoria green fluorescent protein (GFP; lOOpg/ml) was used at a 
concentration of 1:3000 for immunoblotting and purchased from Clontech Laboratories,
Inc (California, USA). Rabbit polyclonal antibody (Ipg/pl) specifically recognising the 
carboxyl-terminal fourteen amino acid peptide YASINFQKQPEDRQ of rat liver IRS-1 
was from Upstate (New York, USA) and used at a concentration of 1:1000 for 
immunoblotting. Rabbit polyclonal antiserum, raised against the cytoplasmic domain of 
rat Syntaxin 4 was used at a concentration of 1:1000 for immunoblotting and obtained 
from Synaptic Systems (Goettingen, Germany). Antibodies against EEAl, Syntaxin 16 and 
a mouse monoclonal antibody that recognises the C-terminus of hGLUT4 (1F8) (James et 
al., 1988) were kindly provided by Professor David James (Garvan Institute of Medical 
Research, Australia).
2.2. Methods
2.2.1. DNA manipulations
Plasmid DNA was routinely isolated from bacterial cultures using the Promega Wizard® 
Plus SV Miniprep kit. Oligonucleotides used in polymerase chain reaction (PCR) 
amplification or site-directed mutagenesis (SDM) of DNA sequences (listed in Table 2.2)
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6 8 °C (Imin/kb)
were manufactured by either Yorkshire Bioscience Ltd (York, UK) or Vhbio Ltd 
(Gateshead, UK) and diluted in nuclease free water to a final concentration of 50pmol/(il. 
The high fidelity polymerase Platinum PJx® (Invitrogen) was used for PCR amplification 
of DNA sequences.
The following indicates a typical recipe for the PCR: 
lOmM dNTPs 5yd
50mM MgSO^ 5 pi
lOX Pfa buffer 5pl
Enhancer 5 pi
ddH^O 26pl
Forward primer (50pmol/pl stock) 1 pi 
Reverse primer (50pmol/pl stock) 1 pi 
Purified plasmid DNA 1 pi
Pfic DNA polymerase 1 pi
Generally, the PCR was completed with the following conditions:
95°C Im in
94°C IminSOsecs
55°C Imin ^  30 cycles ËI:S
6 8 “C lOmin
4"C hold
DNA manipulation techniques were performed using standard procedures (Sambrook,
2001). DNA fragments were resolved electrophoretically through 0.8% (w/v) agarose in 
tris-acetate (TAE) buffer (0.04M Tris-acetate, 0.00IM EDTA). SDM of DNA sequences 
was cai'ried out with PJu® polymerase according to the QuikChange® method 
(Stratagene). The exchange of one amino acid residue for another was performed with the 
use of synthetic oligonucleotides, designed with the desired mutation at the centre of the 
oligonucleotide. Ip l (10 units) Dpnl was added to the reaction mixture following 
completion of the SDM reaction, and further incubated for Ihr at 37°C in order to digest 
the parental DNA. Mutations were confirmed by DNA sequencing,
3
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The following indicates a typical recipe for the SDM reaction:
lOX Pfu buffer 5 pi
lOmM dNTPs Ipl
Pfu polymerase 1 pi
ddHjO to final volume of 50pl
Purified plasmid DNA 50ng
Primer 1 125ng
Primer 2 125ng
Typically, the following conditions were used to complete the SDM reaction: 
95°C Imin
95°C SOsecs
60°C SOsecs
6 8 °C (2min/kb)
>“ 18 cycles
6 8 °C 7min
4°C hold
22.2. Plasmid construction
All plasmids constructed and used in this study are listed in Table 2.3. pRMl was 
constructed by subcloning a BamHi-Pstl fragment, containing sequence encoding HA- 
tagged ubiquitin downstream of the CUPl promoter, from Yepl 12 (Hochstrasser et al., 
1991) into pRS315 (Sikorski and Hieter, 1989).
pWTG4 (pRM2) was constructed by amplifying the human GLUT4 ORF from a cDNA 
(provided by Professor Gwyn Gould) by PCR using oligos 1 and 2 (Table 2.2) to generate 
the GLUT4 ORF flanked by sequences homologous to the 3’ end of the CUPl promoter 
and the proximal end of the PH 08 3 ’UTR. This plasmid was then used to repair a gapped 
pNB701 (constructed by Nia Bryant and based on pRS316 (Sikorski and Hieter, 1989)), 
which contains the ORF encoding the protein RS-ALP (retention sequence-ALP) (Bryant 
et al., 1998b) under control of the CUPl promoter, followed by the 3’UTR of PH08.
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pG47KR (pRM3) was constructed from pWTG4 (pRM2) by using SDM to sequentially 
mutate the codons for the 7 lysine residues (at positions 109, 242, 245, 261, 264, 266 and 
495) to codons for aiginine residues. The pairs of oligonucleotides used (61 and 62, 73 and 
74, 85 and 8 6 ,77 and 78, 117 and 118,119 and 120, 121 and 122), and the ‘intermediate’ 
plasmids created (pRM5, pRMl 1, pRM12, pRM13, pRM14, pRM15 and pRM3) in the 
process of making the final plasmid pG47KR (pRM3) are listed in Tables 2.2 and 2.3, 
respectively.
Plasmids pRM5, pRM 6 , pRM7, pRM 8 , pRM9, pRMlO and pRM16 were constructed from 
pWTG4 (pRM2) by using SDM to individually mutate the codons for the 7 lysine residues 
(at positions 495, 242, 245, 261, 264, 266 and 109, respectively) to codons for arginine 
residues. The pairs of oligonucleotides used in each SDM reaction (61 and 62, 85 and 8 6 , 
87 and 8 8 , 89 and 90, 91 and 92, 93 and 94, 73 and 74) are listed in Table 2.2.
Plasmids pRM17, pRM18, pRM19, pRM20, pRM21, pRM22 and pRM23 were 
constructed from pG47KR (pRM3) by using SDM to individually mutate the codons for 
the 7 arginine residues (at positions 242, 261, 109, 245, 264, 266 and 495, respectively) to 
codons for lysine residues. The pairs of oligonucleotides used in each SDM reaction (233 
and 234, 237 and 238, 231 and 232, 235 and 236, 239 and 240, 241 and 242, 243 and 244) 
are listed in Table 2.2.
pRM34 was constructed using oligos 365 and 366 (Table 2.2) to generate a PCR product 
from pG036 (Odorizzi et al., 2003) encoding GFP(S65T) flanked by sequences 
homologous to the 3’ end of the GLUT4 ORF and the proximal end of the PH 08 3 ’UTR. 
Homologous recombination was used to insert the GFP(S65T) ORF immediately after the 
last codon of GLUT4 by repairing a version of pRM2 in which the GLUT4 STOP codon 
was replaced by an Sphl site (by SDM using oligos 343 and 344; Table 2.2) and 
subsequently linearised using this site.
pG47KRHAUb (pRM24) was constructed using oligos 185 and 186 (Table 2.2) to generate 
a PCR product from pRMl encoding HA-tagged ubiquitin flanked by sequences 
homologous to the 3’ ends of the GLUT4-7K/R ORF and the proximal end of the PH08  
3 'UTR, Homologous recombination was used in insert the HA-tagged ubiquitin ORF
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immediately after the last codon of GLUT4-7K/R by repairing a version of pRM3 in which 
the GLUT4-7K7R STOP codon was replaced by an Sphl site (by SDM using oligos 183 
and 184; Table 2,2) and subsequently linearised using this site.
pRM4 was constmcted using the pairs of oligos 260, 263 and 261, 264 (Table 2.2) to 
generate two PCR products encoding amino acid residues 1 to 75 of wild type HA-GLUT4 
(with the exofacial HA-tag between residues 67 and 6 8 ) and amino acid residues 69 to 509 
of the hGLUT4-7K7R mutant, respectively, using pMEXHAGLUT4 (Benito et al., 1991; 
Shewan et al., 2000) and pRM3 as templates,. These two PCR products were ‘spliced’ 
together in a PCR using oligos 260 and 261 (Table 2.2) and subcloned as an EcoRl-SaH 
fragment into the pBABE-puro retroviral expression vector (Morgenstern and Land, 1990).
2.2.3. DNA sequencing
All plasmids constructed for use in this study were verified by DNA sequencing, which 
was performed by The Sequencing Service (School of Life Sciences, University of 
Dundee, Scotland) using Applied Biosystems Big-Dye Ver 3.1 chemistry on an Applied 
Biosystems model 3730 automated capillary DNA sequencer.
pRM25 was constructed using oligos 260 and 262 (Table 2.2) to generate a PCR product 
from pRM24 encoding GLUT4-7K/R~HA-Ub with EcoRI and Sad restriction sites at the 
5 ’ and 3’ ends, respectively. This PCR product was then subcloned into pBABE-puro 
retroviral expression vector (Morgenstern and Land, 1990).
pRM30 and pRM31 were constructed using oligos 149 and 153 (Table 2.2) to generate a 
PCR product from p i 839 (Piper et al., 1997) encoding LEU2 and regions of ~600bp 
upsti'eam and downstream of the LEU2 gene. This PCR product was used to replace the 
URA3 gene of pRM2 and pRM3 with the LEU2 gene, by homologous recombination.
pCALl was constructed by using SDM to mutate the codons for Met^ '^^  and Phe^ '*^  of 
Dsk2p in the context of the plasmid encoding the GST-UBA fusion protein (Funakoshi et 
al., 2002) to codons for arginine and alanine respectively, using oligos 352 and 353 (Table 
2.2) (this was peifoimed by Chris Lamb, a placement student in the lab).
3
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2.2.4. Transformation o fE .  coli and S. cerevisiae
Bacterial transformations were carried out as described (Hanahan, 1983). Yeast cells were 
made competent and transformed according to lithium acetate method, as described (Ito et 
al., 1983).
2.2.5. APNE assay 
Yeast cells were patched onto solid rich media (YPD) and overlaid with ~ 8 ml reaction 
media (RxM; 0.2M Tris-HCl pH7.4,0.2mg/ml N-acetyl-phenylalanine~p-naphthyl-ester 
(APNE) in dimethylfbrmamide (DMF), 0.8mg/ml Fast Garnet GBC salt and 0.7% (w/v) 
micro agar). Overlaid RxM was allowed to solidify and colour development of patched 
yeast was observed over time. PEP4 strains turn red, pep4-3 strains remain white.
2.2.6. Isolation o f  yeast chromosomal DNA
Yeast cells were grown to stationary phase in 10ml of rich medium, harvested and washed 
in 1ml l.OM sorbitol, O.IM EDTA (pH7.5). Cells were resuspended in 0.4ml l.OM 
sorbitol, O.IM EDTA (pH7.5) and transferred to a 1.5ml microcentrifuge tube. I5pl of 
15mg/ml yeast lytic enzyme (in 50mM Tris-HCl pH7.7, ImM EDTA, 50% (v/v) glycerol) 
was added to the cells prior to a 30min incubation at 37° C. The resulting spheroplasts 
were harvested in a microcentrifuge at 1840 g for 2mins and resuspended in 500/d TE 
(lOmM Tris-HCl pH8.0, ImM EDTA pH8.0). To lyse spheroplasts, 90//1 of lysis solution 
(0.25M EDTA pH8.0,0.4M Tris-HCl pH8.0,2% SDS (w/v)) was added, prior to a brief (2 
sec) period of vortexing and a 30 min incubation at 65°C. After spheroplast lysis, 80/d of 
5M KOAc was added to the lysates, and the samples left on ice for a minimum of 2hours. 
Precipitated matter, including insoluble potassium dodecyl sulphate and denatured 
proteins, was pelleted in a 15 min spin at top speed at 4°C in a microcentrifuge. 
Supernatants were transferred to fresh 1.5ml microcentrifuge tubes and DNA was 
precipitated by the addition of an equivalent volume of ice-cold 1 0 0 % ethanol.
Precipitated DNA was harvested in a 15 min spin at top speed at 4°C in a microcentrifuge.
I
The DNA pellets were washed with 70% ethanol (v/v), recovered in another 15 min spin at 
top speed at 4°C in a microcentrifuge, air-dried at 25°C, and resuspended in lOOjwl TE
(lOmM Tris-HCl pH8.0, ImM EDTA pH8.0). Ipl was routinely used as a template for 
PCR in a 50pl reaction.
: |
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2.2.8b. Cell culture o f Plat~E cells
Plat-E cells were cultured in DMEM supplemented with 10% (v/v) foetal calf serum 
(PCS), 1% (v/v) penicillin and streptomycin, lp.g/ml puromycin (Sigma) and lOpg/ml
■ I®
iri:
2.2.7. Plasmid rescue from  yeast
Yeast cells were grown to stationary phase in 10ml selective media and 5 ODggo 
equivalents of cells were harvested in a microcentifuge at 3610 g for 2mins. Cells were 
resuspended in 0.5ml buffer S (lOOmM K 2 HPO4 PH7 .2 , lOmM EDTA, 50mM |3- 
Mercaptoethanol, 50pg/ml yeast lytic enzyme (in 50mM Tris-HCl pH7.7, ImM EDTA, 
50% (v/v) glycerol)) and incubated at 37°C for 30mins. The resulting spheroplasts were 
harvested using centrifugation in a microfuge and lysed by resuspension and trituration in 
lOOfxl lysis buffer (25mM Tris-HCl pH7.5, 25mM EDTA and 2.5% (w/v) SDS) and 
incubation at 65°C for 30mins. 166pl 3M KOAc was added before incubation on ice for 
lOmins. Lysates were subject to centrifugation at top speed in a microcentrifuge for 
lOmins at 4°C. Supernatants were transferred to fresh microcentifuge tubes, and 0.8ml 
100% cold ethanol was added. Samples were left on ice for lOmins before being subject to 
centrifugation at top speed in a microcentrifuge. Precipitated DNA was washed with 70% 
ethanol (v/v), air dried, and resuspended in 40pl dH 2 0 . 20p,l was commonly used to 
transform XL-1 Blue cells.
2.2.8. Tissue culture techniques
2.2.8a. Cell culture o f3T 3-L l murine fibroblasts and adipocytes 
3T3-L1 fibroblasts were cultured in Dulbecco’s modified Eagle’s medium (DMEM) 
supplemented with 10% (v/v) newborn calf serum (NCS) and 1% (v/v) penicillin and 
sti'eptomycin. Fibroblasts were maintained as sub-confluent cultures at 37°C in a 10% CO 
humidified incubator. Differentiation into adipocytes was initiated 1 to 3 days post- 
confluency by the addition of DMEM containing 10% (v/v) foetal calf serum (FCS), 1% 
(v/v) penicillin and streptomycin, 0.25pM dexamethasone, 0.5mM 3-isobutyl-1- 
methylxanthine and Ipg/ml insulin. After 3 days, the differentiation medium was replaced 
with fresh DMEM supplemented with 10% (v/v) FCS, 1% (v/v) penicillin and 
streptomycin and 1 pg/ml insulin. Adipocytes were re-fed with DMEM supplemented with 
10% (v/v) FCS and 1% (v/v) penicillin and streptomycin every 3 days and utilised for 
experiments at least 8 - 1 2  days following the initiation of differentiation.
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blasticidin (Invitrogen). Plat-E cells were maintained as sub-confluent cultures at 37 °C in 
a 5% CO9  humidified incubator.
2.2.8c. Preparation o f virus using Plat-E cells 
cDNA constructs subcloned into the pBABE-puro retroviral expression vector were 
transfected into Plat-E cells (plated at a density of 5x10^ cells/10cm plate 24hr prior in 
DMEM with 10% (v/v) FCS) using Lipofectamine'^'^ 2000 reagent (Invitrogen) according
■to the manufacturer’s protocol. Transfection medium was replaced after 3hr with 8 ml 
DMEM with 10% (v/v) FCS. After a further 24hr at 37°C this media was replaced with 
6 ml DMEM with 10% (v/v) FCS to increase retroviral titre and following another 24hr at 
37°C, cells were transferred to 32°C for 24hr before harvesting the media, which was 
filtered through a 0.45pm syringe filter (Millipore) and stored at -80°C until required.
2.2.8d. Infection o f  fibroblasts with retrovirus
To generate 3T3-L1 adipocytes stably expressing each construct, 3T3-L1 fibroblasts 
(plated into 10cm dishes to achieve 40% confluence) were infected with the relevant 
retrovirus for 12hr in the presence of lOpg/ml Polybrene® (Sigma). Infected cells were 
selected in DMEM containing 10% (v/v) FCS, 1% (v/v) penicillin and streptomycin 
supplemented with 2pg/ml puromycin (Sigma). These infected fibroblasts were then 
grown to confluence and differentiated into adipocytes exactly as outlined in Section 2.2.8a 
except always with 2 pg/ml puromycin added to the medium.
2.2.9. Electrophoretic separation o f proteins
Electrophoretic separation of proteins was performed using discontinuous SDS 
polyacrylamide gels (SDS-PAGE) following the basic procedures outlined by (Laemmli,
1970). Proteins were separated using gels composed of a stacking region (5% acrylamide 
in stacking buffer; 0.25M Tris-HCl (pH6 .8 ), 0.2% (w/v) SDS) and a separating region 
(routinely 10% acrylamide in separating buffer; 0.75M Tris-HCl (pH8 .8 ), 0.2% (w/v)
SDS). A 30% acrlyamide-bisacrylamide mixture (37.5:1 ratio; Severn Biotech Ltd,
Worcestershire) was used. Gels were run in tiis-glycine electrophoresis buffer (25mM 
Tris-HCl, 250mM glycine, 0.1% (w/v) SDS).
I
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Resolved proteins were visualised by agitating gels in Coomassie Brilliant Blue solution 
(0.25g Coomassie Brilliant Blue R250 in methanol: HgO: glacial acetic acid (4.5:4.5:1 
v/v/v)) for 1 hour, followed by agitation in destain solution (5% (v/v) methanol, 10% (v/v) 
glacial acetic acid) until bands were clearly visible (generally overnight).
2.2.10. Transfer o f proteins onto nitrocellulose
A Bio-Rad Trans-Blot® SD cell was to transfer proteins from polyacrylamide gels onto 
nitrocellulose membranes (Protran, 0.45 p pore size). Gels and membranes were 
sandwiched between 6  pieces of Whatman 3MM paper, presoaked in semi-dry transfer 
buffer (50mM Tris-HCl, 40mM glycine, 0.037% (w/v) SDS, 10% methanol) prior to the 
application of constant 180mA current, which was routinely applied for anywhere between 
35 min (for one gel) up to 60 min (for fom* gels).
2.2.11. Immunoblot analysis
Following protein transfer, unfilled sites on the nitrocellulose membrane were blocked 
with 5% (w/v) non-fat dried milk in PB ST (0.1% (v/v) Tween-20 in phosphate buffered 
saline (PBS; 140mM NaCl, 3mM KCl, 1.5mM KH^PO^, 8 mM Na^HPO^)) by gentle 
agitation for at least 30 min at room temperature. The membranes were then exposed to 
primary antibody for either 2 hours at room temperature, or overnight at 4°C, with gentle 
agitation. Antibody preparations were diluted as described in Section 2.1.4 in 1% (w/v) 
non-fat dried milk in PB ST. Following exposure to primary antibody, the membrane was 
washed with PBST, 6  times for 5 min each, before exposure to secondary antibody for 1 
hour at room temperature [routinely, a-rabbit (at a 1:5000 dilution), a-rat (at a 1:2000 
dilution), or a-mouse (at a 1:2000 dilution) IgG-HRP conjugate; Amersham Biosciences, 
Bucks, UK] in 5% (w/v) non-fat dried milk in PBST. Following another 6  washes of 5 
min each in PBST, protein bands were visualised using ECL.
2.2.12. Preparation o f  yeast cell extracts fo r  immunoblot analysis
To assess the steady-state levels of proteins in yeast whole cell extracts, cells were 
harvested (by centrifugation for 5 min at 660 g on a bench top centrifuge) from yeast 
cultures that had grown to mid-log phase (OD^qq between 0 .6 - 1 .0 ), washed once in distilled 
water and resuspended to 100 OD units/ml in Twirl buffer (50mM Tris (pH 6 .8 ), 8 M urea, 
10% (v/v) glycerol, 5% (w/v) SDS and 0.2% (w/v) bromophenol blue, 10% (v/v) p-
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mercaptoethanol). Cell extracts were generated by a 10 min incubation at 65°C, followed 
by brief vortexing. The denatured proteins contained within 15 pi of cell extract were 
resolved by SDS-PAGE, transferred to nitrocellulose membrane, and subjected to 
immunoblot analysis.
2.2.13. Microscopic Analysis 
2.2.13a. Direct fluorescence with yeast
.
Yeast cells harbouring GFP-expressing plasmids were grown in selective medium 
containing lOO/dVI CuSO^ to an OD^ qq of 0.6-1.0. For labelling with FM4-64 (Molecular 
Probes, Oregon, USA), cells were labelled for Ihr at 30°C with 200nM FM4-64 in 
selective medium (SD). Cells were then washed at least twice before incubating for at 
least 30min at 30°C in selective media (SD). To ensure that the GFP protein was kept at 
the optimal pH level for fluorescence detection, cells were finally resuspended in 200pi 
IM Tris-HCl (pH8 ).
2.2.13b. Indirect immunofluorescence with yeast 
Cells were grown in selective medium (SD) containing 100/iM CuSO^ to an OD^ oo of 0.6- 
1.0. Cells were pre-fixed in 3.7% formaldehyde for Ihr at room temperature before
fixation in 45/fM NaOH, 4% (w/v) paraformaldehyde, O.IM KH2 PO4  for 16hrs at room 
temperature. Cells were converted to spheroplasts using 150/fg/ml yeast lytic enzyme in
1.2M sorbitol, 50mM KPi (pH7.3), ImM MgClg at 30°C for 30min and permeabilised by 
treatment with 1% (w/v) SDS in 1.2M sorbitol for Imin. Cells were then allowed to 
adhere to poly-L-lysine coated multiwell slides. Nonspecific antibody binding was 
blocked by incubation of cells in PBS containing 5mg/ml BSA and 0.1% (v/v) noimal 
donkey serum. Primary antibody incubations were performed at room temperature in a 
humid chamber for 2 hr. Antibodies against hGLUT4 and the HA epitope tag were pre­
absorbed to yeast proteins (to remove non-specific binding) by incubating with cells 
harbouring either pTC2 (a plasmid with a similar background to pWTG4) or cells without 
an HA-tagged protein, respectively. Cells were double labelled for hGLUT4 and 
hemagglutinin epitope (HA) tagged Kex2p by including both antibodies in the primary 
antibody solution. All antibodies were diluted in PBS containing 5mg/ml BSA, which was 
also used for all washes. Cells were then washed at least 7 times before undergoing a 1 In' 
incubation with the appropriate secondary antibodies diluted in PBS containing 5mg/ml
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BSA, which were conjugated to either Alexa Fluor-488 or Alexa Fluor-568 (Molecular' 
Probes, USA). Cells were again washed at least 7 times before being coverslipped with 
immunomount (Thermo Shandon, USA). Cells were visualised through a lOOx oil 
immersion objective on a Zeiss Axiovert fluorescence microscope (Carl Zeiss, Germany) 
equipped with a Zeiss LSM410 laser confocal imaging system. Image sets were processed 
and overlaid using Adobe Photoshop .
2.2.13c. Indirect immunofluorescence with 3T3-L1 adipocytes 
Cells were grown on coverslips (previously autoclaved and coated with gelatine) in 24- 
well plates and were washed twice with PBS prior to being fixed with 200pl of 3% (w/v) 
paraformaldehyde (PFA) in PBS for 30 min at room temperature. After another two 
washes with PBS, free aldehyde groups were neutralised by washing twice with 20mM 
glycine in PBS. Non-specific binding sites were blocked and cells permeabilised by 
incubating with 200(xl 0.1% (w/v) saponin in 2% (w/v) BSA in 20mM glycine in PBS for 
20 min. Cells undergoing staining to detect hemagglutinin epitope (HA) at the cell surface 
were not permeabilised but were incubated in 2% (w/v) BSA in 20mM glycine in PBS for 
20 mins to block non-specific binding sites. Incubation with primary antibodies was 
achieved by placing a 40pl drop of antibody preparation onto parafilm. Coverslips were 
removed from wells, the edges dried, and placed on top of tire drop of antibody, cell side 
down. Cells were double labelled for HA-tagged GLUT4 and endogenous Syntaxinl6  or 
EEAl by including both antibodies in 0.1% (w/v) saponin in 2% (w/v) BSA in 20mM 
glycine in PBS. For cell surface labelling of HA-tagged GLUT4, primary antibody was 
prepared in 2% (w/v) BSA in 20mM glycine in PBS. After a 45 min incubation, the 
coverslips were washed 4 times with either 0.1% (w/v) saponin in 2% (w/v) BSA in 20mM 
glycine in PBS or 2% (w/v) BSA in 20mM glycine in PBS. Secondary antibodies Alexa 
Fluor-488 (Molecular Probes) and Cy3-conjugated antibody (Jackson Immunoresearch) 
were apphed in a manner similar to that of the primary antibody but with a 30 min 
incubation time. After a further 4 washes, the coverslips were embedded in immunomount 
onto microscope slides and stored overnight in the dark at 4°C. Mounted coverslips were 
analysed using a 63x oil Immersion objective fitted to a Zeiss Axiovert fluorescence 
microscope, equipped with a Bio-Rad MRC-600 confocal imaging system. Image sets 
were processed and overlaid using Adobe Photoshop ™.
of cell lysate was reserved for SDS-PAGE analysis before 1ml of lysate was transferred to 
a fresh tube. To each tube, the appropriate primary antiserum (lOpl aGLUT4 (Brant et al., 
1992)) was added. After brief vortexing, lysates and antibodies were mixed by rotation for
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2.2.14. Immunoprécipitation from  yeast cell lysates
Yeast strains harbouring the appropriate plasmids were grown to mid-log phase (ODg^ o 
between 0.6-1.0) in 500ml of suitable selective media containing lOOpM CuSO^ to induce 
expression from the CUPl promoter as required. Cells were harvested (by centrifugation 
for 30 min at 1060 g in a bench top centrifuge) and resuspended in 5ml YPD-sorb (50% 
(v/v) YPD, 50% (v/v) 1.2M sorbitol), to which 50jxl of a 15mg/ml stock of yeast lytic 
enzyme (in 50mM Tris-HCl pH7.7, ImM EDTA, 50% (v/v) glycerol) and 15pl p- 
mercaptoethanol were added. Cells were converted to spheroplasts during a 1 hr 
incubation, with shaking, at 30°C. Spheroplasts were then layered onto 10ml of 1.2M 
sucrose (to cushion spheroplasts during centrifugation) before being harvested at 660 g for 
5min in a bench top centrifuge and transfened to ice. Spheroplasts were disrupted by 
vortexing briefly in 5ml ice-cold lysis buffer (200mM sorbitol, lOOmM KoAc, 1% (v/v) 
Triton X-100, 50mM KCl, 20mM PIPES (pH6 .8 )). Cell debris was removed by a 5 min 
spin at 660 g at 4°C in a bench top centrifuge before the cleared lysate was separated into 
aliquots of 1.2ml into screw-capped tubes. To reduce non-specific binding, 50pl of PrA- 
Agarose (50% slurry; Sigma-Aldrich) was added to the lysates, which were then briefly 
vortexed and incubated on ice for 15 min. PrA-Agarose was then removed by 
centrifugation for 5 min at 7370 g at 4°C in a bench top centrifuge. A small aliquot (lOjrl)
I
I
2 hr at 4°C, prior to the addition of 50p,l PrA-Agarose and a subsequent additional hour of
rotation at 4°C. PrA-Agarose with bound antibody and associated proteins were pelleted 
in a 1 min spin at 7370 g at 4°C in a bench top centrifuge, and pellets washed 3 times in 
1ml lysis buffer. Bound proteins were eluted in 20pl LSB (lOOmM Tris-HCl (pH6 .8 ), 4% 
(w/v) SDS, 20% (v/v) glycerol, 0.2% (w/v) bromophenol blue, 10% (v/v) j3- 
mercaptoethanol) and denatured by incubation for 5 min at 65 °C. PrA-Agarose was 
pelleted in a 5 min spin at top speed in a microcentrifuge and immunoprecipitated proteins 
resolved by SDS-PAGE, transferred to nitrocellulose membrane, and subjected to 
immunoblot analysis.
 '=71
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phenylmethylsulphonyl fluoride (PMSF), lOpg/ml soybean trypsin inhibitor, lOpg/ml 
benzamidine and EDTA-free complete protease inhibitor mix (1 tablet (Roche) / 50ml lysis 
buffer). Pooled cells were homogenised by passing the cell suspension through a 24XG 
needle 10 times and twice through a 26XG needle. In order to remove lipid droplets,
2.2.15. Preparation o f3T 3-L l adipocytes lysate
3T3-L1 adipocytes cultured on 10cm dishes were washed once and incubated at 37 °C in 
serum-ffee DMEM for 2 hr. Following the transfer of plates onto ice, the cells were 
washed 3 times with cold PBS. All subsequent steps were performed on ice unless 
indicated otherwise. Cells were scraped from the plate into 0.25ml/plate lysis buffer 
(50mM sodium HEPES (pH7.5), 150mM sodium chloride, 5mM EDTA, ImM sodium 
vanadate, 6 [iM MG132, ImM N-ethylmaleimide (NEM), 1% (v/v) Triton X-100, O.lmM
homogenized cells were centrifuged at 500 g for 10 min at 4°C in a bench top centrifuge 
and the lysate removed from underneath the floating layer of lipid.
2.2.16. Immunoprécipitation from  3T3-L1 adipocytes lysate
1ml adipocyte lysate (prepared as described in Section 2.2.15) was incubated at 4°C for 1 
hr with rotation before centrifugation at 12470 g for 15 min at 4°C in a bench top 
centrifuge to pellet insoluble material. To reduce non-specific binding, 50 pi of PrA- 
Agarose (50% slurry; Sigma-Aldrich) was added to the lysates, which were then briefly 
vortexed and incubated on ice for 15 min. PrA-Agarose was then removed by 
centrifugation for 5 min at 7370 g at 4°C. A lOpl aliquot of cell lysate was reserved for 
SDS-PAGE analysis before 1ml of lysate was transferred to a fresh tube. To each tube, the 
appropriate primary antisera (e.g. lOpl aGLUT4 (Brant et al., 1992)) was added. After 
brief vortexing, lysates and antibodies were mixed by rotation for 2  hr at 4°C, prior to the 
addition of 50pl PrA-Agarose (50%slun*y; Sigma-aldrich) and a subsequent additional 
hour of rotation at 4°C. PrA-Agarose with bound antibody and associated proteins were 
pelleted in a 1 min spin at 7370 g at 4°C in a bench top centrifuge, and pellets washed 3 
times in 1ml lysis buffer. Bound proteins were eluted in 20pl LSB (lOOmM Tris-HCl 
(pH6 .8 ), 4% (w/v) SDS, 20% (v/v) glycerol, 0.2% (w/v) bromophenol blue, 10% (v/v) p- 
mercaptoethanol) and denatured by incubating for 5 min at 65 °C. PrA-Agarose was 
pelleted in a 5 min spin at top speed in a microcentrifuge and immunoprecipitated proteins 
resolved by SDS-PAGE, transferred to nitrocellulose membrane, and subjected to 
immunoblot analysis.
I
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2.2.17. GST fusion protein expression and purification
Chemically competent BL-21(DE3) cells (Invitrogen) were transformed with plasmids 
driving the production of the appropriate GST fusion protein. Overnight cultures of 
transformed cells were diluted into 400ml Terrific Broth medium (with appropriate 
antibiotics) and incubated, with shaking, at 37°C until an OD^ go of ~0.6 was reached. 
Expression of the recombinant fusion proteins was then induced with ImM isopropyl-p-D- 
thiogalactopyranoside (IPTG) for 4 hr. Cells were harvested by centrifugation in a 
Beckman Coulter SX4750 rotor at 3,273 g for 20 min. Cell pellets were resuspended in 
19,5ml PBS before transfer to 50ml falcon tubes and incubation with lysozyme (at a final 
concentration of 1 mg/ml) for 30 min on ice. Cells were lysed by immersing the probe of a 
Sanyo Soniprep 150 in the suspension and sonicating for 5 x 30 sec pulses, with 30 sec 
cooling periods on ice separating the pulses of sonication. Cell lysates were centrifuged in 
a Beckman JA-20 rotor for 30 min at 4°C at 48,400 g to remove insoluble material. To 
recover fusion proteins, glutathione-Sepharose (Amersham Biosciences) was pre­
equilibrated (as per the manufacturer’s instructions) and made up to a 50% slmiy in PBS. 
An aliquot of glutathione -Sepharose slurry was added to the cleared bacterial lysate 
containing the GST- (glutathione S- transferase) tagged fusion proteins. Generally, -0.5ml 
glutathione-Sepharose slurry was used. Lysates and glutathione-sepharose resin were then 
mixed, with rotation, for at least 1 hr at 4°C. Beads loaded with recombinant proteins were 
routinely harvested in a 2 min spin at 500 g at 4°C, followed by at least 3 washes in cold 
PBS (generally -1ml) to remove non-specifically bound proteins. Beads were resuspended 
in PBS supplemented with protease inhibitors (1 tablet complete inhibitor cocktail 
(Roche)/ 50ml PBS) at a bead:buffer ratio of 1:1.
2.2.18. GST fusion protein pull down assays from  adipocyte cell lysates 
Recombinant GST fusion proteins were purified from transformed E.coli BL21(DE3) 
cultures as outlined above in Section 2,2.17. For pull-down assays, 3T3-L1 adipocytes 
cultured on 10cm dishes were washed once and incubated at 37°C in serum-ffee DMEM 
for 2 hr. Following the transfer of plates onto ice, the cells were washed 3 times with cold 
PBS. All subsequent steps were performed on ice unless indicated otherwise. Adipocyte 
cell lysates (prepared as described in Section 2.2.15) was then incubated at 4°C for 1 hr 
with rotation before centrifugation at 12470 g for 15 min at 4°C in a bench top centrifuge
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to pellet insoluble material A lOpl aliquot of cell lysate was reserved for SDS-PAGE 
analysis before the lysate was split equally amongst the various GST fusion proteins 
(10[xg/sample) immobilised to glutathione-Sepharose beads and incubated with rotation at 
4°C for 2 hr. Beads were recovered by a brief 20 sec centrifugation and washed 3 times 
with lysis buffer prior to the elution of bound proteins by the addition of 20p,l LSB and 
incubation at 65°C for 15 min. Samples were subject to SDS-PAGE and immunoblot 
analysis.
i.
2.2.19. GST fusion protein pull down o f yeast cell lysates
Yeast strains harbouring the appropriate plasmids were grown to mid-log phase (ODggg 
between 0.6-1.0) in 50ml of suitable selective media containing lOOpM CuSO^ to induce 
expression from the CUPl promoter as required. Cells were harvested (by centrifugation 
for 5 min at 900 g in a bench-top centrifuge) and resuspended in 5ml YPD-sorb (50% (v/v) 
YPD, 50% (v/v) 2.4M sorbitol), to which 50pi of a 15mg/ml stock of yeast lytic enzyme 
(in 50mM Tris-HCl pH7.7, ImM EDTA, 50% (v/v) glycerol) and 15pi (3-mercaptoethanol 
were added. Cells were converted to spheroplasts during a 1 hr incubation, with shaking, 
at 30°C. Spheroplasts were collected by centrifuging at 660 g for 5 min in a bench top 
centrifuge and resuspended in 250/d pull-down lysis buffer (50mM sodium HEPES 
(pH7.5), 150mM sodium chloride, 5mM EDTA, ImM sodium vanadate, 6pM MG132, 
ImM N-ethylmaleimide (NEM), 1% (v/v) Triton X-100, O.lmM phenylmethylsulphonyl 
fluoride (PMSF), lOpg/ml soybean trypsin inhibitor, lOpg/ml benzamidine and EDTA-free 
complete protease inhibitor mix (1 tablet (Roche) / 50ml lysis buffer) before transferring to 
a 1.5ml microfuge tube. Cell lysate was then incubated at 4°C for 1 hr with rotation before 
centrifugation at 12470 g for 15 min at 4°C in a bench top centrifuge to pellet insoluble 
material. Samples were equalised for protein concentration by Bradford assay and a small 
aliquot of cell lysate reserved for SDS-PAGE analysis before the lysate was split equally 
amongst the vaiious GST fusion proteins (lOpg/sample) immobilised to glutathione 
Sepharose beads and incubated with rotation at 4°C for 2 hr. Beads were recovered by a 
brief 20 sec centrifugation and washed 3 times with lysis buffer prior to the elution of 
bound proteins by the addition of 20pl LSB and incubation at 65°C for 15 min. Samples 
were subject to SDS-PAGE and immunoblot analysis.
1
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2.2.20. Subcellular membrane fractionation o f 3T3-LI adipocytes
3T3-L1 adipocytes cultured on 10cm dishes were washed once and incubated at 37°C in 
serum-free DMEM for 2 hr, prior to incubation with 200nM insulin for 15 mins. 4
Following the transfer of plates onto ice, the cells were washed 3 times with cold PBS. All
subsequent steps were performed on ice unless indicated otherwise. Cells were scraped 
from the plate into 1 ml/plate HES+PI (250mM sucrose, 20mM HEPES (pH7.4), ImM 
EDTA and 1 protease inhibitor tablet (Roche)/ 50ml HES buffer). Pooled cells were 
homogenised by passing the cell suspension through a 25XG needle 10 times and twice 
through a 27XG needle. In order to remove lipid droplets, homogenized cells were 
centrifuged at 500 g for 10 min at 4°C in a bench top centrifuge and the homogenate 
removed from underneath the floating layer of lipid. Homogenate was subject to 
differential centrifugation to prépaie subcellular membrane fractions. This protocol yields 
four membrane fractions designated as high-density microsomes (HDM), low-density 
microsomes (LDM), plasma membrane (PM) and mitochondria/nuclei (M/N). All 
centrifugation steps were carried out at 4°C. The homogenates were initially centrifuged 
for 12 mins at 12000rpm in an 80Ti rotor (Beckman, Palo Alto, CA, USA) to pellet PM 
and M/N. This pellet was resuspended in 10ml of HES+PI and recentrifuged for 12 mins
at 12000rpm in an 80Ti rotor, the washed pellet was resuspended in 1ml HES+PI and +
%layered onto 10ml high sucrose HES (1.12M sucrose, ImM EDTA, 20mM HEPES •f*(pH7.4)) and centrifuged for 60mins at 25000rpm using a SW41T1 rotor (Beckman, Palo 
Alto, CA, USA). The pellet obtained from this step represents the M/N. The PM fraction 
was removed from the interface, HES added to a final volume of 12ml and the membranes 
collected by centrifugation for 15 mins at 15000rpm in an 80Ti rotor. The supernatant 
from the initial 80Ti centrifugation, comprising LDM, HDM and cytosol was subjected to 
centrifugation for 17 mins at 15000rpm in an 80Ti rotor to isolate the HDM fraction. The
.-i:!resulting supernatant was then subject to centrifugation for 75mins at SOOOOrpm using an 
80Ti rotor to yield the LDM fraction. Membrane fractions were resuspended in HES+PI
'éiand stored at -20°C.
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E.coli strains used in this study:
Strain Genotype Source
BL-21
(DE3)
E  ompT hsdS^{ïj{m^') gal dam (DE3) Invitrogen
XL-1 Blue recAl endAl gyrA96 thi-1 hsdRl 7 supE44 relAl lac /F ’ proAB 
toc/"ZAM75TnlO(Tef)]
Stratagene
S.cerevisiae strains used in this study:
Strain Genotype Construction Source
1 SF838-9Da MATa leu2~3,112 ura3~52 his4-519 
ade6  gal2 pep4-3
(Rothman et 
al., 1989)
2 RFYIO MATa leu2~3,112 ura3~52 his4-519 
adc6  gal2
(Piper et al,, 
1994)
7 MC996A MATa ura3-52 his3-U,15 leu2-3,112 
MAL2 SUC2 GAL MEL
(Reifenberger 
et al., 1995)
8 KY73 MATa ura3-52 his3-ll,15 leu2-3,112 
MAL2 SUC2 GAL MEL 
hxtlA::HIS3::Ahxt4 hxt5::LEU2 
hxt2A::HIS3 hxt3A::LEU2 ::Ahxt6  
hxt7::HIS3
(Reifenberger 
et al., 1995)
1 0 SEY6210 MATa ura3-52 his3-A200 leu2-3,112 
lys2-801 trpl-A901 suc2-A9 ade2- 
101
(Robinson et 
al., 1988)
2 0 RMYl KY73 with pep4-3 pL02010 
(Nothwehr et 
a l, 1995) 
linearised with 
EcoRI was 
used to disrupt 
PEP4 in KY73
This study
2 1 RMY2 MC996A with pep4-3 pL02010 
(Nothwehr et 
al., 1995) 
linearised with 
EcoRI was 
used to disrupt 
PEP4 in 
MC996A
This study
77 SGY73 leu2-3,112 ura3-52 his4-519 ade6  
pep4-3 Avps27::LEU2
(Gerraid et 
al., 2 0 0 0 )
8 8 MBY004 MATa ura3-52 his3~A200 leu2-3,112
lys2-801 trpl-A901
suc2A9ggal : :HIS5spLgga2 : :TRP1 .....................
(Black and 
Pelham, 
2 0 0 0 )
Table 2.1. E.coli and S.cerevisiae strains used in this study
«
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Oligo Description Sequence (5^ => 3’)
1 CUE7hGLUT4 GATATTAAGAAAAACAAACTGTACAATCA
ATCAATCAATCATCACATAAAATGCCGTC
GGGCTTCCAACAGATA
2 3 ’C/ri?hGLUT4 ATTATAACGTATTAAATAATATGTGAAAA
AAGAGGGAGAGTTAGATAGGATCAGTCG
TTCTCATCTGGCCCTAA
61 hGLUT4K495RhGLUT4 CTTTTAGAGCAGGAGGTGCGACCCAGCAC
AGAACTTG
62 reverse compliment of 61 CAAGTTCTGTGCTGGGTCGCACCTCCTGC
TCTAAAAG
73 hGLUT4K109RhGLUT4 CAGTGGCTTGGAAGGCGAAGGGCCATGCT
GGTC
74 reverse compliment of 73 GACCAGCATGGCCCTTCGCCTTCCAAGCC
ACTG
85 hGLUT4K242RhGLUT4 CGAGGGGCCTGCCAGACGAAGTCTGAAG
CGCCTGAC
8 6 reverse compliment of 85 GTCAGGCGCTTCAGACTTCGTCTGGCAGG
CCCCTCG
87 hGLUT4K245RhGLUT4 CTGCCAGAAAGAGTCTGCGACGCCTGACA
GGCTGGG
8 8 reverse compliment of 87 CCCAGCCTGTCAGGCGTCGCAGACTCTTT
CTGGCAG
89 hGLUT4K261RhGLUT4 GAGTGCTGGCTGAGCTGCGAGATGAGAA
GCGGAAGC
90 reverse compliment of 89 GCTTCCGCTTCTCATCTCGCAGCTCAGCCA
GCACTC
91 hGLUT4K264RliGLUT4 CTGAGCTGAAGGATGAGCGACGGAAGCT
GGAGCGTG
92 reverse compliment of 91 CACGCTCCAGCTTCCGTCGCTCATCCTTCA
GCTCAG
93 hGLUT4K266RhGLUT4 GAAGGATGAGAAGCGGCGACTGGAGCGT
GAGCGGC
94 reverse compliment of 93 GCCGCTCACGCTCCAGTGCCCGCTTCTCA
TCCTTC
117 hGLUT4K109RK242RK245
RhGLUT4K109RK242R
CTGCCAGACGAAGTCTGCGACGCCTGACA
GGCTGGG
118 reverse compliment of 117 CCCAGCCTGTCAGGCGTCGCAGACTTCGT
CTGGCAG
119 hGLUT4K109RK242RK245
RK261RK264RhGLUT4K10
9RK242RK245RK261R
CTGAGCTGCGAGATGAGCGACGGAAGCT
GGAGCGTG
1 2 0 reverse compliment of 119 CACGCTCCAGCTTCCGTCGCTCATCTCGC
AGCTCAG
1 2 1 hGLUT4K109RK242RK245
RK261RK264RK266RhGL
UT4K109RK242RK245RK2
61RK264R
GCGAGATGAGCGACGGCGACTGGAGCGT
GAGCGGC
I
J
I
■
4
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1 2 2 reverse compliment of 1 2 1 GCCGCTCACGCTCCAGTCGCCGTCGCTCA
TCTCGC
149 LEU23’ GGTTAAAAAATGAGCTGATTTAAC
153 LEU25’ GGAGACGGTCACAGCTTGTC
183 h G L U T 4 7 K R ^ 3 ’UTR GGGCCAGATGAGAACGACGCATGCTCCTA
TCTAACTCTCCCTC
184 reverse compliment of 183 GAGGGAGAGTTAGATAGGAGCATGCGTC
GTTCTCATCTGGCCC
185 rV T R S p h m b ATTATAACGTATTAAATAATATGTGAAAA
AAGAGGGAGAGTTAGATAGGAGCATGCT
TAACCTCCACGCAGACGCAAGACCAA
186 hGLUT47KR.VpMHA-Ub GGAGGTGCGACCCAGCACAGAACTTGAG
TATTTAGGGCCAGATGAGAACGACGCATG
CATGAAATACCCATACGATGTT
231 hGLUT47KRR109KhGLUT
47KR
CAGTGGCTTGGAAGGAAAAGGGCCATGC
TGGTC
232 reverse compliment of 231 GACCAGCATGGCCCTTTTCCTTCCAAGCC
ACTG
233 hGLUT47KRR242KhGLUT
47KR
GAGGGGCCTGCCAGAAAGAGTCTGCGAC
GCCTG
234 reverse compliment of 233 CAGGCGTCGCAGACTCTTTCTGGCAGGCC
CCTC
235 hGLUT47KRR245KhGLUT
47KR
GCCAGACGAAGTCTGAAGCGCCTGACAG
GCTGG
236 reverse compliment of 235 CCAGCCTGTCAGGCGCTTCAGACTTCGTC
TGGC
237 hGLUT47KRR261KhGLUT
47KR
GTGCTGGCTGAGCTGAAGGATGAGCGAC
GGCGA
238 reverse compliment of 237 TCGCCGTCGCTCATCCTTCAGCTCAGCCA
GCAC
239 hGLUT47KRR264KhGLUT
47KR
GAGCTGCGAGATGAGAAGCGGCGACTGG
AGCGTG
240 reverse compliment of 239 CACGCTCCAGTCGCCGCTTCTCATCTCGC
AGCTC
241 hGLUT47KRR266KhGLUT
47KR
CGAGATGAGCGACGGAAGCTGGAGCGTG
AGCGG
242 reverse compliment of 241 CCGCTCACGCTCCAGCTTCCGTCGCTCATC
TCG
243 hGLUT47KRR495KhGLUT
47KR
CTTTTAGAGCAGGAGGTGAAACCCAGCAC
AGAACTTG
244 reverse compliment of 243 CAAGTTCTGTGCTGGGTTTCACCTCCTGCT
CTAAAAG
260 EcoRIhGLUT4 GGAATTCATGCCGTCGGGCTTCCAACAG
261 ^a/IhGLUT4 AGGGTCGACTCAGTCGTTCTCATCTGGCC
C
262 5'n/IUb AGGGTCGACTTAACCTCCACGCAGACGCA
AG
263 3’hGLUT4 from residue 69 GCCTGGAGGGATGGAGCTGGG
264 5’hGLUT4 from residue 69 CCCAGCTCCATCCCTCCAGGC
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343 hGLUT45/7M3’UTR 
(removing stop)
GCCAGATGAGAACGACGCATGCTATCTAA
CTCTCCCTC
344 reverse compliment of 343 GAGGGAGAGTTAGATAGCATGCGTCGTTC
TCATCTGGC
352 DSK2M342RF344ADSK2 GACAACTAAACGACAGGGGCGCCTTCGAT
TTCGATAGAAAC
353 reverse compliment of 352 GTTTCTATCGAAATCGAAGGCGCCCCTGT
CGTTTATTGGTC
365 hGLUT45pMGFP GGAGGTGCGACCCAGCACAGAACTTGAG
TATTTAGGGCCAGATGAGAACGACGCATG
CATGGGTAAAGGAGAAGAACTTTTC
366 3’UTR5pMGFP ATTATAACGTATTAAATAATATGTGAAAA
AAGAGGGAGAGTTAGATAGGAGCATGCT
TACTTGTATAGTTCATCCATGCCATG
Table 2.2. Oligonucleotides used in this study
%
4
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Plasm id Description Reference
1 pL02010 pep4-AH3 in pRS306 (Nothwehr et al., 
1995)
33 pRM2 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 from the CUPi promoter
This study
6 6 pRMl Yeast expression plasmid {CEN, LEU2) encoding 
HA-tagged ubiquitin from the CL/Pipromoter
This study
133 pTC2 Yeast expression plasmid {CEN, URA3) encoding 
PH 08  under control of CUPipromoter
This study 
(constructed by 
Tom Carr)
155 pRM5 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutation K495R 
from the CUPl promoter
This study
174 pRM 6 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutation K242R 
from the CUPl promoter
This study
175 pRM7 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutation K245R 
from the CUPl promoter
This study
176 pRM 8 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutation K261R 
from the CUPl promoter
This study
187 pl839 Yeast expression plasmid (CEN, LEU2) encoding 
PH08 from the GAL promoter
(Piper et al., 
1997)
190 pRM9 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutation K264R 
from the CUPl promoter
This study
191 pRMlO Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutation K266R 
from the CUPl promoter
This study
197 pR M ll Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutations K495R 
and K242R from the CUPl promoter
This study
198 pRM12 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutations K495R, 
K242R and K245R from the CUPl promoter
This study
203 pRM13 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutations K495R, 
K242R, K245R and K261R from the CUPl 
promoter
This study
204 pRM14 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutations K495R, 
K242R, K245R, K261R and K264R from the 
CUPl promoter
This study
205 pRM15 Yeast expression plasmid {CEN, URA3) encoding 
human GLUT4 with the point mutations K495R, 
K242R, K245R, K261R, K264R and K266R 
from the CUPl promoter
This study
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%
206 pRM3 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4 with lysines 109, 242, 245, 261, 
264, 266, 495 mutated to arginine residues 
(GLUT4-7K7R) from the CUPl promoter
This study
230 pRM16 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4 with the point mutation K109R 
from the CUPl promoter
This study
269 p2313 Yeast expression plasmid (CEN, URA3) encoding 
GFP-tagged Gap Ip from the CUPl promoter
(Scott et al., 
2004)
305 pRM17 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4-7K7R with the point mutation 
R242K fr om the CUPl promoter
This study
306 pRM18 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4-7K/R with the point mutation 
R261K from the CUPl promoter
This study
311 pRM19 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4-7K/R with the point mutation 
R109K from the CUPl promoter
This study
312 pRM20 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4-7K/R with the point mutation 
R245K from the CUPl promoter
This study
313 pRM21 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4-7K/R with the point mutation 
R264K from the CUPl promoter
This study
314 pRM22 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4-7K/R with the point mutation 
R266K from the CUPl promoter
This study
315 pRM23 Yeast expression plasmid (CEN, URA3) encoding 
human GLUT4-7K/R with the point mutation 
R495K fr om the CUPl promoter
This study
316 pRM24 Yeast expression plasmid (CEN, URA3) encoding 
GLUT4-7K/R-HAUb from the CUPl promoter
This study
320 pRM25 Retroviral expression vector encoding GLUT4- 
7K/R-HAUb
This study
321 pRM4 Retroviral expression vector encoding HA-tagged 
GLUT4-7K/R
This study
332 pSN222 Yeast expression plasmid (CEN, LEU2) encoding 
HA-tagged Kex2p
(Nothwehr et al., 
1995)
346 pRM30 Yeast expression plasmid (CEN, LEU2) encoding 
human GLUT4 from the CUFipromoter
This study
347 pRM31 Yeast expression plasmid (CEN, LEU2) encoding 
GLUT4-7K/R from the CfTPi promoter
This study
358 pHA-
GLUT4
Retroviral expression vector encoding HA-tagged 
GLUT4
(Shewan et al., 
2 0 0 0 )
359 pGEX-
DSKuba
Exoli expression vector encoding GST-UBA (the 
UBA domain, residues 328-373 fused to the C- 
terminus of GST), based on pGEX
(Funakoshi et al., 
2 0 0 2 )
390 pCALl Exoli expression vector encoding GST-UBA^^t 
(as pGEX-DSKijBA but with two point mutations.
This study 
(constructed by
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M342R and F344A in the UBA domain) Chris Lamb)
398 GST-GGAl-
VHS-GAT
E.coli expression vector encoding the VHS and 
GAT domains o f G G A l, based on pGEX
(Mattera et al., 
2004)
399 GST-GGA3-
VHS-GAT
E.coli expression vector encoding the VHS and 
GAT domains o f GGA3, based on pGEX
(Mattera et al., 
2004)
405 2256 Yeast expression plasm id (CEN, URA3) encoding 
HA-tagged GGA2
(Scott et al., 
2004)
406 2309 Yeast expression plasm id (CEN, URA3) encoding 
HA-tagged GGA2gatA
(Scott et al., 
2004)
421 pRM34 Yeast expression plasm id (CEN, URA3) encoding 
human GLUT4 tagged with GFP(S65T) from the 
CU Pl promoter
This study
Table 2.3. Plasmids used in this study
Chapter 3: Investigation ofGLUT4 trafficking in yeast 
Saccharomyces cerevisiae
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Chapter 3 : Investigation o f GLUT4 trafficking in yeast Saccharomyces
cerevisiae,
3.1. Introduction
Kaiser and colleagues first noted that yeast possess a regulated membrane trafficking step 
that bears remarkable similarity to the insulin-regulated trafficking of GLUT4; that is the 
nitrogen-regulated trafficking of the general amino acid permease Gap Ip (Roberg et al., 
1997). Fat and muscle cells increase their capacity to take up glucose in response to 
insulin by delivering the GLUT4 transporter to the cell surface from an intiacellular 
storage compartment. Likewise, the general amino acid permease Gap Ip is stored 
intracellularly under nutrient rich conditions but when nutrients are limited. Gap Ip is 
trafficked to the plasma membrane where it facilitates the uptake of amino acids from the 
extracellular media (Roberg et al., 1997).
Given the paiallels that exist between the insulin-regulated trafficking of GLUT4 in fat and 
muscle cells and the nitrogen-regulated trafficking of Gap Ip in S. cerevisiae, a chimeric 
protein was constructed, in which the carboxyl terminal tail of GLUT4 was replaced with 
the analogous portion of Gap Ip. When expressed in adipocytes, this GLUT4/Gaplp 
chimera localises to the TGN, like endogenous GLUT4 (unpublished data; Nia Biyant and 
David James, Figure 1.6). Additionally, like GLUT4 itself, the GLUT4/Gaplp chimera 
tianslocates to the cell surface of adipocytes upon insulin stimulation (unpublished data; 
Nia Bryant and David James, Figui'e 1.6). To build on this observation, I set out to further 
explore the parallels between GLUT4 and Gap Ip regulated trafficking by testing the 
hypothesis that mammalian GLUT4 would traffic in a nitrogen-regulated manner if 
expressed in the S. cerevisiae (yeast).
To this end, I expressed human GLUT4 (hGLUT4) in yeast. This chapter describes how 
this was achieved and also presents data consistent with the above hypothesis.
3.2. Expression o f  hGLUT4 in yeast Saccharomyces cerevisiae.
Previous studies expressing mammalian GLUT4 in yeast have reported that the transporter 
is retained intracellulaily, localising to the endoplasmic reticulum (ER) (Kasahara and 
Kasahara, 1997; Wieczorke et al., 2003). This ER localisation may be due to the high
Rebecca K McCann, 2007 Chapter Three, 59
levels of expression used in these studies as they expressed GLUT4 at very high levels 
from the GALl-10 promoter. In order to produce GLUT4 at more modest levels in yeast, I 
undertook to express the transporter from the regulatable CUPl promoter.
The yeast CUPl promoter is derived from the copper metallothionein protein (Cu-MT); a 
low molecular weight, cysteine-rich protein that binds copper and whose induction in 
response to the addition of copper to yeast cells results in their copper resistance (Butt et 
al., 1984). One advantage of using the CUPl promoter for heterologous gene expression is 
that it is titratable, allowing gene expression to be tightly modulated (Mascorro-Gallardo et 
al., 1996). This can prevent the masking of certain phenotypes that would otherwise occur 
with gene overexpression. The expression features of the CUPl promoter contrast with 
that of the GALl-10 promoter from which GLUT4 has previously been expressed in yeast 
(Kasahara and Kasahara, 1997; Wieczorke et al., 2003), which, in the presence of galactose 
and absence of glucose, induces a 1000-fold increase in gene expression (Adams, 1972; 
Douglas and Hawthorne, 1964). This high level of expression from the GALl-10 promoter 
is either switched ‘on’ or ‘o ff  and lacks the advantages of being more tightly controlled.
In order to place the GLUT4 ORF under CUPl control, the strategy outlined in Figure 3.1 
was adopted to construct plasmid pWTG4 (pRM2) (harbouring hGLUT4 under control of 
the CUPl promoter).
I
' 4 "
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CUP1 ^xho l
3VTR
' +
^^3VTR 
pNB701
V
pNB701 digested with 
XhoMSah
Co-transformed with hGLUT4 
PCR product into SF838-9D<x.
pNB701
\ 7
CUP1
 3VTR
pWTG4
Figure 3.1. Schematic of pWTG4 (pRM2) construction
(details as described in text. Please note that the Xhol and Sail sites indicated in pNBlOl 
are unique).
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Plasmid pNB701 (based on pRS316 (Sikorski and Hieter, 1989), and constructed by Nia 
Bryant) contains the ORF encoding the protein RS-ALP (retention sequence-ALP) (Bryant 
et al., 1998b) under control of the CUPl promoter, followed by the 3'UTR of PH08  (a 
region often containing important regulatory sequences (Mazumder et ah, 2003)). 
Homologous recombination was used to replace the RS-ALP ORF of pNB701 with the 
ORF for hGLUT4. To this end, PCR was used to amplify hGLUT4 from a plasmid 
carrying human GLUT4 cDNA (provided by Professor Gwyn Gould) using hGLUT4 
oligos 1 and 2 (Figure 3.2 and Table 2.2). These primers were designed to produce a 
fragment of DNA, encoding human GLUT4, with ends homologous to the CUPl promoter 
and PH 08 3'UTR. The majority of the ORF for RS-ALP was removed from pNB701 by 
digestion with restriction enzymes Xhol and Sail and the resulting linear plasmid, along 
with the hGLUT4 PCR fragment, was used to co-transform SF838-9Da yeast cells. 
Homologous recombination between the ends of the PCR product and the linearised 
plasmid (as illustrated in Figure 3.1) allowed the hGLUT4 PCR product to repair the gap 
created in pNB701, thereby creating pWTG4 (pRM2).
hGLUT4 oligol
GATATTAAGAAAAACAAACTGTACAATCAATCAATCAATCATCACATAA/Ü 
:------------— — ---------- >  y C U P I  <--------   —
ATGCCGTCGGGCTTCCAACAGATA 
--------------- ^  5'hGLUT4<
hGLUT4 oligo2
^TTATAACGTATTAAATAATATGTGAAAAAAGAGGGAGAGTTAGATAGGA 
— -------  >  G 'o f  3 'U 7 jR  < ----------------------------------
TCAGTCGTTCTCATGTGGCCCTAA 
 p, 3'hGLUT4<---------
Figure 3.2. HGLUT4 primer sequences
Following the co-tiansformation reaction, colonies were selected on media lacking uracil 
(any cells that did not repair the gapped plasmid would not be able to grow as the 
linearised plasmid would not be able to propagate). Colonies were picked from this plate 
and patched onto media lacking uracil and containing 150pM CuSO^. Immunoblot 
analysis was performed to identify colonies that were expressing human GLUT4. This was 
performed by Nia Bryant and is therefore not presented in this thesis. Plasmid was rescued 
from colonies identified as expressing GLUT4 and these were subsequently transformed 
into ‘fresh’ SF838-9Da yeast cells to check for expression of GLUT4. Having obtained 
plasmid DNA that drives the expression of human GLUT4 from the CUPl promoter, I 
confirmed that no errors had been introduced into the GLUT4 ORF using DNA
- ' H l l
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sequencing. The plasmid thus obtained was subsequently used to characterize the 
expression of human GLUT4 in yeast.
The ability of plasmid pWTG4 (pRM2) to drive the expression of hGLUT4 in yeast was 
characterised using immunoblot analysis. pWTG4 (pRM2) was used to transform into 
SF838-9Da yeast cells and the resulting transformants were grown in selective media (SD) 
either containing 100//M CuSO^, or not, (as indicated; Figure 3.3). Proteins contained in 
lysates prepared from 10 ODggg equivalents of cells were separ ated using SDS-PAGE prior 
to immunoblot analysis using an antibody that specifically recognises the carboxyl- 
terminal fourteen amino acids of GLUT4 (Brant et al., 1992).
An immunoreactive band with an apparent molecular weight of ^ 42KDa was detected in 
cells grown in the presence of copper but missing from those cells grown in the absence of 
copper, indicating that this band is a result of expression from the CUPl promoter. No 
such band was detected in SF838-9Da cells harbouring pTC2 (a plasmid harbouring 
PH 08  under the CUPl promoter instead of hGLUT4, from Tom Carr) indicating the band 
was specific to cells carrying pWTG4. Lysate from 3T3-L1 adipocytes was used as a 
positive control for the presence of mammalian GLUT4. Although the predicted molecular 
weight of hGLUT4 is 55kDa (Fukumoto et al., 1989) typically a lower molecular weight of 
around 48kDa is detected by SDS-PAGE analysis, as seen with the 3T3-L1 adipocyte 
lysate in Figure 3.3. Hydrophobic proteins bind SDS at a higher ratio, therefore it is 
common for highly hydrophobic proteins like mammalian glucose transporters to migrate 
faster on SDS-PAGE gels (Birnbaum et al., 1986; Mueckler et al., 1985; Thorens et al., 
1988) and so this lower molecular weight value for hGLUT4 is not unexpected.
i
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Figure 3.3. Expression of hGLUT4 in SF838-9Da cells.
SF838-9Da yeast cells harbouring pWTG4 (hGLUT4 under CUPl promoter) or pTC2 
(empty vector) were grown in selective media either with or without lOOpM CuS0 4 as 
indicated above. The amount ofhGLUT4 in 10 OD^^oof cells was assessed using 
immunoblot analysis. Lysate from 3T3-LI adipocytes was included in the immunoblot as a 
positive control (the amount o f the v-SNARE Vtilp in each sample was similarly assessed 
to control for equal loading).
Figure 3.3 indicates a discrepancy between the molecular weight of hGLUT4 detected in 
the yeast lysate with that of the adipocyte lysate (approximately 42 and 48kDa 
respectively). The heterologous expression of ratGLUTl in yeast cells showed a similar 
reduction in molecular weight of around 5kDa between ratGLUTl expressed in yeast 
(40kDa) compared to that expressed in animal cells (varies from 44 to 55kDa depending on 
tissue and cell type) (Kasahara and Kasahara, 1996). In this case, the glycosylation of 
GLUTl was examined. Treatment of human erythrocyte GLUTl with TV-glycosidase F 
treatment (a deglycosylation enzyme) saw a reduction in molecular mass from 50 to 
40kDa. With the molecular mass of GLUTl in yeast also being 40kDa this indicates yeast- 
made GLUTl is not N-glycosylated to the same extent as it is in mammalian cells 
(Kasahara and Kasahara, 1996). GLUT4 contains a single N-glycosylation site in its first 
extracellular loop (Pessin and Bell, 1992) and is processed by TV-linked glycosylation to 
form the mature transporter in L6 muscle cells (Mitsumoto and Klip, 1992). It is therefore
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likely that, like ratGLUTl, the hGLUT4 expressed in yeast lacks glycosylation. In Figure
3.3, the majority of hGLUT4 detected in yeast is found at 42kDa (indicating 
unglycosylated hGLUT4) but a small minority of hGLUT4 can be detected at SOkDa that 
would indicate glycosylated hGLUT4. Glycosylated proteins often migrate as diffuse 
bands by SDS-PAGE, as indicated with adipocyte lysate, but less so in the yeast lysate.
As discussed above, a major advantage of using the CUPl promoter is that it is titratable, 
allowing gene expression to be tightly modulated (Mascorro-Gallardo et al., 1996). The 
expression characteristics of pWTG4 were established by growing SF838-9Da cells 
harbouring pWTG4 in selective media (SD) containing increasing amounts of CuSO  ^
(Figure 3.4). Proteins contained in lysates prepared from 10 OD^ oo equivalents of cells 
grown in these media were separated using SDS-PAGE. Immunoblot analysis with a- 
GLUT4 antibody shows that an increase of CuSO  ^in the media is related to an increase in 
the expression of hGLUT4.
10 20 50 100 200 500
37kDa -
25kDa -
CUSO4  
(mM)
a GLUT4 
a Vtllp
Figure 3.4. hGLUT4 expression increases in relation to CUSO4 in media.
SF838-9Da yeast cells harbouring pWTG4 (HGLUT4 under CUPl promoter) were grown 
in selective media (SD) with increasing amounts o f CuSO4, as indicated above. The 
amount o f hCLUT4 in 10 OO^QQof cells was assessed using immunoblot analysis (the 
amount o fV tilp  in each sample was similarly assessed to control for equal loading.
3.3. hGLUT4 is stabilised in yeast cells that lack active vacuolar proteases.
The PEP4 gene encodes the vacuolar aspartyl protease, proteinase A which promotes the 
activation of mature vacuolar hydrolases from their inactive precursors (Ammerer et al., 
1986; Woolford et al., 1986). The yeast strain SF838-9Da contains a pep4-3 mutation that 
makes it deficient in active vacuolar protease activity (Rothman et al., 1989) and.
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consequently, allows the stabilisation of proteins that are targeted to the lumen of the 
vacuole or to the proteolytically active endosomal system.
pWTG4 was expressed in the yeast strain SF838-9Da (pep4-3) and the congenic PEP4 
strain, RPYIO (Piper et al., 1995; Piper et al., 1994) and proteins contained in lysates 
prepared from 10 O D ^ equivalents of cells were separated using SDS-PAGE prior to 
immunoblot analysis performed with anti-GLUT4 antibody. hGLUT4 was detected when 
expressed in the pep4-3 strain (SF838-9Da) but not when expressed in the congenic PEP4 
strain (RPYIO), suggesting that hGLUT4 is stabilised in strains that lack active vacuolar 
proteases (Figure 3.5).
Yeast Strain 
PEP4
Q900su_(f)
0
CO CN §> > > cnQ_ 0a: QL CC
+ + +
CX GLUT4
a  VtUp
Figure 3.5. hGLUT4 is stabilised in yeast lacking active vacuolar proteases
SF838-9Da, RPYIO, KY73, RMYl, MC996A and RMY2 yeast cells (PEP4 or pep4-3, as 
indicated above) harbouring pWTG4 (hGLUT4 under CUPl promoter) were grown in 
selective media (SM) with lOOpM CUSO4. The amount o f hGLUT4 in 10 OD(,00 o f cells was 
assessed using immunoblot analysis (the amount o fV tilp  in each sample was similarly 
assessed to control for equal loading). SF838-9Da, RMYl and RMY2 are congenic to 
RPYIO, KY73 and MC996A respectively; in each case the congenic pairs differ only at the 
PEP4 locus, with the latter being wild-type and the former null mutant.
To investigate this further, the PEP4 gene was disrupted in strains KY73 and MC996A to 
create the congenic strains RMYl and RMY2 respectively. The PEP4 gene was disrupted 
in strains KY73 and MC996A using the loop in/loop out gene disruption method with the 
plasmid pL02010 (Nothwehr et al., 1995). This involved transforming strains KY73 and
»a
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MC996A with plasmid pL02010 linearised following digestion with EcoRI. pL02010 
contains the URA3 selectable marker flanked by homologous sequences to PEP4 
(Nothwehr et al., 1995). The PEP4 gene was replaced by the URA3 containing fragment
following its integration by homologous recombination and cells with the URA3 disruption 
were selected by growth on SD-URA solid media. The URA3 marker is also flanked by
sequences of DNA that enable the URA3 marker to Toop-out’ by homologous
■ ■recombination. Cells successful in looping out URA3 were selected by growth on media 
containing 5-fluoroorotic acid (5-FOA) (Nothwehr et al., 1995). The URA3 gene encodes 
orotine-5’-monophosphate (OMP) dicarboxylase, which converts the non-toxic 5-FOA to 
fluorodeoxyuridine (Boeke et al., 1987). Fluorodeoxyuridine is toxic to cells and so, only 
those strains lacking the URA3 gene can grow in the presence of 5-FOA (Boeke et al.,
1987). Finally, the N-acetyl-phenylalanine-p-naphthyl-ester (APNE) overlay assay (Wolf 
and Fink, 1975) was used to confirm the pep4-3 mutant colonies and their lack of vacuolar 
protease activity. The APNE overlay assay detects the activity of caiboxypeptidase Y
(CPY) (Wolf and Fink, 1975), which is activated by proteinase A, the PEP4 gene product. ■;.îCPY mediates the release of (3-naphtliol from APNE, which is detected in the APNE 
overlay assay from its reaction with the Fast Garnet GBC salt and the resulting formation 
of an insoluble red dye. PEP4 strains therefore turn red, whereas pep4-3 strains (with their 
lack of active CPY) remain white.
Immunoblot analysis using anti-GLUT4 antibody with cells harbouring pWTG4 (grown on 
copper-containing media) detects hGLUT4 in the strains lacking active vacuolar proteases 
(pep4 mutants; SF838-9Da, RMYl and RMY2, Figure 3.5) but not in the congenic parent 
strains (wild-type PEP4; RPYIO, KY73 and MC996A, Figure 3.5). These data indicate 
that, when expressed in yeast, hGLUT4 is delivered to a proteolytically active 
compartment.
■
3,4. hGLUT4 localises to the Golgi in yeast.
In order to determine the subcellular distribution of hGLUT4 in yeast, SF838-9Da cells 
harbouring pWTG4 (expressing hGLUT4) and pSN222 (which drives expression of HA- 
tagged Kex2p) were visualised using indirect immunofluorescence microscopy (Figure 
3.6). Kex2p is a well-characterised endoprotease in S.cerevisiae, which cleaves the
precursors of several proteins, such as the mating pheromone a-factor (Fuller et al., 1989),
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in the late Golgi compartment of yeast cells, likely the yeast equivalent of the mammalian 
TGN (Bryant and Boyd, 1993; Redding et ah, 1991; Wilcox and Fuller, 1991; Wilcox et 
al., 1992). Figure 3.6 shows an intracellular punctate staining of hGLUT4, which co- 
localises significantly with that of the TGN marker Kex2p. This Golgi-localised punctate 
staining seen for hGLUT4 (Figure 3.6) is in contrast to that previously described (Kasahara 
and Kasahara, 1997; Wieczorke et ah, 2003), where it was reported that mammalian 
GLUT4, when expressed in yeast, localised to the ER. However, as noted earlier, this is 
likely due to the fact that in these studies GLUT4 was expressed at very high levels from 
the GAL 1-10 promoter, perhaps resulting in GLUT4 misfolding and failing to leave the 
ER.
GLUT4 Kex2p merge
Figure 3.6. hGLUT4 colocalises with Kex2p (TGN) in yeast.
SF838-9Da cells harbouring pWTG4 (hGLUT4 behind the CUPl promoter) andpSN222 
(encoding HA-tagged Kex2p) were grown in selective media (SD-ura-leu) containing 
lOOpM CUSO4, fixed in formaldehyde and double labelled with anti-HA and anti-GLUT4 
antibodies. Rat anti-HA was visualised with alexa568-coupled secondary antibody (red in 
merged image) and rabbit anti-GLUT4 was visualised with alexa488-coupled secondary 
antibody (green in merged image).
3.5. hGLUT4 accumulates in the ^^ class compartment in vps27 cells.
Like other yeast TGN proteins, Kex2p is retained in the yeast TGN by continually cycling 
through the endocytic system (Brickner and Fuller, 1997; Bryant and Stevens, 1997), and a 
similar phenomenon has been described for GLUT4 in adipocytes (Shewan et al., 2003). 
Resident TGN proteins such as Stel3p and Kex2p localise to the exaggerated
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endosoraal/prevacuolar compartment (PVC) that accumulates in Class E vps mutants such 
as vps27A cells (Piper et al., 1995). VPS27 is one of 13 Class E vacuolar protein sorting 
(VPS) genes, that act together to regulate membrane traffic through the PVC (Raymond et 
al., 1992). Mutations in any one of these genes causes the accumulation of the “Class E 
compartment” which contains TGN proteins, as well as biosynthetic and endocytic traffic 
en route to the vacuole (Raymond et al., 1992). To fuither investigate the localisation of 
hGLUT4 in yeast, I set out to ask whether hGLUT4 also accumulates in the Class E 
compartment of vps27A mutant cells. ;
For this purpose a GFP(S65T)-tagged version of hGLUT4 was produced (the mutant
,GFP(S65T) emits a brighter fluorescence and acquhes fluorescence up to four times faster 
than wild-type GFP (Heim et al., 1995)). Site-directed mutagenesis was used to replace 
the ‘stop’ codon of the hGLUT4 ORE in pRM2 with an Sph\ site. Following digestion 
with Sphl to linearise the resulting plasmid, sequence encoding GFP(S65T)was introduced 
immediately after the last codon of hGLUT4 ORE by homologous recombination (for this, 
sequence encoding GFP(S65T) was amplified by PCR using oligos 365 and 366 (Table
I
Î
2.2) as primers and pG036 (Odorizzi et al., 2003) as a template, to carry ends homologous 
to the 3’ end of the hGLUT4 ORF and the proximal region of the PH08 3’UTR). The 
resulting plasmid, pRM34 therefore encodes a GFP(S65T)-tagged version of hGLUT4 
from the copper-inducible CUPl promoter. The construction of this plasmid was verified 
by DNA sequencing.
■SF838-9Da cells, producing a GFP(S65T)-tagged version of hGLUT4 show an 
intracellular punctate distribution for hGLUT4 that is reminiscent of the indirect 
immunofluorescence of hGLUT4, seen in Figure 3.6. Importantly, when expressed in 
vps27A mutant cells, the distribution of GFP(S65T)-tagged hGLUT4 is mai'kedly different 
from that seen in wild-type cells, localizing to one or two tight spots. These were 
identified as the Class E compartment by their accumulation of the lipophilic styryl dye N- 
(3 -triethylammoniumpropyl) -4-(p-diethylaminopheny 1-hexatrienyl) pyridium dibromide ■■Si:
(FM4-64; Molecular Probes, Oregon, USA). In wild-type cells FM4-64 is endocytosed 
and delivered to the limiting membrane of the vacuole (Vida and Emr, 1995), but becomes 
trapped in the Class E compartment of vps27A mutant cells (Bryant et al., 1998a). The 
data presented in Figure 3.7 are consistent with a model in which, like Kex2p, GLUT4
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achieves localization to the yeast TGN by continually cycling through the endosomal 
system.
wild-type vps27A
GLUT4 GLUT4 FM4-64
Figure 3.7. hGLUT4 accumulates in the class E compartment in vps27A cells
GFP(S65T) was visualised in SF838-9Da (VPS27) and SGY73 (vps27A) cells harbouring 
pRM34 (GFP(S65T)-tagged hGLUT4 under the CUPl promoter), which were grown in 
selective media (SD) with lOOpM CUSO4. SGY73 (vps27A) cells were also labelled with 
FM4-64 to mark the Class E compartment.
The data presented in Figures 3.6 and 3.7 indicate that, in yeast, as in adipocytes (Shewan 
et al., 2003), hGLUT4 localises to the TGN, and that this localisation is achieved by the 
transporter recycling through the PVC. Intriguingly, the Golgi-localised punctate staining 
observed for hGLUT4 in yeast (Figure 3.6) is reminiscent of that found for Gap Ip under 
nutrient rich conditions (Roberg et al., 1997), and importantly Gap Ip also localises to the 
PVC of Class E vps mutants (Nikko et al., 2003; Rubio-Texeira and Kaiser, 2006).
3.6. hGLUT4 is stabilised by growth on proline-containing media.
Mutant GLUT4 lacking its carboxyl-terminal tail fails to translocate to the plasma 
membrane of mammalian cells in response to insulin (Figure 1.6, unpublished results; Nia 
Bryant and David James). This indicates that the trafficking information regarding the 
translocation of GLUT4 resides in the carboxyl-terminal tail. GLUT4 contains a 
carboxyl-terminal di-leucine motif and an acidic-cluster-based motif that have important
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roles in the internalisation and subcellular targeting of GLUT4 (Cope et al., 2000; Shewan 
et al., 2000). When this region of GLUT4 is replaced with the carboxyl-terminal tail of the 
yeast general amino acid permease, Gap Ip, the translocation of GLUT4 to the plasma 
membrane of mammalian cells in response to insulin is recovered (Figure 1.6, unpublished 
results; Nia Bryant and David James). This demonstrates that the targeting motifs required 
for insulin-regulated GLUT4 trafficking are conserved between GLUT4 and Gap Ip.
Gap Ip also contains a dileucine motif within its carboxyl-terminal tail that is required for 
its nitrogen-regulated transport (Hein and Andre, 1997).
As outlined in Section 1.8, the general amino acid permease, Gap Ip, actively transports all 
naturally occurring amino acids across the plasma membrane of yeast (Grenson et al.,
1970; Jauniaux and Grenson, 1990). When yeast cells aie grown on non-preferred 
nitrogen sources such as proline or urea, Gap Ip is mobilised from an intracellular storage 
pool to the plasma membrane, where it allows amino acids into the cell for use as a source 
of nitrogen (Roberg et al., 1997). However, when yeast cells are grown on preferred 
sources of nitrogen such as glutamate. Gap Ip transported to the proteolytically active yeast 
endosomal system (Roberg et al., 1997). The parallels noted between the nitrogen- 
regulated transport of Gap Ip in yeast and the insulin-responsive transport of GLUT4 in 
mammalian cells (Roberg et ah, 1997) led me to investigate the hypothesis that GLUT4 
would traffic in the same pathway as Gap Ip when expressed in yeast.
i
In order to address this hypothesis, the effect of the nitrogen source in the growth media on 
hGLUT4 stabilisation was determined (Figure 3.8). KY73 (PEP4) and RMYl (pep4-3) 
yeast cells harbouring pWTG4 were grown in media containing lOO^M CuSO^ and 
utilizing either, 0.5% ammonium chloride, 0.1% glutamate or 0.1% proline as the sole 
source of nihogen. Proteins contained in lysates prepared from 10 OD^ qo equivalents of 
cells were separated using SDS-PAGE prior to immunoblot analysis, performed with anti- 
GLUT4 antibody.
:
:i
I
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Figure 3.8. hGLUT4 is stabilised by growth on proline-containing media.
KY73 (PEP4) and RMYl (pep4-3) yeast cells harbouring pWFG4 (hGLUT4 under CUPl 
promoter) were grown in media containing lOOpM CUSO4 and, either, 0.5% ammonium 
chloride, 0 .1% glutamate or 0 .1% proline as the sole nitrogen source, as indicated above. 
The amount o f hGLUT4 in 10 O D ^ o f  cells was assessed using immunoblot analysis (the 
amount o fV tilp  in each sample was similarly assessed to control fo r equal loading).
As in Figure 3.5, hGLUT4 could be detected in pep4-3 strains (lane2) but not in PEP4 
strains (lanel) grown in media containing ammonium chloride. Interestingly, however, a 
greater amount of hGLUT4 could be detected in KY73 (PEP4) cells when grown in media 
that contained proline as the sole source of nitrogen, but not when grown in media with 
glutamate as the nitrogen source. hGLUT4 was, therefore, more stable in yeast grown with 
limited nutrients, which mirrors that found with Gap Ip (Roberg et al., 1997) and led to the 
hypothesis that hGLUT4 was being directed away from the endosomal system when 
nutrients were limited and therefore prevented from degradation by active vacuolar 
proteases. This is reminiscent of the nitrogen-regulated trafficking of Gap Ip and provides 
further indication that, when expressed in yeast, hGLUT4 traffics within the same transport 
pathway as Gap Ip.
3.7. Chapter summary
This chapter describes how I expressed human GLUT4 (hGLUT4) in yeast in order to 
explore the possibility of using yeast as a model system in the study of insulin-regulated
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GLUT4 trafficking. I determined that, when expressed in yeast, hGLUT4 shows 
significant colocalisation with the TGN marker Kex2p, and accumulates in the Class E 
compartment of vps27A mutant cells, consistent with a model in which GLUT4 localises to
■ithe TGN of yeast by continually cycling through the endosomal system. Furthermore, I 
show that hGLUT4 is stabilised when expressed in pep4A yeast lacking active vacuolar 
proteases, thus indicating the delivery of hGLUT4 to a proteolytically active compartment.
These findings led me to further investigate the parallels between GLUT4 and Gap Ip 
regulated tiafficking by examining the trafficking of hGLUT4 when expressed in yeast 
grown with either a good, or poor, supply of nitrogen. Like Gap Ip, hGLUT4 was 
transported away from a proteolytically active compartment when exposed to poor
,nutrients, thus supporting the hypothesis that hGLUT4 shares the same transport pathway 
as Gap Ip when expressed in yeast.
I
J
Chapter 4: Examination of the ubiquitination ofGLUT4
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Chapter 4: Examination o f the ubiquitination ofGLUT4.
4.1. Introduction
The data presented in Chapter 3 demonstrates that, in yeast, hGLUT4 traffics in a nitrogen- 
regulated manner akin to that of Gap Ip. The nitrogen-dependent trafficking of Gap Ip is 
regulated, at least in part, by the ubiquitination of the transporter (Magasanik and Kaiser, 
2002). Ubiquitination of Gap Ip is required, not only for the endocytosis of Gap Ip from 
the plasma membrane in response to favourable nutrient conditions (Springael and Andre, 
1998; Springael et al., 1999) but also for the direct sorting of Gap Ip from the TGN to the 
proteolytically active compartment (Helliwell et al., 2001). Therefore, in view of the 
similarities between Gap Ip and GLUT4 trafficking, I set out to examine whether hGLUT4, 
like Gap Ip, was also ubiquitinated in yeast.
This chapter presents data to show that hGLUT4 is ubiquitinated when expressed in yeast, 
and also outlines attempts made to determine the specific lysine residue(s) within hGLUT4 
that is/ai'e ubiquitinated. However, it is important to note that the purpose of investigating 
the trafficking of hGLUT4 in yeast was to provide a model system for understanding the 
insulin-regulated trafficking of GLUT4 in mammalian cells, and therefore, with this in 
mind, this chapter also presents data to show that GLUT4 is also ubiquitinated in the 
insulin-sensitive murine cell line 3T3-L1 adipocytes.
4.2. hGLUT4 is ubiquitinated in yeast.
As an initial approach to investigate whether, like Gap Ip, GLUT4 is ubiquitinated in yeast, 
GLUT4 was immunoprecipitated from yeast cells that were also expressing an HA-tagged 
version of ubiquitin. These experiments were carried out in SF838-9Da (pep4-3) yeast 
cells to minimize the possibility of degradation of any ubiquitin conjugates by vacuolar 
proteases, and pRMl was used to express HA-Ub at high levels, in order to ensure a pool 
of free ubiquitin and also to provide an epitope tag for the easy detection of the ubiquitin 
conjugates. SF838-9Da cells harbouring pWTG4 (pRM2) and also pRM l (HA-tagged 
ubiquitin under control of the CUPl promoter), or not, were grown in selective media 
containing lOOjwM CuSO^ to induce expression from the CUPl promoter. 
Inununoprecipitates formed from yeast cell lysates using rabbit anti-GLUT4 antibody were 
subject to immunoblot analysis with rat anti-HA antibody in order to detect any HA-Ub
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that was conjugated to hGLUT4 and mouse anti-GLUT4 monoclonal antibody to verify 
that equal amounts of hGLUT4 and hGLUT4-7K/R were immunoprecipitated (Figure 4.1).
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Figure 4.1. hGLUT4 is conjugated to HA-tagged ubiquitin in yeast
SF838-9Da yeast cells harbouring either pWTG4 or p7KRG4 (as indicated above; WT or 
K/R, respectively) with HA-Ub or not (as indicated above +/-) were grown in selective 
media (SD) containing lOOpM CuSO^. Immunoprecipitates formed with lOpl anti-GLUT4 
antibody were subject to immunoblot analysis with anti-HA antibody (to investigate 
whether HA-tagged ubiquitin was conjugated to hGLUT4 in yeast) and 1F8 antibody (a 
GLUT4 monoclonal antibody) to verify whether equal amounts o fW T  and 7K/R protein 
were immunoprecipitated.
Ubiquitination is the post-translational conjugation of the small molecule, ubiquitin, most 
commonly to specific lysine residues on a target protein (Hicke and Dunn, 2003). There 
are seven lysine residues in the sequence of hGLUT4 that are predicted to be cytosolically 
disposed (Figure 4.2): each one of these represents a potential site of ubiquitination. The 
first of these residues (K109) is predicted to be within the first intracellular loop, five of
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these residues (K242, K245, K261, K264 and K266) have a predicted location within the 
large intracellular loop between transmembrane domains 6 and 7, and the final lysine 
residue (K495) is in the carboxyl-terminal tail (Figure 4.2).
Sugar moiety
Plasma
membrare
Cytoplasm
COOH
Figure 4.2. Schematic diagram of the predicted membrane topology of GLUT4 
indicating the positions of cytoplasmic lysine residues
(adapted from (Bryant et at., 2002))
To characterise the ubiquitination of hGLUT4 observed using HA-tagged ubiquitin, I made 
a mutant version of hGLUT4 in which the 7 cytosolically-disposed lysines are mutated to 
arginine residues to serve as a non-ubiquitinated control. Both lysine and arginine residues 
contain basic side chains, but whereas lysine has a free amino group to which ubiquitin 
covalently attaches to target proteins, arginine does not: arginine is therefore routinely used 
to replace lysine in order to abolish ubiquitination without grossly altering the overall 
higher-order structure of the protein. Codons encoding the seven cytosolically-disposed 
lysine residues (K109, K242, K245, K261, K264, K266 and K495) of hGLUT4 were 
mutated in a series of SDM reactions using pRM2 as the original template. The pairs of 
oligonucleotides used (61 and 62, 73 and 74, 85 and 86, 77 and 78, 117 and 118, 119 and 
120, 121 and 122), and the ‘intermediate’ plasmids created (pRM5, pRM ll, pRM12, 
pRM13, pRM14, pRM15 and pRM3) in the process of making the final plasmid encoding 
the ubiquitin-deficient mutant (hGLUT4-7K/R) are listed in Tables 2.2 and 2.3,
VS;*:,:
-
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respectively. The final plasmid pG47KR (pRM3) encodes hGLUT4 with all seven 
cytoplasmic lysines mutated to arginine residues from the CUPl promoter.
;.î
When hGLUT4-7K/R was immunoprecipitated from SF838-9Da cells that were also Iproducing HA-tagged ubiquitin, no ubiquitination was detected (Figure 4.1). Importantly, s:
the bottom panel of this figure shows that hGLUT4-7K/R was precipitated just as 
efficiently as its wild-type counterpart (which clearly is ubiquitinated) in this experiment.
;An immunoreactive band with an apparent molecular weight of -50kDa was detected in 
the immunoprecipitate o f those cells expressing both wild type hGLUT4 and HA-tagged 
ubiquitin, demonstrating that HA-Ub was conjugated to hGLUT4 in yeast. This band was 
absent from the immunoprecipitate of those cells expressing solely wild type hGLUT4 or 
those cells expressing the ubiquitination-deficient form of hGLUT4 (hGLUT4-7K/R) with 
HA-Ub, indicating the band was specific to cells carrying pWTG4 and HA-Ub. An 
immunoreactive band of ~42kDa could be detected in all immunoprecipitates when they 
were subject to immunoblot analysis with 1F8 antibody (a GLUT4 mouse monoclonal 
antibody) confirming that equal amounts of wild type hGLUT4 and hGLUT4-7K/R were 
immunoprecipitated. This increase of ~ 8 kDa in the molecular weight between the 42kDa 
band detecting hGLUT4 and the 50kDa band detecting HA-Ub conjugated to hGLUT4 is 
consistent with the conjugation of one ubiquitin moiety to the hGLUT4 molecule, implying 
that hGLUT4 is monoubiquitinated.
5It was necessary to confirm that the ubiquitination of hGLUT4 detected in Figure 4.1 was 
not due to the overexpression of HA-tagged ubiquitin in yeast. Therefore, an approaeh was 
taken to establish whether hGLUT4 expressed in yeast was ubiquitinated by endogenous 
ubiquitin (Figure 4.3). SF838-9Da cells harbouring either pWTG4 (pRM2) or p7KRG4 
(pRM3) were grown in selective media containing 100/fM CuSO^ to induce expression of 
hGLUT4 and hGLUT4~7K/R, respectively. Immunoprecipitates formed with rabbit anti- 
GLUT4 antibody were subject to immunoblot analysis with mouse anti-ubiquitin antibody, 
in order to detect whether endogenous ubiquitin was conjugated to hGLUT4, and mouse 
anti-GLUT4 monoclonal antibody to verify whether equal amounts of hGLUT4 and 
hGLUT4-7K/R were immunoprecipitated (Figure 4.3).
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Figure 4.3 hGLUT4 is conjugated to endogenous ubiquitin in yeast
SF838-9Da yeast cells harbouring either pWTG4 or p7KRG4 (as indicated above; WT or 
K/R, respectively) were grown in selective media containing lOOpM CuSO^. 
Immunoprecipitates formed with lOpl anti-GLUT4 antibody were immunoblotted with 
anti-Ub antibody to investigate whether endogenous ubiquitin was conjugated to hGLUT4 
in yeast and 1F8 antibody (a GLUT4 monoclonal antibody) to verify whether equal 
amounts o f wild type hGLUT4 (WT) and hGLUT4-7K/R (K/R) protein were 
immunoprecipitated.
In agreement with Figure 4.1, an immunoreactive band with an apparent molecular weight 
of ~50kDa was detected in the immunoprecipitate of those cells expressing wild-type 
hGLUT4 but not in those cells expressing the ubiquitination-deficient mutant hGLUT4- 
7K/R, with the levels of immunoprecipitated wild type hGLUT4 and hGLUT4-7K/R being 
approximately equal. Again, this is consistent with the addition of a single ubiquitin 
molecule to hGLUT4 and shows that hGLUT4 is bound to endogenous ubiquitin in yeast.
The above immunoprécipitation experiments establish that hGLUT4 is ubiquitinated in 
yeast, but this was always to be a model system for the study of the insulin-regulated
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trafficking of GLUT4 and the end goal always to determine whether GLUT4 was 
ubiquitinated in mammalian cells. However, immunoprécipitation of 3T3-L1 adipocyte 
lysate with anti-GLUT4 antibody and subsequent immunoblot analysis with anti-ubiquitin 
antibody failed to yield any presentable data, and I therefore sought an alternative approach 
to investigate the possibility that GLUT4 is ubiquitinated in adipocytes. To this end, 1 
utilised a GST fusion protein harbouring a ubiquitin-binding domain from the yeast protein 
Dsk2p.
Dsk2p is a member of a family of proteins that possess an N-terminal ubiquitin-like (Ubl) 
domain and a C-terminal ubiquitin-associated (UBA) domain (Jentsch and Pyrowolakis, 
2000). This family of proteins plays an important role in protein degradation by the 
ubiquitin-proteasome pathway possibly as an adaptor between ubiquitinated proteins 
destined for proteasomal degradation and the proteasome complex (Funakoshi et al., 2002). 
The C-terminal UBA domain of Dsk2p binds to Lys"^®-linked poly ubiquitin chains while 
the N-terminal Ubl domain interacts with the proteasome (Funakoshi et al., 2002). It has 
been established that the C-terminal UBA domain alone (residues 328-373 of Dsk2p) 
binds, not only poly ubiquitin but also monoubiquitin when produced as a GST-fusion 
protein (Funakoshi et al., 2002). I therefore sought to use this GST-fusion protein in ‘pull­
down’ experiments to determine whether GLUT4 is ubiquitinated in adipocytes.
It was important to include a negative control for these experiments and I therefore set out 
to obtain a version of this protein whose ability to bind ubiquitin is impaired. The structure 
of the UBA domain of Dsk2p in complex with ubiquitin has been solved and identifies 
residues within the UBA domain as being important for the binding of ubiquitin (Ohno et 
al., 2005): M efm ed ia te s  two contacts between the UBA domain and ubiquitin; it forms a 
hydrophobic contact with the Ile'^kcentred pocket of ubiquitin and a hydrogen bond to 
Gly'^  ^of ubiquitin. Phe^‘*‘'^ makes hydrophobic contacts with Gly^ ^^  of ubiquitin (Ohno et al., 
2005). These two residues were mutated by SDM to Arg^ '*^  and Ala^‘*‘^ in order to abolish 
ubiquitin binding of the Dsk2p-UBA domain (this was performed by Chris Lamb, a 
placement student in the lab).
This mutant was designed to act as a non-ubiquitin-binding control in the GST pull-down 
assays investigating GLUT4 ubiquitination. However, before using this new approach
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with 3T3-L1 adipocytes, I set out to validate its effectiveness in specifically detecting 
ubiquitinated GLUT4 with the yeast system.
The recombinant fusion proteins, GST-UBA (GST fused to the UBA domain of Dsk2p; 
residues 328-373 (Funakoshi et al., 2002)) and GST-UBAmut (GST fused to the UBA 
domain of Dsk2p harbouring the two point mutations M342R and F344A) were expressed 
in BL-21(DE3) cells (Invitrogen) and purified using glutathione-Sepharose beads. The 
concentration of fusion proteins immobilised on the beads was estimated using SDS-PAGE 
and staining with Coomassie Blue, and comparison with a series of protein standards (2pg, 
4p,g and lOpg BSA) included on the same gel (Figure 4.4). Figure 4.4 shows bands of 
equal intensity for both GST-UBA and GST-UBAmut, with an apparent molecular weight 
of ~30kDa, around 5-6kDa larger than GST alone, consistent with the addition of the UBA 
and UBAmut domains.
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Figure 4.4. SDS-PAGE protein assay for immobilised GST fusion proteins
GST-fusion proteins, GST-UBA and GST-UBAmut were expressed in bacteria and purified 
with glutathione-Sepharose beads. Proteins eluted from the beads were separated by SDS- 
PAGE and the gel stained with Coomassie Blue. In order to estimate the quantity o f 
protein bound to the beads, a series o f protein standards; 2pg, 4pg and lOpg BSA were 
also loaded.
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In order to validate the use of the GST fusion proteins in the detection of GLUT4 
ubiquitination, lysates prepared from SF838-9Da cells producing either hGLUT4 (from 
pRM30) or hGLUT4-7K/R (from pRM31), in addition to a GFP-tagged version of Gap Ip 
(from p2313; to serve as a control) were incubated with either GST-UBA and GST- 
UBAmut immobilised on glutathione-Sepharose beads. Following the washes described in 
Section 2.2.19, proteins bound to the GST-fusion proteins were eluted and subject to SDS- 
PAGE and immunoblot analysis with anti-GFP antibody and anti-GLUT4 antibody (Figure 
4.5). 0.25% of the input lysate was also subject to SDS-PAGE and immunoblot analysis 
with anti-GFP and anti-GLUT4 antibodies in order to check that equivalent amounts of 
GaplpGFP, wild-type hGLUT4 or hGLUT4-7K/R proteins were added to the two different 
GST fusions.
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Figure 4.5. hGLUT4 interacts with GST-UBA in a GST pull down assay
Lysate prepared from SF838-9Da yeast cells harbouring either pWTG4LEU2 (pRM30) or 
p7KRG4LEU2 (pRM3J) (as indicated above; WT or K/R, respectively) and p2313 (GFP- 
tagged Gaplp) were incubated with glutathione-Sepharose beads that carried either o f the 
GST-fusion proteins, GST-UBA and GST-UBAmut. Proteins eluted from the beads were 
subject to immunoblotting with anti-GFP antibody (top panel) and anti-GLUT4 antibody 
(bottom panel). 0.25% input (left panel; top and bottom) was also loaded as a control to 
verify whether equal amounts o f proteins were expressed.
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GFP-tagged Gaplp provided a control in this experiment as a protein known to be 
ubiquitinated in yeast (Hein and Andre, 1997; Helliwell et al., 2001; Springael and Andre, 
1998; Springael et al., 1999). Immunoblot analysis with anti-GFP antibody detected an 
iimnunoreactive band of an apparent molecular weight of ~80kDa in the GST-UBA pull­
down assays but not in the pull-down performed using the GST-UBAmut (Figure 4.5), 
indicating that, as predicted, the point mutations introduced here have indeed abolished the 
ability of the UBA domain to bind ubiquitin.
Immunoblot analysis with anti-GLUT4 antibody detects a band with an apparent molecular 
weight of ~50kDa in the GST-UBA pull down assay from a yeast cell lysate containing 
wild type hGLUT4, but not from a lysates prepared from cells expressing the 
ubiquitination-deficient hGLUT4-7K/R (Figure 4.5). The GLUT4 immunoreactive band is 
also absent from the pull down performed using the GST-UBAmut fusion with lysate 
prepared from cells expressing wild-type hGLUT4. The levels of wild type hGLUT4 and 
hGLUT4-7K/R added to the pull-down assays were comparable, as visualised by 
immunoblot analysis of the input lysate, which indicates immunoreactive bands of similar
intensities with apparent molecular weights of ~42kDa in each case. GST-UBA binds
:.T
ubiquitin, and therefore, ubiquitinated proteins are isolated in the GST pull-down assays. 
The detection of an immunoreactive band at -50kDa in cells expressing wild-type 
hGLUT4, but not in cells with the ubiquitination-deficient hGLUT4-7K/R, thus indicates
that hGLUT4 is ubiquitinated in yeast, probably by the addition of one ubiquitin moeity. 
This supports the data obtained with the immunoprécipitation experiments, and establishes 
this technique as a suitable method to investigate GLUT4 ubiquitination.
4.3. GLUT4 is ubiquitinated in adipocytes
The ubiquitination of GLUT4 in adipocytes was determined by incubating lysate prepared 
from 3T3-L1 adipocytes with glutathione-Sepharose beads carrying the GST fusion 
proteins, GST-UBA (ubiquitin-binding) and GST-UBAmut (non-ubiquitin binding). 
Proteins pulled-down by GST-UBA and GST-UBAmut were analysed by immunoblot 
analysis with anti-GLUT4 antibody (to detect any GLUT4 bound to the GST fusion 
proteins), anti~Syntaxin4 antibody (as a non-ubiquitinated protein control) and anti-IRS-1 
antibody (as a ubiquitinated protein control) (Figure 4.6). 2.5% of the input lysate was also 
subject to SDS-PAGE and immunoblot analysis with the various antibodies to verily to
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presence of the different proteins in the lysate. The coomassie staining of the purified 
GST-fusion proteins used is also shown in Figure 4.6 to confirm that equivalent amounts 
of the two fusion proteins were used in the pull-downs experiments.
Adipocytes
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Figure 4.6. GLUT4 is ubiquitinated in 3T3-L1 adipocytes
Lysate prepared from 3T3-L1 adipocytes was incubated with glutathione-Sepharose beads 
that carried the GST-fusion proteins, GST-UBA and GST-UBAmut. Proteins eluted from  
the beads were subject to immunoblotting with anti-GLUT4, anti-IRS-1 and anti-Syntaxin4 
antibodies. 2.5% input (lane I) was also loaded as a control.
Immunoblot analysis with anti-GLUT4 antibody in Figure 4.6 shows an immunoreactive 
band only in proteins eluted from the beads carrying GST-UBA, not from those beads 
carrying an equivalent amount of the GST-UBAmut control. This immunoreactive band 
has a slightly larger molecular weight than the GLUT4 immunoreactive band detected in 
the input lysate, which is expected with ubiquitinated GLUT4. The binding of GLUT4 
from adipocytes to the ubiquitin-binding UBA domain, but not to the non-ubiquitin
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binding UBAmut domain, demonstrates that endogenous GLUT4 is ubiquitinated in 
adipocytes.
The protein levels of the insulin receptor substrate 1 (IRS-1) are regulated by its 
ubiquitination (Zhande et al., 2002) and subsequent proteasomal degradation (Sun et al.,
1999). Therefore, the presence of 1RS-1 in the pull-down assays was determined (as a 
protein known to be ubiquitinated in these cells) by immunoblot analysis with anti-IRS-1 
antibody. Figure 4.6 demonstrates that IRS-1 is pulled out of the adipocytes lysates by 
GST-UBA, but not by the GST-UBAmut, confirming the specificity of binding of GST- 
UBA to ubiquitinated proteins. Syntaxin 4 is a target (t)-SNARE located at the plasma 
membrane of adipocytes (Tellam et al., 1997; Volchuk et al., 1996). As it is unlikely to be 
a target for ubiquitination it was used as a negative control for the GST pull-down assays. 
Input lysate subject to immunoblot analysis with anti-Syntaxin4 antibody detected an 
immunoreactive band of the predicted molecular weight of Syntaxin4, which was absent 
from the GST pull-downs; providing yet further evidence that the GST pull-down assays 
were specific for ubiquitinated protein.
Having confirmed that endogenous GLUT4 in adipocytes is ubiquitinated, I wanted to 
assess whether this ubiquitination was abolished by mutation of the 7 lysines of GLUT4 
that are predicted to be cytosolically disposed (Figure 4.2). I therefore created a retroviral 
expression vector to drive the expression of the hGLUT4-7K/R mutant in 3T3-L1 
adipocytes (the construction of this vector, production of retiovirus and the expression of 
wild-type HA-tagged GLUT4 and HA-tagged GLUT4-7K/R in infected adipocytes is 
outlined in the following chapter).
Lysates from 3T3-L1 adipocytes expressing either wild-type HA-tagged GLUT4 or HA- 
tagged GLUT4-7K/R were incubated with glutathione-Sepharose beads loaded with either 
GST-UBA and GST-UBAmut as described in materials and methods. Proteins eluted from 
the beads were subject to immunoblotting with anti-HA antibody to detect any HA-tagged 
GLUT4 bound to the GST fusion proteins (Figure 4.7). 2.5% of the input lysate was also 
subject to SDS-PAGE and immunoblot analysis with anti-HA antibody to verily equal 
levels of expression of wild type GLUT4 and GLUT4-7K/R (Figure 4.7).
44"4
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Figure 4.7.GST pull down with adipocytes expressing HA-GLUT4 or HA-GLUT4-7K/R
Lysate prepared from 3T3-L1 adipocytes expressing either HA-GLUT4 or HA-GLUT4- 
7K/R (as indicated above; WT and K/R respectively) was incubated with glutathione- 
Sepharose beads that carried the GST-fusion proteins, GST-UBA and GST-UBAmut. 
Proteins eluted from the beads were subject to immunoblotting with anti-HA antibody. 
2.5% input lysate was also loaded as a control.
Immunoblot analysis with anti-HA antibody detected immunoreactive bands with apparent 
molecular weights of ~48kDa in the input lysate of adipocytes expressing either wild type 
or the ubiquitination-deficient form of HA-GLUT4. However, the immunoreactive band 
was a lot less pronounced in the case of HA-GLUT4-7K/R, likely due to poorer expression 
from the HA-GLUT4-7K/R retrovirus. An immunoreactive band can also be detected in 
the GST-UBA pull down from the lysates prepared from adipocytes expressing wild-type 
HA-GLUT4, indicating ubiquitinated HA-GLUT4 (as demonstrated in Figure 4.6). This 
band is absent from the GST-UBAmut control pull-down. No such band was detected in 
the GST-UBA pull-down from adipocytes lysates containing HA-GLUT4-7K/R.
However, due to the low levels of expression of this mutant in this experiment it cannot be 
determined whether this control does, in fact, abolish ubiquitination. Unfortunately, due to 
time constraints, 1 was unable to fully optimise this experiment in order to acquire equal 
levels of wild-type HA-GLUT4 and HA-GLUT4-7K/R.
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4.4. Mapping the ubiquitination sites o f  hGLUT4
Having determined that GLUT4 is modified by the addition of, at least one ubiquitin 
moiety, I set out to map the ubiquitination site(s) in the transporter. Having demonstrated 
that mutation of all 7 of the lysine residues within hGLUT4 that are predicted to be 
localised in the cytosol (Figure 4.2) abolishes the ubiquitination of GLUT4 (Figures 4.1 
and 4.3), my first approach to mapping the site of ubiquitination was to create a series of 
lysine ‘knock-out’ mutants of GLUT4: with the 7 lysine residues mutated individually to 
arginines. The pairs of oligonucleotides; 61 and 62, 85 and 86, 87 and 88, 89 and 90, 91 
and 92, 93 and 94, 73 and 74 (listed in Table 2.2) were used in a set of seven separate 
SDM reactions to individually mutate the lysine residues of hGLUT4, encoded by pWTG4 
(pRM2), to arginines. This created the series of GLUT4 ‘knock-out’ mutants under control 
of the CUPl promoter; pRM5 (K495R), pRM6 (K242R), pRM7 (K245R), pRM8 
(K261R), pRM9 (K264R), pRMlO (K266R), pRM16 (K109R) (listed in Table 2.3). These 
mutants were used, along with pWTG4 (pRM2) and p7KRG4 (pRM3), to investigate 
which of the lysine residues in hGLUT4 was ubiquitinated. This was achieved by 
expressing the various forms of hGLUT4 in SF838-9Da yeast, using anti-GLUT4 
antibodies to immunoprecipitate the transporter, and then probe each of the precipitated 
versions of GLUT4 with anti-ubiquitin antibodies (in a manner similar to that presented in 
Figuie 4.3). The rationale behind this experiment was that mutation of the ubiquitination 
acceptor site would abolish the ubiquitination of hGLUT4 (as seen for the hGLUT4-7K/R 
mutant in Figures 4.1 and 4.3).
SF838-9Da cells harbouring either pWTG4 (pRM2), p7KRG4 (pRM3) or one of the 7 
lysine ‘knock-out’ mutants, K109R (pRM16), K242R (pRM6), K245R (pRM7), K261R 
(pRM8), K264R (pRM9), K266R (pRMlO) and K495R (pRM5) were grown in selective 
media (SD) containing 100/fM CuSO^ to induce expression of hGLUT4, hGLUT4-7K/R 
and the 7 mutants. Immunoprecipitates formed with rabbit anti-GLUT4 antibody were 
subject to immunoblot analysis with mouse anti-ubiquitin antibody, in order to detect 
whether endogenous ubiquitin, normally conjugated to hGLUT4, was prevented from 
ubiquitinating any of the 7 ‘knock-out’ mutants. Immunoblot analysis with mouse anti- 
GLUT4 monoclonal antibody was used to ascertain whether equivalent amounts of
hGLUT4, hGLUT4-7K/R and the seven ‘knock-out’ mutants were immunoprecipitated 
(Figure 4.8).
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Figure 4.8. Investigation into the ubiquitination of GLUT4 lysine *knock-out  ^mutants.
SF838-9Da yeast cells harbouring any one ofpWTG4, p7KRG4 or one o f the 7 lysine 
‘knock-out’ mutants (described in the text above) were grown in selective media containing 
lOOpM CUSO4. Immunoprecipitates formed with lOpl anti-GLUT4 antibody were 
immunoblotted with anti-Ub antibody and 1F8 (a GLUT4 monoclonal antibody).
The data presented in Figure 4.8 are consistent with those presented in Figures 4.1 and 4.3, 
in that the anti-ubiquitin antibody detects a band with an apparent molecular weight of 
~50kDa in the immunoprecipitate from cells expressing wild-type hGLUT4 but not in that 
obtained from cells expressing the hGLUT4-7K/R mutant. However, all of the seven 
‘knock-out’ mutants showed a similar 50kDa immunoreactive band, indicating ubiquitin 
conjugation; none showed the removal of ubiquitin binding to hGLUT4 as seen with the 
ubiquitination-deficient mutant, as would have been expected had any of the ‘knock-out’ 
mutants abolished ubiquitination of hGLUT4.
Although the data presented thus far are consistent with hGLUT4 being monoubiquitinated 
(modified by a single ubiquitin molecule on one of its lysine residues), it is possible that 
the protein is multi-monoubiquitinated (modified by a single ubiquitin molecule on more 
than one lysine residue), as oppose to polyubiquitination, which refers to chains of 
ubiquitin molecules (Amason and Ellison, 1994; Hicke and Dunn, 2003). This would 
explain the data presented in Figure 4.8, in that even if one of the ubiquitination sites had 
been knocked out, another one (at least) would still be ubiquitinated. 1 therefore undertook 
to make a series of ’knock-in’ mutants where each of the 7 putative ubiquitination sites
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were ‘put back into’ the ubiquitination-deficient (hGLUT4~7K/R) mutant, thus generating 
7 individual mutants with only one lysine residue available for ubiquitination. The pairs of 
oligonucleotides; 233 and 234, 237 and 238, 231 and 232, 235 and 236, 239 and 240, 241 
and 242, 243 and 244 (listed in Table 2.2) were used in a set of 7 separate SDM reactions 
to individually mutate the arginine residues at positions 109, 242, 245, 261, 264, 266 and 
495 of hGLUT4-7K/R (in pRM3) back to lysine residues, thus making a series of ‘knock­
in’ mutants under control of the CUPl promoter; pRM17 (7KRK242), pRM18 
(7KRK261), pRM19 (7KRK109), pRM20 (7KRK245), pRM21 (7KRK264), pRM22 
(7KRK266), pRM23 (7KRK495) (listed in Table 2.3). As described for the ‘knock-out’ 
mutants, these ‘knock-in’ mutants were used, along with pWTG4 (pRM2) and p7KRG4 
(pRM3), to examine which of the lysine residues was subject to ubiquitination.
SF838-9Da cells harbouring either pWTG4 (pRM2), p7KRG4 (pRM3) or one of the 7 
lysine ‘knock-in’ mutants, were grown in selective media containing 100//M CuSO^ to 
induce expression of hGLUT4, hGLUT4-7K/R and the 7 mutants. Immunoprecipitates 
formed with rabbit anti-GLUT4 antibody were subject to immunoblot analysis with mouse 
anti-ubiquitin antibody, in order to detect whether endogenous ubiquitin was conjugated to 
any of the individual lysine residues within the hGLUT4 ‘knock-in’ mutants. Immunoblot 
analysis with mouse anti-GLUT4 monoclonal antibody was used to ascertain whether 
equivalent amounts of hGLUT4, hGLUT4-7K/R and the seven ‘knock-in’ mutants were 
immunoprecipitated (Figure 4.9).
fü,
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Figure 4.9.Investigation into the ubiquitination of GLUT4 lysine ^knock-in  ^mutants.
SF838-9Da yeast cells harbouring any one ofpWTG4, p7KRG4 or one o f the 7 lysine 
‘knock-in ' mutants (as described in the text above) were grown in selective media 
containing lOOpM CUSO4. Immunoprecipitates formed with lOpl anti-GLUT4 antibody 
were immunoblotted with anti-Ub antibody, to investigate whether ubiquitin conjugation 
was retained in any o f the ‘knock-in' mutants, and 1F8 antibody (a GLUT4 monoclonal 
antibody).
The data presented above in Figure 4.9 is consistent with that seen in Figures 4.1, 4.3 and 
4.8, in that an immunoreactive band with apparent molecular weight of ~50kDa is detected 
by the anti-ubiquitin antibody in the immunoprecipitate from cells producing wild-type 
hGLUT4 but not from those cells producing the ubiquitin-deficient mutant hOLUT4-7K/R. 
Disappointingly however, all of the 7 ‘knock-in’ mutants still showed the presence of 
similar 50kDa immunoreactive band, with the exception of, perhaps, hGLUT4-7K/RK266. 
However, this experiment was repeated on a number of occasions, without any consistency 
in the results.
This knock-in/knock-out approach to mapping the site of hGLUT4 ubiquitination was 
unsuccessful. This has also been the case in other studies attempting to map ubiquitination 
sites. Lysine to arginine mutants of the three ubiquitination substrates; c-Jun (Treier et al., 
1994), the T-cell receptor ^ subunit (Hou et al., 1994) and the encephalomyocarditis 
(EMC) virus 3C protease (Lawson et al., 1999), showed every single mutant to retain 
nearly wild-type susceptibility to ubiquitination. Therefore, it would seem that E3 ligases
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can be rather nonselective with respect to which lysine in the target protein is 
ubiquitinated. If a particular lysine residue is unavailable for modification by 
ubiquitination, it is probable the E3 ligase moves along the protein until it finds a lysine 
that can be ubiquitinated. This would explain why all of the GLUT4 ‘knock-in’ and 
‘knock-out’ mutants created appeared to be ubiquitinated.
4.5. Chapter summary
In view of the finding that, when expressed in yeast, hGLUT4 traffics in a nitrogen- 
regulated manner analogous to the regulated trafficking of Gap Ip, the aim of this chapter 
was to address whether, also like Gap Ip, GLUT4 was subject to ubiquitination. By way of 
a series of immunoprécipitation experiments and pull-down assays, I show that hGLUT4 is 
indeed ubiquitinated in yeast, and importantly, also in the insulin-sensitive, murine cell line 
3T3-L1 adipocytes, most likely by monoubiquitination. This chapter also outlines efforts 
made towards identifying the specific lysine residue(s) of GLUT4 that is/are subject to 
ubiquitination.
.S .,
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Chapter 5: Analysis of the role of ubiquitination in GLUT4
trafficking
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nitrogen-regulated trafficking of GLUT4 in yeast.
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Chapter 5: Analysis o f the role o f ubiquitination in GLUT4 trafficking.
I
5.1. Introduction
The finding that GLUT4 is subject to ubiquitination adds to the similarities between the
regulated trafficking of GLUT4 in insulin-sensitive cells and the general amino acid
permease, Gap Ip in yeast. Given that hGLUT4, when expressed in yeast, follows the same
nitrogen-regulated trafficking pathway as Gap Ip, and the sorting of Gap Ip to the 
.proteolytically active compartment in nutrient-rich conditions is regulated by its 
ubiquitination (Hein and Andre, 1997; Helliwell et al., 2001; Springael and Andre, 1998;
Springael et al., 1999), I set out to test the hypothesis that ubiquitination plays a role in the
By using yeast that produce either a ubiquitination-deficient mutant of hGLUT4 
(hGLUT4-7K/R), or a constitutively-ubiquitinated hGLUT4 fusion protein (hGLUT4- 
7K/R-HAUb), I set out to address whether, like Gap Ip, the ubiquitination of hGLUT4 in 
yeast serves as a signal to direct the transporter to the proteolytically active compaitment 
for degradation. This chapter presents data to support the above hypothesis, and also 
presents experiments directed towards defining a role for ubiquitination in the regulated 
trafficking of GLUT4 in the insulin-sensitive murine cell line, 3T3-L1 adipocytes. 
Through a series of experiments studying the trafficking of either wild type HA-GLUT4, 
the ubiquitin-deficient mutant HA-GLUT4-7K/R or the constitutively- ubiquitinated 
hGLUT4-7K/R-HAUb in adipocytes, I propose a model in which the ubiquitination of 
GLUT4 is requked for its exit from the TGN into the GLUT4 storage vesicles (GSVs) 
from where it can be mobilised to the plasma membrane in response to insulin.
5.2. Ubiquitination o f  HGLUT4 in yeast targets it fo r  degradation by active vacuolar 
proteases
In order to build on the findings presented in Chapters 3 and 4: namely that when 
expressed in yeast, hGLUT4 traffics in a nitrogen-regulated manner analogous to Gap Ip; 
and, again like Gap Ip, GLUT4 is ubiquitinated, I set out to determine whether the 
ubiquitination of GLUT4 is detennined for its nitrogen-regulated trafficking in yeast. To 
this end, I asked whether the ubiquitination-deficient mutant hGLUT4-7K7R (Figures 4.1,
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4.3 and 4.5) is subject to the same nitrogen-regulated trafficking as its wild-type 
counterpart in yeast.
KY73 cells {PEP4\ wild-type, i.e. containing active vacuolar proteases) expressing either
wild-type hGLUT4 or the ubiquitination-deficient hGLUT4-7K/R were grown in media
containing either 0.5% ammonium chloride or 0.1 % proline as the sole source of nitrogen
(Figure 5.1). Proteins contained in lysates prepared from 10 OD^ oo equivalents of cells
were separated using SDS-PAGE prior to immunoblot analysis, performed with anti-
GLUT4 antibody (and also anti-Vtilp as a loading control).
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Figure 5.1. hGLUT4-7KIR is stabilised in PEP4 cells.
KY73(PEP4) yeast cells harbouring either pWTG4 (pRM2; hGLUT4 under control o f the 
CUPJ promoter) or pG47KR (pRM3; hGLUT4-7K/R under control o f the CUPJ 
promoter) were grown in media containing lOOpM CuS0 4 and, either, 0.5% ammonium 
chloride or 0.1% proline as the sole nitrogen source, as indicated above. The amount o f 
hGLUT4 or hGLUT4-7K/R in 10 O D ^  equivalents o f cells was assessed using immunoblot 
analysis with anti-GLUT4 antibody (the amount o fV tilp  in each sample was similarly 
assessed to control for equal loading).
Consistent with the data presented in Figure 3.8, wild type hGLUT4 can be detected in 
KY73(PEP4) cells grown in media providing proline as the sole source of nitrogen (a poor 
nitrogen source), but not when grown in media containing ammonium chloride (a rich
Rebecca K McCann, 2007 Chapter Five, 94
nitrogen source) (Figure 5.1). This indicates that wild-type hGLUT4 is more stable in 
yeast grown with limited nutrients, such as proline, likely due to the fact that it is being 
directed away from the proteolytically active endosomal system (as seen for Gap Ip).
In contrast to its wild-type counterpart, the ubiquitination-deficient hGLUT4-7K/R mutant 
was easily detectable in cells containing active vacuolar proteases and grown on
ammonium chloride (Figure 5.1). This indicates that hGLUT4-7K/R is being prevented 
from degradation, likely due to it being directed away from the endosomal system, thus 
avoiding vacuolar proteases, even under conditions where the wild type hGLUT4 is being
transported to a proteolytically active compartment. As hGLUT4-7K/R lacks modification
by ubiquitin, this adds further weight to the hypothesis that the ubiquitination of hGLUT4 
subsequently causes its transport to the proteolytically active endosomal system.
To further investigate the role that ubiquitin modification plays in hGLUT4 trafficking, I 
created a translational fusion of hGLUT4-7K/R with an HA-tagged ubiquitin moiety. This 
fusion protein was produced by using site directed mutagenesis to replace the ‘stop’ codon 
of the hGLUT4-7K/R ORF in pRM3 with an Sphl site. Following digestion with Sphl to 
linearise the resulting plasmid, sequence encoding HA-tagged ubiquitin (which had been 
amplified using PGR to caiTy homologous to the hGLUT4-7K/R ORF and the PH08  
yjJTK) was introduced to the carboxy-terminal end of hGLUT4-7K/R by homologous 
recombination (see Section 2.2.2 for details). The resulting plasmid, pG47KRHAUb 
(pRM24) encodes constitutively-ubiquitinated fusion protein hGLUT4-7K/R-HAUb from 
the copper-inducible CUPl promoter. The construction of this plasmid was verified by 
DNA sequencing.
KY73(F£'F4) and 'PMYl{pep4-3) cells expressing the constitutively-ubiquitinated 
hGLUT4-7K/R-HAUb fusion protein were grown in media containing 0.5% ammonium 
chloride or 0.1% proline as the sole source of nitrogen (Figure 5.2). Proteins contained in 
lysates prepared from 10 ODgog equivalents of cells were separated using SDS-PAGE prior 
to immunoblot analysis, performed with anti-HA antibody to detect the hGLUT4-7K/R- 
HAUb fusion protein and anti-Vtilp as a loading control.
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Figure 5.2. hGLUT4-7KIR-HAUb is degraded by vacuolar proteases regardless of the 
nitrogen source.
KY73(PEP4; containing active vacuolar proteases) and RMYl(pep4-3; without active 
vacuolar proteases) yeast cells harbouring pRM24 (hGLUT4-7K/R-HAUb fusion protein 
under control o f the CUPl promoter) were grown in media containing lOOpM CuS0 4 and 
either 0.5% ammonium chloride or 0.1% proline as the sole nitrogen source, as indicated. 
The amount o f hGLUT4-7K/R-HAUb fusion protein in 10 OD^ooequivalents o f cells was 
assessed by immunoblot analysis with anti-HA antibody (the amount o f Vtilp in each 
sample was similarly assessed to control for equal loading).
Immunoblot analysis with anti-HA antibody detects an immunoreactive band with an 
apparent molecular weight of ~50kDa in the lysate produced from cells that lack active 
vacuolar proteases (Figure 5.2). This is consistent with the predicted molecular weight of 
the hGLUT4-7K/R-HAUb fusion protein, as it accounts for the addition of one 8kDa 
ubiquitin moiety to the ~42kDa hGLUT4-7K/R protein. Importantly, no such band was 
detected in the lysate prepared from cells, expressing the fusion protein, that contain active 
vacuolar proteases. These data are consistent with a model in which the hGLUT4-7K/R- 
HAUb fusion protein is delivered to the proteolytically active endosomal system where it
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is degraded by active vacuolar proteases (as only in cells that lack vacuolar proteases is the 
fusion protein stabilised).
As shown in Figures 3.8 and 5.1, wild-type hGLUT4 is degraded in cells grown in 
ammonium chloride but not in cells grown in proline. I have interpreted this as reflecting 
the diversion of hGLUT4 away from the proteolytically active endosomal system under
y
nitrogen-limiting conditions, as observed for Gap Ip (Roberg et al., 1997). hi contrast, the
ubiquitination-deficient mutant hGLUT4-7K/R is stabilised, not only in cells grown using 
the poor nitrogen source proline, but also in the presence of the rich nitrogen source 
ammonium chloride (Figure 5.1); indicating that ubiquitination of GLUT4 is required for 
its nitrogen-regulated sorting to the endosomal system. The constitutively-ubiquitinated 
hGLUT4-7K/R-HAUb fusion protein is degraded regardless of the nitrogen source, and is 
only stablilised upon inactivation of vacuolar- proteases (Figure 5.2). Thus it appears that 
the in-frame ubiquitin fusion protein is trafficked to the proteolytically active endosomal 
system regardless of nitrogen source. These data indicate that the addition of a ubiquitin 
moiety to hGLUT4 is sufficient to direct the transporter to the endosomal system in yeast.
5.3. Expression o f recombinant GLUT4 proteins in 3T3-L1 adipocytes 
Having characterised the trafficking of both the ubiquitin-deficient mutant hGLUT4-7K/R 
and the constitutively ubiquitinated hGLUT4-7K/R-HAUb fusion protein in the yeast 
model system, I moved on to use these proteins to investigate the role of ubiquitination in 
the trafficking of GLUT4 in insulin-sensitive cells. For this purpose, I set out to create two 
retroviral expression vectors that would drive the expression of the hGLUT4-7K/R mutant 
and the hGLUT4-7K/R-HAUb fusion protein in the insulin-sensitive murine cell line 3T3- 
L1 adipocytes.
For these experiments, it was necessary for the retrovirally expressed GLUT4 molecules to 
carry an HA-epitope tag in order to distinguish them from endogenous GLUT4 expressed 
by 3T3-L1 adipocytes. I obtained a retroviral expression construct that drives the 
expression of wild-type GLUT4 hai’bouring an HA tag in the fust exofacial loop of 
GLUT4, from Professor David James. This molecule is subject to insulin-regulated 
h’afficking in 3T3-L1 adipocytes in a manner indistinguishable from the endogenous 
protein (Shewan et al., 2003). To create an HA-tagged version of the hGLUT4-7K/R 
mutant I used an approach that involved ‘splicing’ two gene fragments together by the
. i : ; :
' II
Rebecca K McCann, 2007 Chapter Five, 97
gene splicing by overlap extension (SOEing) PCR technique (Horton et al., 1990). This 
technique is a method of recombining DNA sequences without depending on restriction 
sites or the use of restriction endonucleases or ligase, allowing the precise design of 
junctions between DNA sequences. In brief, gene SOEing relies on the gene fragments to 
be recombined sharing a complimentary sequence at one end, allowing the DNA strands 
from the two different fragments to form an overlap. The extension of this overlap by 
DNA polymerase yields a recombinant molecule in which the original DNA fragments are 
‘spliced’ together.
To construct an HA-tagged version of the hGLUT4-7K/R mutant, cDNA encoding amino 
acid residues 1 to 75 of wild type HA-GLUT4 (with the exofacial HA-tag between residues 
67 and 68) was ‘spliced’ together with cDNA encoding amino acid residues 69 to 509 of 
the hGLUT4-7K/R mutant, which includes all of the lysine to arginine changes. Therefore 
two fragments of DNA were generated in two separate PCRs with pairs of oligos 260, 263 
and 261, 264 (Table 2.2) using pMEXHAGLUT4 (Benito et al., 1991; Shewan et al., 2000) 
and pG47KR (pRM3) as templates, respectively. These two fragments contain 
overlapping regions of identical sequence between the cDNA encoding amino acids 69 to 
75 of GLUT4 and were used together as template DNA in a final PCR to extend the 
overlap (using oligos 260 and 261) to produce a final recombinant molecule encoding an
HA-tagged version of the mutant GLUT4-7K/R.
'•c
In order to construct retroviral expression vectors that will drive the expression of HA- 
GLUT4-7K/R and the hGLUT4-7K/R-HAUb fusion protein in adipocytes, PCR products 
encoding HA-tagged GLUT4-7K/R and hGLUT4-7K/R-HAUb were introduced into the 
pBABE-puro retioviral expression vector (Morgenstern and Land, 1990). Note that the 
hGLUT4-7K/R-HAUb fusion protein already contains an HA-tag between the carboxyl 
terminal of the GLUT4 molecule and the first methionine of ubiquitin; therefore there was 
no need to engineer a tag into this sequence.
In addition to producing the final recombinant HA-GLUT4-7K/R encoding DNA, oligos 
260 and 261 were designed to add EcoRl and Sail restriction sites at the 5’ and 3’ ends, 
respectively, of the HA-GLUT4-7K/R molecule. This allowed for the subcloning of the 
HA-GLUT4-7K/R mutant as an EcoRl-SaE fragment into the pBABE-puro retiovhal
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expression vector (Morgenstern and Land, 1990). Similarly, the hGLUT4-7K/R-HALTb 
encoding DNA was amplified using PCR with oligos 260 and 262; also designed to add 
EcoRl and Sail restriction sites at the 5’ and 3’ ends, respectively, of the PCR product, 
again enabling it to be subcloned into the pBABE-puro retroviral expression vector. The 
resulting plasmids, pRM4 and pRM25 thus encode HA-GLUT4-7K/R and hGLUT4-7K/R- 
HAUb, respectively, in the retroviral expression vector, pBABE-puro (Morgenstern and 
Land, 1990).
The production of infectious retrovirus containing the constructs, pRM4, pRM25 and 
pHA-GLUT4; encoding HA-tagged wild type GLUT4 in pBABE-puro (Shewan et al.,
2000), was carried out with the use of the packaging cell line, Platinum-E (Plat-E) (Morita 
et al., 2000). The Plat-E cells constitutively express the viral structural genes, gag, pot and 
env, which encode essential protein components for the production of infectious retrovirus, 
including the viral reverse transcriptase and retroviral coat proteins (Morita et a i, 2000).
As fully described in Section 2.2.8c, the Plat-E cell line was stably transfected with the 
retroviral expression vectors using liposome-mediated transfection. The Plat-E packaging 
cell line produces retrovkal particles (containing the retroviral expression vectors), which 
are released into the media surrounding the packaging cells. This media, containing the 
relevant retrovirus, can then be added directly to the media of 3T3-L1 fibroblasts to allow 
infection of these cells and consequent uptake of the recombinant GLUT4 cDNA. The 
pB ABE-puro retroviral expression vector contains a drug selectable marker that confers 
resistance to infected cells in medium containing puromycin (Morgenstern and Land,
1990). Subsequent differentiation of infected 3T3-L1 fibroblasts thus generated 3T3-L1 
adipocytes that stably express each of the 3 GLUT4 constracts (wild-type HA-GLUT4; the 
ubiquitin deficient HA-GLUT4-7K/R; and the GLUT4-7K/R mutant carrying an in-frame 
ubiquitin fusion hGLUT4-7K/R-HAUb), which were used to analyse the role of 
ubiquitination in insulin-regulated GLUT4 trafficking.
5.4. Ubiquitination ofG LU T4 is required fo r  its exit from  the Syntaxinlô positive 
compartment into insulin responsive GSVs.
As described for Gap Ip, the conjugation of ubiquitin to transmembrane proteins can act as 
a sorting signal for their transport into vesicles that bud into the lumen of multivesicular 
bodies (MVB) (Katzmann et a i, 2002). MVBs subsequently fuse with the mammalian 
lysosome, or the yeast vacuole, resulting in the eventual proteolysis of the MVB contents
y
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(Katzmann et al., 2002).
The ubiquitination of proteins at the cell surface also acts as a signal for their 
internalisation (Urbe, 2005). This was first described in yeast where Ste6p, an ABC (ATP- 
binding cassette) transporter accumulates in a ubiquitinated form in end (endocytosis- 
defective) mutant cells (Kolling and Hollenberg, 1994). The ubiquitination of many 
proteins has subsequently been shown to be required for their internalisation from the cell 
surface (Urbe, 2005). In mammalian cells, the ubiquitination of the renal aquaporin-2 
(AQP2) water channel at the apical membrane of the kidney-collecting duct upon removal 
of the hormone arginine-vasopressin triggers its internalisation and subsequent delivery to 
the lysosome (Kamsteeg et al., 2006). Conversely, the ubiquitination o f major 
histocompatibility complex class II molecules (MHC H) ceases upon dendritic cell 
maturation, allowing for its accumulation at the plasma membrane (Shin et al., 2006). A 
ubiquitination-deficient mutant of MHC 11 is retained at the plasma membrane of immature 
dendritic cells, while a constitutively ubiquitinated MHC 11 molecule is retained 
intracellularly (Shin et al., 2006). Likewise, a ubiquitination-deficient mutant of AQP2 
localised mainly to the apical membrane of kidney cells while a constitutively 
ubiquitinated form of AQP2 localised primarily to the internal vesicles of MVBs 
(Kamsteeg et al., 2006). In light of the above studies, and the data presented thus far in 
this thesis, demonstrating that ubiquitination of hGLUT4 in yeast acts as a signal to direct 
the ti-ansporter to the proteolytically active endosomal system, 1 embarked on a series of 
experiments to study the role that ubiquitination plays in the trafficking of GLUT4 in 3T3- 
L1 adipocytes.
To assess whether ubiquitination was required for the insulin-dependent delivery of 
GLUT4 from an intracellular store to the plasma membrane of adipocytes, 1 utilised an 
assay that takes advantage of the exofacial HA-tag carried by wild-type HA-GLUT4 and 
the ubiquitin-deficient HA-GLUT4-7K/R mutant. Antibodies that specifically recognise 
the HA-epitope (in the first exofacial loop of the two retrovirally expressed GLUT4 
constructs) were used to visualise GLUT4 molecules present at the cell surface of 
adipocytes that had either been treated with insulin, or not. This experiment (presented in 
Figure 5.3) was carried out in collaboration with Jacqueline Stoeckli at the Garvan Institute 
of Medical Research, Australia. The labelling of surface GLUT4 was carried out in the
■‘I'
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absence of any cell permeabilisation (see Section 2.2,13c for details), but was followed by 
a second round of labelling with anti-HA antibody after subsequent permeabilisation with 
saponin. This allowed for the labelling of total HA-tagged GLUT4 and was used as a 
control to check that absence of HA staining at the cell surface was not due to lack of 
expression (Figure 5.3). Due to the fact that the HA tag present in the constitutively- 
ubiquitinated hGLUT4-7K/R-HAUb is in the cytosolically-disposed carboxyl terminal tail 
of the GLUT4-7K/R molecule, rather than in an exofacial HA-tag, I was unable to include 
hGLUT4-7K/R-HAUb in this experiment.
Basal Insulin
surface GLUT4 surface GLUT4 total GLUT4
wt
7K/R
Figure 5.3. HA-GLUT4-7KIR fails to translocate to the plasma membrane in response to 
insulin.
3T3-L1 adipocytes expressing wild-type HA-tagged GLUT4 (wt) or HA-GLUT4-7K/R 
(7KIR), incubated for lOmins in the presence (Insulin) or absence (Basal) oflOOnM 
insulin, were fixed and processed for surface and internal GLUT4 staining as described in 
Section 2.2.13c. Surface GLUT4 (labelled with anti-HA antibody) is shown in red, DAPl 
in blue and total HA staining is shown in white. Scale bar = 10pm.
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The insulin-stimulated translocation of wild-type HA-GLUT4 to the plasma membrane of 
adipocytes is evident in Figure 5.3, as indicated by the surface labelling of HA-GLUT4 
(shown in red) following treatment of adipocytes expressing wild type HA-GLUT4 with 
insulin. If the ubiquitination of GLUT4 acted as a signal to direct its internalisation from 
the plasma membrane of adipocytes, I would have expected the ubiquitination-deficient 
HA-GLUT4-7K/R to be constitutively localised to the adipocyte plasma membrane. 
However, Figure 5.3 shows a lack of surface labelling of the ubiquitination-deficient HA- 
GLUT4-7K/R in adipocytes regardless of whether they were treated with insulin or not. 
This is despite there being approximately equal levels of internal GLUT4 (shown in white) 
between adipocytes expressing wild type HA-GLUT4 or ubiquitination-deficient HA- 
GLUT4-7K/R. The low levels of HA-GLUT4-7K/R surface labelling compared to the 
wild-type protein following insulin treatment, demonstrates a failure of the ubiquitination- 
deficient HA-GLUT4-7K/R to translocate to the plasma membrane in response to insulin. 
Therefore, rather than indicating a role for ubiquitination in the internalisation of GLUT4 
from the plasma membrane of adipocytes, it would appear that ubiquitination of GLUT4 
may be required for its insulin-stimulated translocation to the plasma membrane.
To further investigate these findings, I used differential centrifugation to perform 
subcellular fractionation on adipocytes expressing HA-GLUT4, HA-GLUT4-7K/R or 
GLUT4-7K/R-HAUb to determine the subcellular distribution of the three GLUT4 
molecules, before and after insulin treatment. This technique yields four membrane 
fractions that have previously been characterised in detail (Piper et al., 1991) and are 
designated as; the high-density microsomal fraction (HDM), containing large endosomal
components and the endoplasmic reticulum (ER), the low-density microsomal fraction 
(LDM), emiched in GLUT4 storage vesicles (Millar et al., 1999), the plasma membrane 
fraction (PM) and the mitochondria/nuclei fraction (M/N). Proteins contained within the 
PM, LDM and HDM fractions were separated by SDS-PAGE and subjected to immunoblot 
analysis with anti-HA antibody (Figure 5.4).
■S
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Figure 5.4.HA-GLUT4-7KIR fails to translocate to the plasma membrane in response to 
insulin.
3T3-L1 adipocytes expressing either wild-type HA-GLUT4 (WT), or HA-GLUT4-7K/R 
(7KR) were incubated in the absence (-) or presence oflOOnM insulin for 20 min.
Cells were then fractionated into PM, LDM and HDM fractions as described in materials 
and methods. Aliquots o f each fraction ( lOpg o f protein) were then immunoblotted with 
anti-HA antibody.
As previously demonstrated (Shewan et al., 2000), the amount of wild type HA-GLUT4 in 
the PM fraction increases in response to insulin treatment, with a corresponding decrease 
in the LDM fraction. This demonstrates the translocation of wild type HA-GLUT4 from 
the GLUT4 storage vesicles, contained within the LDM fraction, to the PM. Although the 
amount of HA-GLUT4-7K/R in the PM does increase slightly following insulin 
stimulation, there is no corresponding decrease of HA-GLUT4-7K/R in the LDM fraction. 
This suggests that the small increase of HA-GLUT4-7K/R at the PM, in response to 
insulin, is unlikely due to its translocation from GLUT4 storage vesicles.
The data presented in Figures 5.3 and 5.4 indicate that ubiquitination of GLUT4 is required 
for the insulin-stimulated translocation of the transporter to the plasma membrane of 
adipocytes. One possibility is that an insulin signal might result in the ubiquitination of 
GLUT4 and cause GLUT4 to traffic to the plasma membrane. If this were the case, I 
would expect to see an increase in GLUT4 ubiquitination upon treatment of the adipocytes 
with insulin. To address this, I prepared lysate from adipocytes that were either treated 
with 200nM insulin or not and investigated the ubiquitin status of the endogenous GLUT4
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from these adipocytes. This was achieved by incubating the lysates with glutathione- 
Sepharose beads carrying the GST fusion protein, GST-UBA (ubiquitin-binding) and, as a 
control, GST alone. Proteins pulled-down by GST-UBA and GST were analysed by 
immunoblot analysis with anti-GLUT4 antibody (to detect any GLUT4 bound to GST 
alone or to the GST fusion protein), anti-Syntaxin4 antibody (as a non-ubiquitinated 
protein control) and anti-IRS-1 antibody (as a ubiquitinated protein control) (Figure 5.5). 
2.5% of the input lysate was also subject to SDS-PAGE and immunoblot analysis with the 
various antibodies to verify to presence of the proteins in the lysate.
Lysate GST
1SOkDa-
GST-
UBA
+ 200nM Insulin
-IRS-1
(X-GLUT4
SOkDa
2SkDa
m #mm «-Syntaxln 4
(1-GLUT4 
(longer exposure)
Figure 5.5. GLUT4 is ubiquitinated in 3T3-L1 adipocytes with and without insulin 
stimulation
Lysate prepared from 3T3-LI adipocytes, treated with 200nM insulin or not for 15mins 
(+/- respectively) was incubated with glutathione-Sepharose beads that carried the GST- 
fusion protein GST-UBA or GST alone. Proteins eluted from the beads were subject to 
immunoblotting with anti-GLUT4, anti-IRS-1 and anti-Syntaxin4 antibodies. 2.5% input 
(lanes 1 and 2) was also loaded as a control.
'"=51
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Consistent with the data shown in Figure 4.6, immunoblot analysis with anti-GLUT4 
antibody in Figure 5.5 reveals that GLUT4 binds selectively to the GST-UBA fusion 
protein. Immunoreactive bands of approximately equal intensity and with the expected 
larger molecular weight to represent ubiquitinated GLUT4 (as compared to the input 
lysate) were detected from adipocytes that were, or were not, treated with insulin. This 
indicates that GLUT4 is ubiquitinated in adipocytes regardless of whether the cells are 
stimulated with insulin, or not.
I next performed a series of indirect immunofluorescence experiments to further 
characterise the HA-GLUT4-7K/R mutant in adipocytes. Adipocytes expressing wild-type 
HA-GLUT4, HA-GLUT4-7K/R or GLUT4-7K/R-HAUb were incubated for 20 mins either 
with, or without 200nM insulin before being processed for indirect immunofluorescence, 
as described in Section 2.2.13c. Cells were double labelled with antibodies specific for the 
HA-epitope tag (to label the recombinant GLUT4 molecules) and either antibody specific 
for the TGN marker Syntaxinl6 (Figure 5.6), or antibody specific for early endosomal 
antigen 1 protein (EEAl), a marker of early endosomes (Mu et al., 1995) (Figure 5.7).
I
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Figure 5,6. HA-GLUT4-7K/R and GLUT4-7K/R-HAUb co-localise with the Syntaxinlô 
positive compartment.
3TS-L1 adipocytes expressing wild-type HA-GLUT4 (WT), HA-GLUT4-7K/R (7K/R) or 
GLUT4-7K/R-HAUb (7K/R-HAUb) were incubated in the presence or absence o f200nM  
insulin fo r  15min. Cells were then fixed  in 3% paraformaldehyde and double labelled with 
anti-HA antibody and an antibody specific fo r  Syntaxinlô. Mouse anti-HA was visualised 
with Cy3-coupled secondary antibody, rabbit anti-Syntaxin 16 was visualised by alexa488- 
coupled secondary antibody.
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Figure 5.7.HA-GLUT4-7K/R and GLUT4-7K/R-HAUb do not colocalise with EEAL
3T3-L1 adipocytes expressing wild-type HA-GLUT4 (WT), HA-GLUT4-7K/R (7K/R) or 
GLUT4-7K/R-HAUb (7K/R-HAUb) were incubated in the presence or absence o f200nM  
insulin fo r  15min. Cells were then fixed  in 3% paraformaldehyde and double labelled with 
anti-HA antibody and an antibody specific fo r  EEAL Mouse anti-HA was visualised with 
Cy3-coupled secondary antibody, rabbit anti-EEAJ was visualised with alexa488-coupled 
secondary antibody.
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Consistent with previous studies (Martin et al., 2000a; Shewan et al., 2000; Shewan et al., 
2003), Figure 5.6 demonstrates that wild-type HA-GLUT4 (shown in red), localises to the 
peri-nuclear region of basal adipocytes, co-localising with the TGN marker Syntaxinl6 
(shown in green), and also to small punctate structures throughout the cytoplasm, thought 
to represent GSVs (Martin et al., 2000a). Although HA-GLUT4-7K/R also shows 
colocalisation with Syntaxinlô in the perinuclear region of the cell, it is striking that there 
is a distinct lack of labelling of the cytosolic vesicles with this mutant, which shows a less 
dispersed staining compared to the wild-type (Figure 5.6). The labelling of these 
peripheral punctate structures by wild-type HA-GLUT4 is also evident in Figure 5.7, 
where again the HA-GLUT4-7K/R mutant shows less diffuse labelling throughout the 
cytoplasm of the adipocytes. In addition, to further support that seen in Figures 5.3 and
5.4, wild-type HA-GLUT4 displays a marked translocation to the plasma membrane in 
response to insulin, whereas the HA-GLUT4-7K/R mutant does not respond to insulin in 
this manner.
The observation that HA-GLUT4-7K/R is excluded from punctate, GSV-like, structures in 
adipocytes and is not insulin responsive, supports a model in which the ubiquitination of 
GLUT4 facilitates its entry into GSVs from where it is mobilised to the cell surface in 
response to insulin. As the HA-GLUT4-7K/R mutant lacks ubiquitin modification, it is 
prevented from entering the GSVs, and hence does not translocate to the plasma membrane 
in response to insulin.
One prediction of the above model is that the constitutively-ubiquitinated GLUT4-7K/R- 
HAUb fusion protein would have a subcellular localisation that mirrors that seen for wild- 
type GLUT4. However, indirect immunofluorescence performed on adipocytes expressing 
the GLUT4-7K/R-HAUb fusion protein (Figures 5.6 and 5.7) show it to have the same 
subcellular localisation as the ubiquitination-deficient HA-GLUT-7K/R in basal cells (note 
that that the GLUT4-7K/R-HAUb is also absent from the peripheral GSV-like stiuctures), 
and also demonstrate that this mutant is not responsive to insulin. Although 1 found that 
this method of attaching ubiquitin to GLUT4 was sufficient to direct its trafficking to the 
endosomal system in yeast (Figure 5.2) it does not appear to be sufficient to direct the 
entry of GLUT4 into GSVs in adipocytes. It is possible that the specific site of ubiquitin 
attachment to the GLUT4 molecule is important for this function.
addition, the GGA2 isoform shows significant colocalisation with GLUT4 in the 
perinucleai* region of adipocytes (Li and Kandi'or, 2005).
■ft-
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5.5. GGAs are required fo r  ubiquitin-dependent hGLUT4 trafficking 
Gga proteins are essential for the nitrogen-regulated trafficking of Gap Ip in yeast (Scott et 
al., 2004). The interaction between ubiquitin on Gap Ip and the GAT domain of the Gga 
proteins is an absolute requirement, as Gap Ip remains stable in yeast expressing Gga2p 
lacking its GAT domain (gga2-AGAT) as the sole Gga protein, under conditions where it is 
normally degraded (Scott et al., 2004).
f
GGA proteins have also been implicated in regulating the entry of GLUT4 into its insulin- 
responsive location in 3T3-L1 adipocytes (Li and Kandi’or, 2005; Watson et al., 2004b). 
The entry of newly synthesised GLUT4 into its insulin-sensitive pool was blocked in 
adipocytes expressing a ‘dominant-negative’ GGA mutant (containing only the VHS and I
-GAT domains) (Watson et al., 2004b). This mutant also selectively inhibited the in vitro 
budding of GLUT4-containing vesicles (while having no effect on the generation of 
vesicles containing GLUTl and/or the transferrin receptor) (Watson et al., 2004b). In
The involvement of GGA proteins in the regulated sorting of both Gap Ip (in yeast) and 
GLUT4 (in adipocytes) adds to the parallels between these two systems and makes it 
tempting to speculate that the ubiquitination of GLUT4 might control its association with 
GGA proteins, an interaction which may be involved in the biogenesis of the insulin- 
sensitive pool of GLUT4.
To explore this possibility, I set out to investigate whether, as with Gap Ip, Gga proteins 
were required for the trafficking of hGLUT4 to the yeast endosomal system. hGLUT4 and 
hGLUT4-7K/R were expressed in the yeast strains MBY004 (gga), deficient in Gga 
proteins, and the congenic, wild-type GGA strain, SEY6210 (Black and Pelham, 2000; 
Robinson et al., 1988). Proteins contained in lysates prepared from 10 OD^ og equivalents of 
cells were separated using SDS-PAGE prior to immunoblot analysis, performed with anti- 
GLUT4 antibody (Figure 5.8; carried out in conjunction with Nia Bryant).
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Figure 5.8. GGAs are required for ubiquitin-dependent hGLUT4 trafficking
SEY6210 (GGA) and MBY004 (gga) yeast cells harbouring either pWTG4 or pG47KR (as 
indicated above; WT and K/R, respectively) were grown in selective media (SD) containing 
lOOpM CUSO4. The amount o f wild type hGLUT4 and hGLUT4-7K/R in 10 
equivalents o f cells was assessed using immunoblot analysis (the amount o f Vtilp in each 
sample was similarly assessed to control fo r  equal loading).
As shown previously (Figure 3.5), steady state levels of wild-type GLUT4 in wild-type 
(GGA) yeast (containing active vacuolar proteases) grown under the nitrogen-rich 
conditions used here are low, due to the delivery of the transporter to the proteolytically 
active endosomal system (Figure 5.8). In contrast, the ubiquitin-deficient mutant 
hGLUT4-7K/R is not delivered to the endosomal system and remains stable under the 
same conditions (Figure 5.8). Importantly, levels of wild-type GLUT4 expressed in cells 
lacking Gga proteins (ggaA) were similar to those seen for hGLUT4-7K/R expressed in 
both wild-type (GGA) and ggaA mutant cells. Note that it was not possible to look at the 
nitrogen dependency of this observation since the ggaA cells would not grow when 
supplied with unfavourable nitrogen sources such as proline. This is presumably due to a 
failure of Gap Ip to reach the cell surface under these conditions (since this trafficking step 
required the Gga proteins). The data presented in Figure 5.8 are consistent with the model 
in which the Gga proteins are required to sort ubiquitinated GLUT4 into the proteolytically 
active endosomal system in yeast.
Since the interaction between the Gga GAT domain and ubiquitin is an absolute 
requirement for Gap Ip sorting in yeast (Scott et al., 2004), I set out to investigate whether 
there was a similar interaction with the ubiquitin conjugated to hGLUT4. GLUT4 was
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immunoprecipitated from yeast expressing either wild-type hGLUT4 or ubiquitin-deficient 
hGLUT4-7K/R, with either HA-tagged wild-type Gga2p or a version lacking the ubiquitin- 
binding GAT domain (HA-tagged GGA2Agat). The Gga constructs used here were those 
used in (Scott et al., 2004); obtained from Rob Piper, University of Iowa.
Immunoprecipitates were subject to immunoblot analysis with rat anti-HA antibody (to 
detect whether any HA-tagged GGA2 had coprecipitated with hGLUT4), and mouse anti- 
GLUT4 monoclonal antibody to assess whether equal amounts of hGLUT4 and hGLUT4 
7K/R were immunoprecipitated (Figure 5.9).
,S
If there were an interaction between hGLUT4 and Gga2p, I would expect the immunoblot 
analysis with anti-HA antibody to detect a band in the immunoprecipitate from yeast 
expressing both wild-type hGLUT4 and HA-tagged Gga2p. If this interaction was between 
the ubiquitin, bound to hGLUT4, and the GAT domain of Gga2p, I would predict that this 
band would not be present in the immunoprecipitate prepared from yeast expressing 
hGLUT4-7K/R or HA-tagged GGA2Agat. Figure 5.9 shows no evidence for an interaction 
between HA-tagged Gga2p and hGLUT4. However, this experiment was flawed since 
immunoblot analysis with anti-GLUT4 monoclonal antibody demonstrates that equal 
amounts of wild-type hGLUT4 or hGLUT4-7K/R were not immunoprecipitated. Indeed, 
the lack of a band representing GLUT4 in the lysates indicates that neither the wild-type 
not the 7K/R mutant were even expressed in these cells (although a band was detected in =
one of the immunoprecipitates). Unfortunately, due to time constraints I was unable to 
repeat this experiment in order to acquire equal levels of wild-type hGLUT4 and hGLUT4- 
7K/R and am therefore not able to conclude whether, like Gap Ip, ubiquitinated GLUT4 
interacts with the Gga GAT domain in yeast. Another problem with this approach is that I 
do not know whether the putative interaction between the Gga protein and the ubiquitin on 
GLUT4 would survive the conditions used in this experiment.
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Figure 5.9. Immunoprécipitation to determine an interaction between hGLUT4 and HA- 
tagged GGA2, in yeast.
SF838-9Da yeast cells producing either wild-type hGLUT4 (from pRM2) or the 
ubiquitination-deficient hGLUT4-7K/R mutant (from pRM3) and either HA-tagged Gga2p 
(from p2256) or HA-tagged GGA2A gat (from p2309) were grown in selective media (SD) 
containing lOOpM CuSO^. Immunoprecipitates formed with lOpl anti-GLUT4 antibody 
were subject to immunoblot analysis with rat anti-HA antibody and mouse anti-GLUT4 
monoclonal antibody (1F8).
I also performed experiments to examine whether GLUT4 associates with any of the three 
GGA isoforms expressed in adipocytes. To investigate an interaction with GGA2, 
previously implicated in GLUT4 sorting into GSVs (Li and Kandror, 2005; Watson et al., 
2004b), GLUT4 was immunoprecipitated from 3T3-L1 adipocytes. This 
immunoprecipitate was subsequently subject to immunoblot analysis using an anti-GGA2 
antibody, obtained from Juan Bonifacino, National Institutes of Health, Bethesda. (Figure 
5.10).
Rebecca K McCann, 2007 Chapter Five, 114
3T3-L1 adipocytes! I
I
c a
D_
GGA2I
- 250kDa  
-150kD a  
- lOOkDa 
- 75kDa
- SOkDa
- 37kDa
- 25kDa
IB: GGA2
Figure 5.10. Immunoprécipitation to determine an interaction between endogenous 
GLVT4 and GGA2, in adipocytes.
Immunoprecipitates formed with lOpl anti-GLUT4 antibody from lysate prepared from 
3T3-L1 adipocytes were subject to immunoblot analysis with anti-GGA2 antibody (to 
investigate whether GGA2 interacted with endogenous GLUT4 in adipocytes). 2.5% input 
(lane 1 ) was also loaded as a control.
Immunoblot analysis with anti-GGA2 antibody detects an immunoreactive band of 
-67kDa (the predicted MW of GGA2) in the adipocyte lysate (Figure 5.10). However, 
GGA2 appears not to have coprecipitated with GLUT4, as a similar immunoreactive band 
cannot be detected above background levels in the immunoprecipitate formed with anti- 
GLUT4 antibody. It is possible that the levels of GGA2 bound to GLUT4 at any one time 
are too low for detection by this approach, particularly if GGA2 interacts only with 
ubiquitinated GLUT4. As with the experiment presented in Figure 5.9, another caveat here 
is that the conditions used for the immunoprécipitation may have disrupted an interaction 
between ubiquitin and the Gga proteins. Further experiments carried out under different 
conditions will be required to investigate this. Yet another problem with this experiment is 
that I was unable to probe the immunoprecipitates with anti-GLUT4 antibody since the 
GGA2 antibody was also a mouse monoclonal.
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To investigate an interaction between GLUT4 and the other GGA isoforms expressed by 
adipocytes, I took another approach where I utilised GST fusion proteins containing the 
GAT and VHS domains of GGA 1 and GGA3, GST-GGAl-GAT-VHS and GST-GGA3- 
GAT-VHS, respectively (obtained from Rob Piper, University of Iowa), Lysate prepared 
from 3T3-L1 adipocytes was incubated with glutathione-Sepharose beads carrying the 
GST fusion proteins, GST-GGAl-GAT-VHS and GST-GGA3-GAT-VHS and, as a 
control, GST alone. Proteins pulled-down by the GST fusion proteins or by GST alone 
were analysed by immunoblot analysis with anti-GLUT4 antibody (to detect any GLUT4 
bound to the GST fusion proteins) (Figure 5.11). 2.5% of the input lysate was also subject 
to SDS-PAGE and immunoblot analysis with anti-GLUT4 antibody to verify the presence 
ofGLUT4.
3T3-L1 ad ipocy tes
0 5Ii
0 5I9h-
0 5o
250kD a - 
1SOkDa -
lO O kO a- 
75kO a -
SOkDa -
37kD a -
IB; GLUT4
2SkD a -
Figure 5.11. GST pull down assays to determine an interaction between endogenous 
GLUT4 and GGA proteins, in adipocytes.
Lysate prepared from 3T3-L1 adipocytes was incubated with glutathione-Sepharose beads 
that carried GST alone or the GST-fusion proteins, GST-GGAl-GAT-VHS and GST- 
GGA3-GAT-VHS. Proteins eluted from the beads were subject to immunoblot analysis 
with anti-GLUT4 antibody. 2.5% input (lane I) was also loaded as a control.
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Immunoblot analysis with anti-GLUT4 antibody detects an immunoreactive band with an 
apparent molecular weight of ~48kDa in the adipocyte lysate, thus indicating the presence 
of GLUT4 (Figure 5.11). However, no such band was detected in the proteins pulled- 
down by either of the GST fusion proteins, presenting no evidence for an interaction of 
GLUT4 with either GGAl or GGA3. However, this experiment lacks a positive control.
To substantiate this experiment, I would need to perform immunoblot analysis of proteins 
known to interact with GGAl and GGA3, such as the cation-independent mannose 6- 
phosphate receptor (CI-MPR) or the cation-dependent mannose 6-phosphate receptor (CD- 
MPR) (Puertollano et al., 2001).
Although GGA2 has been implicated in the sorting of GLUT4 in adipocytes, no direct 
interaction between GGA2 and GLUT4 has been previously detected (Li and Kandror, 
2005). Consistent with this, I was unable to coprecipitate GGA2 and GLUT4 from 3T3-L1 
adipocytes (Figure 5.10), or demonstrate binding of GLUT4 from an adipocyte lysate to 
either GST-GGAl or GST-GGA3 fusion proteins (Figure 5.11). However, I am aware that 
these results are preliminary due to the caveats discussed.
5.6. Chapter summary
In this chapter I aimed to address the role that ubiquitin plays in the nitrogen-regulated 
tiafficking of GLUT4 when expressed in yeast, as well as in the insulin-regulated 
trafficking of GLUT4 in the murine cell line 3T3-L1 adipocytes. By investigating the 
intracellular trafficking of a ubiquitination-deficient mutant of hGLUT4 (hGLUT4-7K/R), 
or a constitutively-ubiquitinated hGLUT4 fusion protein (hGLUT4-7K/R-HAUb), I 
determined that, in yeast, the ubiquitination of GLUT4 is both necessary and sufficient to 
direct it to the proteolytically active endosomal system. Furthermore, through a series of 
experiments studying the trafficking of wild-type HA-GLUT4, the ubiquitin-deficient 
mutant HA-GLUT4-7K/R and the constitutively- ubiquitinated hGLUT4-7K/R-HAUb in 
adipocytes, I have presented data to support a model in which ubiquitination of GLUT4 is 
required for its exit from the TGN into the GLUT4 storage vesicles (GSVs) from where it 
can be mobilised to the plasma membrane in response to insulin.
Chapter 6: Final Discussion
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Chapter 6: Final Discussion
The overall goal of this thesis was to further our understanding of the insulin-regulated 
trafficking of the facilitative glucose transporter GLUT4 in fat and muscle cells. One of 
the major consequences of insulin binding to its receptor on fat and muscle cells is the 
translocation of GLUT4 from an intracellular store to the plasma membrane (Bryant et al., 
2002). This allows the uptake of glucose into muscle and adipose tissue, thereby reducing 
levels of plasma glucose (Bryant et al., 2002). The insulin-resistant state associated with 
Type-2 diabetes and obesity is chaiacterised by an insufficient recruitment of GLUT4 to 
the plasma membrane in response to insulin, despite there being normal levels of GLUT4 
expression (Bjornholm and Zierath, 2005). Therefore, understanding the molecular 
mechanisms that control the insulin-regulated trafficking of GLUT4 is of high priority as it 
has the potential to aid us in the development of therapeutic interventions to treat and/or 
prevent Type-2 diabetes.
:
Despite the fact that the intracellular trafficking of GLUT4 has been intensely studied for 
nearly 20 yeai's, two fundamental questions remain largely unanswered (Bryant et al., 
2002):
How is GLUT4 sorted into its insulin-sensitive pool?
How is GLUT4 mobilised to the plasma membrane in response to insulin?
One of the major problems with the study of insulin-regulated GLUT4 trafficking is that, 
as they are terminally differentiated, insulin-responsive cells are hai'd to work with 
experimentally (Quon et al., 1993). A common approach used to circumvent such a 
problem in cell biology is to use an experimentally tractable eukaryote system, such as the 
budding yeast Saccharomyces cerevisiae (Baker’s yeast) (Broach et al., 1991; Guthrie and 
Fink, 1991). There is a high degree of conservation in some of the major signalling 
pathways and basic cellular processes between S.cerevisiae and mammalian cells (Broach 
et al., 1991; Guthrie and Fink, 1991). This has led to Sxerevisiae becoming a well- 
established and powerful tool that has greatly furthered the knowledge of many aspects of 
cell biology, such as membrane trafficking, cell cycle control, cell signalling and DNA 
repail* (Broach et al., 1991; Guthrie and Fink, 1991). However, given that yeast neither
1
■A
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respond to insulin, nor express GLUT4, it is not immediately apparent how yeast might be 
a good system in which to study the insulin-regulated trafficking of GLUT4.
Despite their lack of insulin-responsiveness, it is clear that yeast do possess a regulated 
membrane trafficking step that bears remarkable similarity to the insulin-regulated 
trafficking of GLUT4, namely the nitrogen-regulated trafficking of the general amino acid 
permease, Gap Ip (Roberg et al., 1997). Gap Ip is retained intracellularly under nutrient- 
rich conditions but when nutrients ar e limited. Gap Ip is trafficked to the plasma 
membrane, where it facilitates the uptake of amino acids from the extracellular media 
(Roberg et al., 1997). Like GLUT4, Gap Ip is predicted to span the membrane twelve 
times (Jauniaux and Grenson, 1990) and interestingly, contains motifs in its cytosolic 
carboxyl terminal tail that are analogous to those required for GLUT4 trafficking (Hein 
and Andre, 1997). Furthermore, when a chimeric protein, in which the carboxyl terminal 
tail of GLUT4 was replaced with the analogous portion of Gap Ip, is expressed in 
adipocytes, it localises to the TGN and translocates to the cell surface in response to 
insulin, similar to endogenous GLUT4 (Nia Bryant and David James; unpublished data; 
Figure 1.6).
To build on these observations, and to assess the suitability of using yeast as a model 
system in the study of the insulin-regulated GLUT4 tiafficking, I expressed human GLUT4 
(hGLUT4) in yeast to further explore the parallels between GLUT4 and Gap Ip regulated 
trafficking. In Chapter 3 ,1 describe how I expressed hGLUT4 in yeast and presented data 
to demonstrate that hGLUT4 traffics in yeast in a nitrogen-regulated manner analogous to 
that observed for Gap Ip.
I used indirect immunofluorescence to demonstmte that, like Gap Ip (Roberg et al., 1997), 
hGLUT4 shows an intracellular' punctate staining, which co-localises significantly with 
Kex2p, a marker of the yeast TGN (Redding et al., 1991; Wilcox and Fuller, 1991; Wilcox 
et al., 1992). This observation is in contrast to previous studies expressing mammalian 
GLUT4 in yeast (Kasahara and Kasahara, 1997; Wieczorke et al., 2003), which reported 
that the transporter localises to the endoplasmic reticulum (ER). This is likely due to the 
high levels of expression used in these studies, as they expressed GLUT4 at very high 
levels fi:om the GALl/10 promoter (Kasahara aud Kasahara, 1997; Wieczorke et al., 2003).
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It is likely that when expressed at such high levels a large proportion of GLUT4 is 
misfolded and therefore fails to exit the ER. In order to produce GLUT4 at more modest 
levels in yeast I used the regulatable CUPl promoter, which allows gene expression to be 
tightly modulated (Mascorro-Gallardo et al., 1996). The colocalisation of GLUT4 with 
Kex2p was encouraging as GLUT4 colocalises with the TGN marker Syntaxinl6 in 
mammalian cells (Figure 5.6) (Shewan et al., 2003).
Kex2p is retained in the yeast TGN by continually cycling through the endocytic system 
(Brickner and Fuller, 1997) and a similar' phenomenon has been described for GLUT4 in 
adipocytes (Shewan et al., 2003). The yeast endocytic system is proteolytically active 
(Bryant and Stevens, 1997) and so my finding that I can only detect hGLUT4 at steady 
state levels in yeast cells devoid of active vacuolar proteases (Figures 3.5 and 3.8) supports 
the immunofluorescence data and indicates that hGLUT4 localises to the yeast TGN by 
continually cycling through the endosomal system.
I
A
Importantly, Chapter 3 demonstrates that hGLUT4 traffics in yeast in a nitrogen-regulated 
manner akin to Gap Ip. When yeast producing hGLUT4 were grown in media containing 
ammonium chloride as the sole nitrogen source (a good source of nitrogen), hGLUT4 was 
directed to the proteolytically active endosomal system and degraded. However, when the : ;
same cells were provided with proline (a poor source of nitrogen) as thek sole nitrogen 
source, hGLUT4 was stabilised, indicating that it had been directed away from the 
endosomal system and therefore not degraded. This mirroring of the niti'ogen-regulated 
trafficking of Gap Ip (Roberg et al., 1997) indicates the two transporters are similarly 
trafficked in yeast, further advances the parallels between GLUT4/Gaplp trafficking, and 
firmly establishes the use of yeast as a suitable model system to study GLUT4 trafficking.
Gaplp moves to plasma membrane in response to limited nutrients (Roberg et al., 1997).
Unfortunately I was unable to assess whether hGLUT4 also traffics to the plasma 
membrane in yeast grown with limited nutrients. With more time, I could have taken a 
number of approaches to address this. I could have used indirect immunofluorescence (or 
a GFP-tagged version of hGLUT4) to localise hGLUT4 in yeast grown in proline- 
containing media. In addition, another approach would be to utilise the hex A yeast strains,
KY73 and RM Yl, which are normally unable to grow on glucose-containing media due to
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the fact that they lack endogenous hexose transporters and instead must be supplied with 
an alternative carbon source (such as maltose). If hGLUT4 does indeed traffic to the 
plasma membrane in response to limited nutrients, it should enable the growth of hex A 
yeast in proline-containing, glucose-containing media.
Nonetheless, the data presented in Chapter 3 clearly demonstrate that hGLUT4 is 
trafficked away from the endosomal system under poor nitrogen conditions, but enters 
proteolytically active compartments when nitrogen is plentiful. The nitrogen-regulated 
trafficking of Gaplp is regulated by the ubiquitination of the transporter, targeting it for 
degradation by active vacuolar proteases as a mechanism to control nitrogen uptake under 
nutrient rich conditions (Hein and Andre, 1997; Helliwell et al., 2001; Springael and 
Andre, 1998; Springael et al., 1999). With this in mind, and noting the similarities that 
exist between Gaplp and GLUT4,1 demonstrated that hGLUT4 was also subject to 
ubiquitination when expressed in yeast.
This was presented in Chapter 4 through a series of immunoprécipitation experiments and 
pull-down assays. The initial indications from these studies point towards hGLUT4 being 
monoubiquitinated, as a prominent immunoreactive band at -'SOkDa detected in both the 
immunoprécipitation experiments and the GST-UBA pull down assays suggest the addition 
of one ubiquitin moiety to the transporter. The modification of a protein by monoubiquitin 
can be a signal for the targeting of transmembrane proteins, from both endocytic and 
biosynthetic pathways, into vesicles budding into the lumen of the multivesicular body 
(MVB), which subsequently fuses with, and consequently delivers its contents to, the 
mammalian lysosome or yeast vacuole (Katzmann et al., 2002).
Having provided evidence that hGLUT4 is ubiquitinated in the yeast model system, and 
having established the suitability of the GST-UBA pull down assay as a technique to 
determine whether a particular protein is ubiquitinated (Figures 4.1, 4.3 and 4.5), I went on 
to use the pull-down approach to demonstrate that endogenous GLUT4 is ubiquitinated in 
the insulin-sensitive, murine cell line 3T3-L1 adipocytes (Figure 4.6). Unfortunately, I 
was not able to definitively ascertain whether the mutant HA-GLUT4-7K/R is, as 
predicted, not ubiquitinated when expressed in adipocytes. This was due to inadequate 
levels of expression from the retrovirus in the cells used for this experiment. With more
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time, I would have optimised this expression either by infecting more adipocytes or 
producing a fresh preparation of virus with a higher titre of infectivity. However, given 
that the 7K/R mutant was not ubiquitinated in yeast, it seems reasonable to assume that it 
will not be in adipocytes either.
I also presented efforts made towards identifying the specific lysine residue(s) in the 
GLUT4 molecule that is (ai'e) ubiquitinated. Frustratingly, these studies were unsuccessful 
at identifying definitive sites of ubiquitination and due to time constraints I was unable to 
explore an alternative approach. One possible avenue that could have been taken to 
address this issue would be to use tandem mass spectrometry (MS/MS) to identify the 
precise site of ubiquitination (Peng et al., 2003). This would require substantial work as I 
would need to optimise conditions to purify sufficient quantities of GLUT4 for these 
experiments, and given that the transporter has 12 transmembrane domains this would be 
no small undertaking. However, establishing that hGLUT4 is ubiquitinated is a very novel 
and exciting finding that has opened up new avenues of research and furthered our 
understanding of the insulin-regulated trafficking of GLUT4.
I
As a first step towards understanding the role of GLUT4 ubiquitination I followed the 
trafficking of the ubiquitination-deficient mutant GLUT4-7K/R, and also a constitutively- 
ubiquitinated GLUT4 fusion protein (GLUT4-7K7R-HAUb) in yeast and in adipocytes 
(Chapter 5). I determined that ubiquitination is both necessary and sufficient to direct 
hGLUT4 to the proteolytically active endosomal system in yeast, and in adipocytes, I 
observed that ubiquitination of GLUT4 is required for its insulin-stimulated translocation 
to the plasma membrane. This observation suggests that ubiquitination is either required 
for the delivery of GLUT4 from GSVs to the cell surface, or into GSVs in the first place. I
■
favour a model in which ubiquitination is requhed for the sorting of GLUT4 into GSVs 
(rather than from GSVs to the cell smface) for the following reasons; firstly, if 
ubiquitination was the insulin-regulated signal that allows GLUT4 to exit from GSVs to 
the cell surface, I would expect to see an increase in the ubiquitination of the transporter in 
response to insulin. This was not observed (Figure 5.5) and instead I detected that GLUT4 
is constitutively ubiquitinated in basal adipocytes (Figures 5.5). In addition, 
immunofluorescence microscopy indicates that wild-type HA-GLUT4 localises, not only 
to the TGN (colocalising with Syntaxinl6), but also to cytosolic puncta, previously
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identified as GSVs (Martin et al., 2000a). The HA-GLUT4-7K/R localised only to the 
TGN with the punctate staining being conspicuously absent.
I had hoped to use the constitutively ubiquitinated version of GLUT4 (GLUT4-7K/R- 
HAUb) to distinguish between the two models proposed above. If ubiquitination is 
required for the delivery of GLUT4 from GSVs to the cell surface, then I would predict 
that this mutant would localise to the cell surface of adipocytes even in the absence of 
insulin-stimulation. If, on the other hand, ubiquitination is required for GLUT4’s delivery 
into GSVs then I would predict that this mutant would behave like wild-type GLUT4, 
requiring insulin-stimulation for translocation to the plasma membrane. Unfortunately, 
this mutant proved hard to characterise in that, when expressed in basal adipocytes it 
showed the same localisation as the ubiquitin-defective HA-GLUT4-7K/R mutant: 
localising to the peri-nuclear TGN region of the cell, but lacking the cytosolic punctate 
staining observed for wild-type HA-GLUT4. No plasma membrane staining was detected 
either in basal adipocytes or following insulin-stimulation (Figures 5.6 and 5.7). It is 
possible that the ubiquitin moeity fused onto GLUT4 is not correctly folded in adipocytes 
and thus GLUT4-7K/R-HAUb behaves like HA-GLUT4-7K/R.
GGA proteins are a family of clathrin adaptors that facilitate protein sorting in the 
TGN/endosomal system (Pelham, 2004). They have been found to play a role in both the 
nih'ogen-regulated trafficking of Gaplp in yeast (Scott et al., 2004) and in the regulated 
trafficking of GLUT4 in insulin-sensitive cells (Li and Kandror, 2005; Watson et al., 
2004b). The ubiquitination of Gaplp, caused when yeast are grown on rich sources of 
nitrogen (e.g. ammonium), regulates its interaction with the yeast GGAs (through the 
ubiquitin-binding GAT domain) (Scott et al., 2004), which deliver Gaplp to the endosomal 
system and divert it away from the plasma membrane (Scott et al., 2004). Under poor 
nitrogen conditions (e.g. proline) however, Gaplp is not ubiquitinated, does not bind 
GGAs, and is therefore trafficked to the cell surface (Soetens et al., 2001). This finding 
provides a link between the ubiquitination of Gaplp under nitrogen-rich conditions and the 
ti'ansporter’s regulated trafficking.
Intriguingly, over-expression of a dominant-interfering GGA mutant (VHS-GAT) in 
adipocytes inhibits the sorting of newly synthesised GLUT4 into an insulin-sensitive pool,
■ "W
f
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but it does not inhibit the movement of GLUT4 from GSVs to the cell surface (Watson et 
al., 2004b). The finding that the ubiquitination-deficient GLUT4 mutant (GLUT4-7K/R) 
displays defective entry into the regulated cell surface recycling pathway could reflect a 
role for GGAs in binding to ubiquitinated GLUT4, a step that would be impaired with the 
GLUT4-7K/R mutant. Indeed, wild-type hGLUT4 was stabilised when expressed in 
mutant yeast cells lacking GGA proteins {ggaA; Figure 5.8), grown under the nitrogen-rich 
conditions that noimally deliver hGLUT4 to the proteolytically active endosomal system 
for degradation (Figure 3.5), thus indicating a requiiement for GGA proteins in this 
trafficking step. The steady-state levels of hGLUT4-7K/R were similar when expressed in 
either wild-type or ggaA cells, and not significantly different to that observed for wild-type 
hGLUT4 in ggaA cells (Figure 5.8). This is consistent with a model in which the 
ubiquitination of hGLUT4 facilitates its tiafficking within the endosomal/TGN system in 
concert with the GGA proteins. By analogy with the regulated trafficking of Gaplp, it is 
tempting speculate that the ubiquitination of GLUT4 might control its association with 
GGA proteins (Scott et al., 2004). However, although GGA2 has been imphcated in the 
sorting of GLUT4 in adipocytes, no direct interaction between GGA2 and GLUT4 has 
been detected (Li and Kandror, 2005). Furthermore, I was unable to demonstrate, by either 
coprecipitating any of the GGA isoforms with GLUT4 or by GST fusion protein pull-down 
assay, any interaction between GLUT4 and any of the GGA isoforms, in yeast, or in 
adipocytes (Figures 5.9, 5.10 and 5.11). However, I am aware that these studies are 
preliminary and require further work for the results to be substantiated.
I
■:î
Ubiquitination has been implicated as a signal in the regulated trafficking of a number of 
other molecules, including MHC class II and aquaporin-2 (Kamsteeg et al., 2006; Shin et 
al., 2006). In these instances, a loss of the ubiquitin modification results in the 
accumulation of the protein at the cell surface, implying a role for ubiquitination in 
controlling endocytosis. Similarly, a loss of the ubiquitin modification of Gaplp results in 
its accumulation at the cell smface (Helliwell et al., 2001; Soetens et al., 2001). Notably 
however, this is not the case for GLUT4, as the ubiquitination-deficient GLUT4-7K/R 
mutant did not accumulate at the cell surface, but rather in the TGN area of adipocytes and 
was rendered insulin insensitive. This is consistent with the model for GLUT4 transport 
proposed in (Bryant et al., 2002), which suggests that GLUT4 is selectively targeted into 
an intr acellular tr ansport loop between endosomes and the TGN and is therefore
A
A44-I
I
Rebecca K McCann, 2007 Chapter Six, 125
;
consequently excluded from the cell-surface recycling pathway. Within this intracellular
transport loop GLUT4 is packaged into insulin responsive GSVs from where it can move
to the cell surface in response to insulin. The lack of insulin responsiveness, and the
absence from peripheral punctate GSV-like structures in adipocytes, of the ubiquitination-
deficient GLUT4-7K/R mutant supports a role for ubiquitination in the trafficking of
GLUT4 from the TGN/endosomal system into GSVs. Overall, this model bears 
.remarkable similarities to that proposed for the sorting of Gaplp in yeast, and the finding 
that certain elements of this regulated pathway can be transfeiTed to GLUT4 represents yet 
another example of the conservation between these essential trafficking pathways and the 
machinery that controls them.
Future Work
This study has been successful in implicating a role for ubiquitination in the insulin- 
regulated trafficking of GLUT4 in adipocytes. This finding has opened up a new area of 
research that can now be directed towards understanding more about this process. Of high 
priority will be to determine precisely which of the 7 cytosolically disposed lysine residues 
are ubiquitinated in adipocytes. In addition, since the E3 ubiquitin ligase is often regarded 
as the key regulatory determinant of the ubiquitination process (Hicke and Dunn, 2003), it 
would be of great interest to identify which ligase transfers the ubiquitin moiety onto 
GLUT4 in adipocytes.
A'
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